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Abstract 
In mammals, runt-related family of transcription factors is encoded by the three distinct 
genes, RUNX1, RUNX2 and RUNX3 that share an evolutionarily conserved 128 amino acid 
Runt domain, which is responsible for the dual function of DNA binding and hetero-
dimerization with the co-factor CBFβ. Gene ablation and gain of function experiments 
established all three proteins as key regulators of lineage-specific gene expression in major 
developmental pathways. Mutations in RUNX genes have been frequently associated with 
human diseases. Despite many studies to unveil mechanisms of RUNX3 action, available data 
is insufficient to fully understand its physiological role, particularly the importance of each 
isoform. We cloned for the first time a variety of transcript variants for both zebrafish runx3 
and cbfβ genes, identified their temporal expression by qPCR and localized runx3 sites of 
expression by in situ hybridization in adult tissues and during early embryonic development. 
As runx3-P1 and runx3-P2 transcripts were found to be differentially expressed, we used a 
promoter in silico comparative approach for both P1 and P2 runx3 gene promoter regions 
and in vitro and in vivo promoter analysis to identify regulatory regions and conserved 
transcription factor binding sites, allowing us to select, from an extensive list of putative 
transcription binding sites, the best candidates to regulate runx3 promoter regions. 
Furthermore, through in vitro analysis, we have examined the possible cross- and auto-
regulation of runx3 promoters by Runx2 and Runx3 isoforms, respectively. In conclusion, we 
have used computational and molecular approaches to improve our understanding of the 
complexity of Runx and Cbfβ variants and their implication for function, using zebrafish as a 
model. Altogether, our structural and functional data provide further support to the 
assumption that the expression of runx3 variants is tightly regulated, leading to a highly 
specific spatial-temporal expression pattern.  
 
Keywords: Runx3, alternative promoters, splicing variants, Cbfβ, transcriptional promoter 
analysis, expression pattern, zebrafish. 
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Resumo 
O termo CBF (“core binding factor”) corresponde a um complexo heterodimérico de factores 
de transcrição, composto por duas subunidades, designadas de subunidade α e β. A 
subunidade α é caracterizada por possuir uma região de 128 aminoácidos no seu N-terminal, 
designada de domínio Runt, que se manteve bastante conservada ao longo da evolução. O 
domínio Runt possui uma dupla função, sendo essencial não só para a ligação da subunidade 
α ao ADN, que reconhece a sequência específica PyGPyGGT (sendo Py uma pirimidina), mas 
também para a heterodimerização com a subunidade β. A subunidade β não possui 
capacidade de ligação ao ADN, mas actua como um co-factor que se liga à subunidade α, 
sendo essencial para aumentar a sua afinidade na ligação às regiões promotoras dos genes 
alvo, e também para a regulação do seu “turnover”, protegendo o complexo da degradação 
mediada por proteossomas via proteínas ubiquitinadas. 
A subunidade α do complex CBF pode ser qualquer uma das três proteínas da família RUNX. 
Os genes RUNX surgiram muito cedo na evolução e mantiveram um elevado grau de 
semelhança nos vertebrados. Os metazoários primitivos, tais como o ouriço-do-mar e C. 
elegans parecem conter apenas um gene da família RUNX, enquanto que, até à data, foram 
já descritos três genes RUNX em mamíferos, quatro em insectos, no fugu e no peixe zebra, 
embora neste último caso seja por possuir dois genes runx2, runx2a e runx2b, para além do 
runx1 e runx3. Os diversos genes runx sugerem a necessidade de uma rigorosa e elaborada 
regulação da actividade das proteínas RUNX ao especificar eventos complexos de 
desenvolvimento em organismos superiores. No entanto, a subunidade β, designada CBFβ, 
parece ser codificada apenas por um gene, excepto no caso dos insectos, em que até à data 
foram descritos dois genes. Os factores de transcrição RUNX têm sido comprovados por 
vários estudos como sendo determinantes na regulação de vários processos biológicos, de 
modo a orquestrar a correcta diferenciação celular durante o desenvolvimento embrionário, 
e são ainda responsáveis por uma diversidade de patologias. 
Todos os membros da família RUNX possuem semelhanças estruturais, no entanto têm sido 
implicados em actividades biológicas distintas. A existência de uma variedade de transcritos 
para todos os membros da família RUNX foi anteriormente descrita. Esta diversidade de 
transcritos deve-se em parte ao facto dos genes Runx serem transcritos através de dois 
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promotores alternativos (P1 e P2), que se encontram separados por vários milhares de pares 
de bases (pb), mas sendo essa diversidade aumentada pelo grande número de “splicing” 
alternativo verificado nesses transcritos, assim como a presença de locais de poliadenilação 
alternativos. Cada gene Runx codifica para duas isoformas proteicas principais, que diferem 
na sua sequência N-terminal, dependendo se são codificadas a partir de transcritos 
derivados do promotor P1 ou do promotor P2. As proteínas que são geradas a partir de 
transcritos derivados do promotor P2 contêm uma sequência de cinco aminoácidos 
específicos no seu N-terminal – o pentapeptídeo M(R/H)IPV. Por sua vez, as proteínas que 
são geradas a partir de transcritos derivados do promotor P1 contêm uma sequência de 19 
aminoácidos específicos no seu N-terminal, originados por “splicing” alternativo do exão 1 
para um local the “splicing” conservado no exão 2, localizado 16 pb a montante do codão de 
iniciação (ATG) do transcrito P2. Estas duas isoformas são geralmente designadas como 
isoforma RUNX3-MA(S/D)NS e isoforma RUNX3-M(R/H)IPV, dependendo se são traduzidas 
de transcritos derivados do promotor P1 ou P2, respectivamente. Em termos de estrutura 
proteica, todos os membros da família RUNX possuem os mesmos domínios e motivos 
característicos: domínio Runt (RD), domínio de transactivação (TAD), domínio de inibição 
(ID), sinal de localização nuclear (NLS), motivo PY (ou PPxY) e o motivo VWRPY, que 
corresponde aos últimos cinco aminoácidos do C-terminal. A proteína RUNX2 apresenta 
ainda um domínio extra, apenas observado neste membro da família, o domínio QA, que é 
composto por um fragmento de resíduos Q e A. 
Embora as proteínas RUNX sejam tradicionalmente descritas como sendo factores de 
transcrição, que podem actuar como homodímeros ou heterodímeros na ligação ao 
promotor dos genes alvo, foram reconhecidas mais recentemente como sendo moléculas 
multifacetadas que se podem associar com uma extensa variedade de proteínas, 
dependente do contexto celular. O resultado final da regulação da transcrição de 
determinado gene alvo parece ser afectado pela interação entre as proteínas RUNX e co-
factores específicos de cada ambiente celular, dependendo da aproximação do local de 
ligação entre os factores ou da sua disponibilidade no núcleo. É evidente que cada uma das 
três proteínas RUNX tem funções diferentes, mas o facto de por vezes serem co-expressas 
no mesmo tecido indica que algumas dessas funções poderão actuar sinergisticamente ou 
corresponder a funções complementares que actuam em diferentes etapas temporais. 
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Enquanto o RUNX1 tem sido repetidamente comprovado como sendo um dos alvos mais 
frequentes de alterações genéticas associadas à leucemia, o RUNX2 é descrito como 
indispensável na formação normal do osso e na diferenciação de osteoblastos, sendo 
fundamental no desenvolvimento do esqueleto em mamíferos. O RUNX3, por sua vez, é 
essencial para a regulação de um tipo celular específico de neurónios proprioceptivos TrkC+ 
nos gânglios das raízes nervosas dorsais (“dorsal root ganglia”, DRGs) e para a maturação 
dos condrócitos durante a esqueletogénese. Está ainda envolvido na regulação da 
proliferação e da sobrevivência de vários tipos celulares, incluindo células epiteliais gástricas, 
desenvolvimento das células T e diferenciação de células imunes, incluindo as células 
“natural killer”, células dendríticas e células B.  
Dos três genes que pertencem à família dos factores de transcrição RUNX, o RUNX3 é o mais 
pequeno em termos de sequência nucleotídica e o que apresenta menor número de exões. 
No entando, a proteína apresenta todos os domínios característicos dos membros desta 
família. Estudos filogenéticos usando sequências dos vários Runxs de uma diversidade de 
espécies indicam que a evolução destes genes foi possivelmente originada a partir de um 
gene runx3 em invertebrados progredindo para a existência de múltiplos genes em espécies 
superiores. Embora o RUNX3 esteja predominantemente localizado no núcleo, onde exerce 
a sua função como factor de transcrição, a sua localização foi também observada no 
citoplasma em diferentes células cancerígenas, evidenciando a importância da localização 
celular das proteínas RUNX no exercício da sua função. O RUNX3 é expresso numa variedade 
de tecidos, incluindo tecidos moles e cartilagíneos. A análise da expressão em termos de 
cada variante mostrou que diferentes transcritos do RUNX3 são expressos de modo distinto 
nos vários tecidos; os mesmos autores mostraram ainda que os transcritos do RUNX3 são co-
expressos em alguns tecidos, juntamente com os transcritos dos outros membros da família 
RUNX. Apesar de nos últimos anos ter sido publicado um grande número de artigos focando 
o estudo do RUNX3 em diferentes aspectos da sua função, a informação recolhida continua 
a não ser suficiente para descrever exactamente quais os seus mecanismos de acção e qual a 
sua importância para o desenvolvimento, nomeadamente no que diz respeito à função de 
cada uma das múltiplas isoformas existentes para todas as proteínas desta família.  
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O peixe zebra foi escolhido como modelo de estudo para a realização deste projecto. 
Considera-se que os peixes teleósteos, grupo ao qual pertence o peixe zebra, tenham sido o 
primeiro grupo a desenvolver um esqueleto ósseo e, simultaneamente, toda a maquinaria 
necessária para a sua formação e manutenção. A combinação da genética e da embriologia 
estabeleceu o peixe zebra como sendo um organismo modelo importante para análises de 
desenvolvimento, fisiologia e comportamento em vertebrados. O desenvolvimento de 
técnicas especiais de clonagem, mutagénese e transgénese permitiu a identificação de um 
número importante de mutantes nesta espécie. A compreensão da inter-relação entre os 
genomas do peixe zebra e humano poderá ajudar na identificação da função de genes 
humanos a partir de mutações existentes nos genes correspondentes (ortólogos) do peixe 
zebra, tornando-o um bom modelo de estudo para certas doenças bem como para testes 
que resultem na identificação de novos agentes terapêuticos. Outras das vantagens da 
utilização deste modelo são, por exemplo, o seu desenvolvimento externo, a possibilidade 
de análise in vivo do desenvolvimento devido à transparência dos embriões, uma prole 
numerosa (200-300 ovos por fêmea) e um desenvolvimento rápido (em 48 a 72 horas evolui 
do estado de zigótico para larva e torna-se adulto aos 3 meses de vida) são atributos que 
favorecem a utilização deste modelo na investigação de inúmeras doenças humanas. 
Para melhor conhecer e caracterizar as funções do gene runx3, a primeira etapa deste 
trabalho foi a clonagem, em peixe zebra, dos diferentes transcritos derivados de cada um 
dos promotores, P1 e P2, e a utilização dessas sequências para a realização de uma análise 
genómica comparativa. O resultado do alinhamento múltiplo entre as proteínas RUNX3 de 
várias espécies revelou que o domínio Runt, constituído por 128 aminoácidos, descrito como 
essencial para a dupla função de ligação ao ADN nas regiões reguladoras dos genes alvo e de 
heterodimerização com o co-factor CBFβ, evidencia um elevado grau de conservação ao 
longo da evolução das espécies. Verificou-se também que os restantes domínios da proteína 
são igualmente conservados entre as várias espécies analisadas. 
Durante a clonagem dos diferentes transcritos, derivados do promotor P1 e do promotor P2 
do gene runx3, foram obtidas dez novas variantes, aqui descritas pela primeira vez, estando 
de acordo com o previamente descrito para os outros genes desta família, para os quais 
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diversas variantes foram também identificadas, algumas com um papel fundamental na sua 
regulação.  
O padrão de expressão do gene runx3 foi determinado pela análise da expressão temporal 
específica dos transcritos derivados dos promotores P1 e P2, por hibridação in situ e por PCR 
quantitativo (qPCR), ao longo dos estadios de desenvolvimento embrionário e larvar e em 
tecidos do animal adulto. Os resultados da análise de qPCR demonstram que, embora os 
transcritos do runx3 derivados dos promotores P1 e P2 sejam expressos numa variedade de 
tecidos, incluindo tecidos moles e tecidos mineralizados, e também nos diversos estadios 
embrionários e larvares testados, estes apresentam um padrão de expressão diferente. 
Enquanto os transcritos derivados do promotor P2 foram detectados em todos os tecidos 
estudados, no caso dos transcritos derivados do promotor P1 não se detectou expressão, ou 
a expressão relativa foi muito baixa em alguns tecidos não cartilagíneos. No entanto, para 
ambos os transcritos, os valores relativos de expressão foram mais acentuados nos tecídos 
cartilagíneos. É Interessante notar que os transcritos derivados do promotor P1 são 
expressos em estadios anteriores ao início da expressão zigótica, indicando a sua herança 
maternal, contrariamente aos derivados do promotor P2 que não foram detectados nestes 
estadios. Pela análise dos resultados da hibridação in situ usando uma sonda de ARN que 
reconhece uma região comum a ambos os transcritos, a expressão do runx3 foi determinada 
nos gânglios trigerminais, neurónios sensoriais designados “Rohon-Beards” e em tecidos 
cartilagíneos craniofaciais. Usando uma sonda específica para os transcriptos do promotor 
P2, observou-se que a expressão coincide com a expressão observada quando uma sonda 
que detecta a região comum do runx3 foi utilizada. No entanto, utilizando uma sonda 
específica para os transcritos derivados do promotor P1 não foi possível identificar qualquer 
sinal específico, provavelmente devido à sensibilidade do método utilizado.  
As regiões reguladoras P1 e P2 do runx3 permanecem até ao momento pouco estudadas, e 
portanto a regulação deste gene constitui ainda um tema de estudo em aberto e de 
importante significado. Fragmentos das regiões promotoras P1 e P2 do runx3 de peixe zebra 
foram identificados e clonados, sendo depois sujeitos a uma análise comparativa in silico 
para identificação de possíveis motivos de ligação a factores de transcrição reguladores. 
Ambos os fragmentos dos promotores P1 e P2 analisados foram capazes de mediar a 
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transcrição da luciferase, usada como gene repórter, tanto in vitro em linhas celulares ósseas 
e não-ósseas, como in vivo em embriões de peixe zebra, verificando-se que ambos os 
promotores são activos nas condições testadas. Posteriormente, delecções de ambos os 
fragmentos foram testadas nas diferentes linhas celulares, permitindo a identificação de 
regiões reguladoras positivas e negativas em ambos os promotores do runx3, assim como a 
identificação de potenciais motivos de ligação a factores de transcrição reguladores nessas 
regiões, anteriormente determinados na nossa análise in silico.  
Sabendo que o CBFβ é um co-factor que se liga ao domínio Runt de todos os membros da 
família RUNX, formando um heterodímero com maior afinidade de ligação ao ADN, 
decidimos amplificar o transcrito que codifica para esta proteína, para posteriormente 
introduzir num vector de expressão, de modo a testar a sua actividade em ensaios de 
transfecção. No decorrer dessa tarefa, 10 novas variantes, geradas por “splicing” alternativo, 
foram obtidas e analisadas em termos da sequência por comparação com variantes do CBFβ 
descritas noutras espécies. Após a análise de todas as variantes, quatro destas isoformas 
(isoformas 1-4) foram escolhidas como potencialmente interessantes para a análise da sua 
actividade in vitro. As isoformas 1 e 3 possuem uma região C-terminal distinta enquanto as 
isoformas 2 e 4 correspondem a variantes das isoformas 1 e 3, respectivamente. Para testar 
a capacidade de ligação e indução de cada uma dessas isoformas, foi usado um fragmento 
do ColXα1 previamente descrito como sendo regulado pela isoforma MASN-Runx2. Os 
resultados obtidos mostram que as isoformas 1 e 2 do Cbfβ possuem uma maior capacidade 
de indução do promotor do ColXα1 pela isoforma MASN-Runx2, comparado com o efeito 
observado pelas isoformas 3 e 4. 
Foi ainda testada a hipótese do runx3 ser regulado pelo Runx2 ou por si próprio (auto-
regulação). Para isso, analisou-ses o efeito das isoformas do Runx2 e do Runx3, na presença 
ou ausência do CBFβ, na regulação dos promotores P1 e P2 do gene runx3. Os resultados 
preliminares obtidos indicam a existência de um efeito na regulação dos promotores do 
runx3 pelas isoformas do Runx2 e do Runx3, na presença e na ausência da isoforma do Cbfβ 
testada, dependendo do promotor e das isoformas co-transfectadas. No entanto estes 
resultados precisam ainda de ser confirmados. 
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Por fim, foi testada a capacidade de cada um dos fragmentos dos promotores P1 e P2 do 
runx3 reproduzir a expressão endógena em linhas trangénicas de peixe zebra. Para isso, 
foram construídos dois plasmídeos (Runx3-P1:GFP e Runx3-P2:GFP) contendo a sequência 
que codifica para a GFP (“green fluorescent protein”) sob o controlo de cada um dos 
fragmentos do promotor do runx3 a analisar. Estas construções foram injectadas em 
embriões de peixe zebra no estadio embrionário de 1 célula e a expressão da GFP analisada  
in vivo durante os estadios iniciais do desenvolvimento. Embora apenas se tenham analisado 
estes resultados transientemente, uma vez que no decorrer deste trabalho não se chegou a 
identificar nenhum portador do transgene, observou-se que nos peixes injectados com a 
contrução Runx3-P1:GFP a expressão da GFP foi muito reduzida, em contraste com a 
expressão observada nos embriões injectados com a contrução Runx3-P2:GFP, em que parte 
da expressão endógena do runx3 obtida por análise de hibridação in situ foi reproduzida.  
Com este trabalho pretendeu-se estudar a regulação do gene runx3 de peixe zebra e a 
importância das suas diferentes isoformas para a respectiva função. Foram determinados 
padrões de expressão das isoformas do runx3 tanto nos estadios iniciais de 
desenvolvimento, como em vários tecidos adultos, observando-se que as isoformas são 
diferencialmente expressas dependendo se derivam do promotor P1 ou promotor P2. Foi 
ainda realizada uma extensa análise das regiões reguladores dos promotores P1 e P2 do 
runx3, in silico, in vitro and in vivo, permitindo a identificação das regiões reponsáveis pela 
sua actividade basal, assim como a identificação de potenciais regiões reguladoras deste 
gene, tanto positivas como negativas, e a identificação de potenciais motivos de ligação de 
factores de transcrição que possam ser responsáveis pela regulação dessas regiões. 
 
Palavras-chave: Runx3, promotores alternativos, análise da regulação de promotores, 
“splicing” alternativo, Cbfβ, padrões de expressão, peixe zebra. 
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Abreviations & Acronyms 
 
aa amino acid 
 AML acute myeloid leukemia 
bp base pair 
Co-IP Co-immunoprecipitation 
CBFα  core binding factor alpha 
cDNA complementary DNA 
DBA DNA block aligner 
DMEM Dulbecco’s modified eagle’s medium 
DNA deoxyribonucleic acid 
dNTP  deoxyribonucleotide triphosphate   
dpf days post-fertilization 
DRG dorsal root ganglion  
EDTA ethylenediaminotetracetate 
FBS fetal bovine serum 
hpf hours post-fertilization 
ISH in situ hybridization 
kb kilobase pairs 
kDa kilodaltons 
mRNA messenger RNA 
MW molecular weight 
ORF open reading frame 
OSF2 osteoblast-specific factor 2 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PEBP polyomavirus enhancer-binding protein 
PWM position weight matrices 
qPCR quantitative real-time PCR 
RNA ribonucleic acid 
RUNX runt homology domain transcription factor 
Taq  Thermus aquaticus DNA polymerase  
TFBS transcription factor binding site 
TFs transcription factors 
TSS transcription start site 
uATG upstream ATG 
uORF upstream ORF 
UTR untranslated region 
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1.1 Transcription in Eukaryotes - the first step in gene expression 
The completion of “The Human Genome Project” in 2003 has revealed that the human 
genome encodes between 20.000 and 25.000 protein-coding genes, a number much lower 
than the initially predicted. The protein-coding sequences correspond to just 1.5% of the 
human genome, so all the remaining 98.5% correspond to non-coding DNA sequences. 
One fundamental point in Biology is to understand how the different cell types are specified 
in a multicellular organism. In order to our bodies to be formed from a unique cell and 
develop into a broad range of very diverse cell types, sharing the same genetic information, 
there has to be a complex mechanism for controlling gene expression in a very precise way. 
In some cells, certain genes are “turned off” while in other cells they are “turned on” in order 
to be transcribed and translated into proteins. Eukaryotes have developed diverse chemical 
and physical mechanisms including chromatin condensation, DNA methylation, 
transcriptional initiation, alternative splicing of RNA and mRNA stability to control gene 
expression. Failure to do so can lead to dire consequences, so a tight controlled gene 
expression is essential to insure that the right gene is activated in the right cell at the right 
time during the development (Lodish et al, 2000).  
One of the most important and highly regulated gene expression processes is the 
transcription of the DNA template to generate a RNA molecule. There are different elements 
in the transcription-control regions of the gene that regulate the transcription. In 
eukaryotes, transcription is carried out by three nuclear RNA polymerases (Patikoglou and 
Burley, 1997), RNA Polymerase I, II, and III, that transcribe different classes of genes. RNA 
polymerase I transcribes rRNA (ribosomal RNA), RNA polymerase II transcribes mRNA 
(messenger RNA), microRNAs and most snRNAs (small nuclear RNAs), and RNA polymerase 
III transcribes tRNA (transfer RNA), rRNA 5S and other small RNAs (Carter and Drouin, 2009). 
The vast majority of the genes in eukaryotic genomes encode functional proteins and 
contain a promoter region upstream from the gene, with certain specific motifs (nucleotide 
sequences) that recruit RNA Polymerase II (Zwan et al, 2003). The promoter region usually 
contains a highly conserved sequence called the TATA box (frequently at ≈25-35 base pairs 
upstream from the transcription start site) or an alternative promoter element called 
initiator that, unlike the TATA box, has an extremely degenerated consensus sequence 
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(Lodish et al, 2000). However, in some cases, genes do not contain a TATA box or an initiator 
but may contain a GC-rich sequence (20-50 nucleotides within ≈100 base pairs upstream of 
the transcription start site). The TATA-binding protein (TBP) initiates the formation of the 
basal transcription complex along with multiple TBP-associated proteins and multiple 
additional general transcription factors. Thus, TBP together with its TBP-associated proteins 
was originally identified as a fraction called TFIID and this group of proteins is required to 
build a basal transcription complex from TATA-containing or TATA-less promoters (Pugh and 
Tjian, 1991). The transcription by RNA polymerase II can be regulated by activators or 
repressors, called transcription factors (TFs) that bind to promoter elements and enhancers. 
These functional regulatory elements are generally found within several hundred bases of 
the transcription start site of the gene to which they are linked, but they can occasionally be 
located tens of kilobases upstream or downstream from a promoter, within an intron, or 
downstream from the final exon of a gene (Lodish et al, 2000; Fickett and Wasserman, 
2000). The fundamental logic of transcriptional regulation in eukaryotes is that it is 
combinatorial: each gene has a particular combination of regulatory elements, where the 
nature, number, and spatial arrangement of which determine the gene unique pattern of 
expression. These promoter or enhancer elements control in which cell types the gene is 
expressed, the times during development in which it is expressed, and the level at which it is 
expressed in adults (Collingwood et al, 1999). 
 
1.2 Transcription Factors 
In eukaryotes, genes are usually in a default "off" state, so TFs serve mainly to turn gene 
expression "on". The TFs can bind alone or attract other TFs creating a complex that can 
either facilitate or repress the binding by RNA polymerase II to specific target genes, thus 
beginning or shutting the process of transcription (Roeder, 1996; Lee and Young, 2000; 
Levine and Tjian, 2003) (Figure 1.1). Because TFs are crucial to the regulation of gene 
expression, understanding their action of mechanisms is a major area of ongoing research in 
cell and molecular biology.  
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Figure 1.1 Complex metazoan transcriptional control modules. A complex arrangement of 
multiple clustered enhancer modules interspersed with silencer and insulator elements 
which can be located 10-50 kilobases (kb) either upstream or downstream of a composite 
core promoter containing TATA box (TATA), Initiator sequences (INR), and downstream 
promoter elements (DPE). Figure adapted from Levine and Tjian, 2003. 
 
The control of gene expression in mammalian cells requires interactions among many 
combinations of transcription regulatory proteins (reviewed in Levine and Tjian, 2003). 
These interactions must be both versatile to enable individual TFs to interact with a variety 
of structurally unrelated proteins, as well as selective to enable different members of the 
same transcription factor family to have differential effects on gene expression (Hu et al, 
2002). 
 
1.3 The core binding factor (CBF) transcription complex 
The core binding factor (CBF) is a heterodimeric transcription factor composed by two 
subunits, an α-subunit and a β-subunit. The α-subunit is characterized by containing a 
heterodimerization domain, responsible for the binding to the DNA as well as binding to the 
β-subunit (Kanno et al, 1998). The β-subunit does not bind the DNA itself, but acts as a co-
factor, increasing the affinity of the α-subunit to the DNA of the target genes (Hart and 
Foroni, 2002).  
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1.4 The β-subunit of the CBF complex – CBFβ protein 
CBFβ is the non-DNA binding subunit of the heterodimeric core binding factor (CBF). It is 
able to dimerize with its DNA-binding subunit, the product of each of the three identified 
RUNX genes, mediating a variety of biological responses according to the RUNX protein (1, 2 
or 3) associated into the complex (Lund and van Lohuizen, 2002). One model for CBFβ 
function is that this protein helps to stabilize a conformation of the runt domain that has the 
highest affinity for DNA. CBFβ may have developmental and clinical significance beyond its 
association with the runt domain. Furthermore, the CBFβ protein is more widely distributed 
than either the mammalian runt domain proteins that have been identified (Ogawa et al, 
1993; Wang et al, 1993). This suggests that CBFβ may participate in a wide variety of 
developmental pathways, possibly by interacting with other types of DNA-binding proteins 
(Kagoshima et al, 1993).  
 
1.5 The α-subunit of the CBF complex - runx transcription factors 
The α-subunit of the CBF complex corresponds to the runt-related transcription factors 
(RUNX) that comprise a small family of transcription factors identiﬁed by their highly 
conserved DNA binding domain, designated the runt domain. The first characterized 
member of this family was the Drosophila regulatory gene runt, discovered in a genetic 
screen (Nüsslein-Volhard and Wieschaus, 1980) and named for its mutant phenotype, which 
reflects its role as a “primary pair rule” gene in establishing the pattern of segments in the 
embryo (Gergen and Butler, 1988). Subsequently, the gene was found to have additional 
genetic functions in Drosophila, being implicated in sex determination and neurogenesis 
(Duffy and Gergen, 1991; Duffy et al, 1991). Due to its localization in the nucleus, it was 
predicted that the RUNX protein product could act as a transcription factor regulating the 
transcription of other genes (Kania et al, 1990). Some years later, a second Drosophila runt-
related gene, lozenge, was identified, and shown to be required in cell patterning in the eye 
and developing antenna, as well as in cell fate specification during hematopoiesis (Gupta and 
Rodrigues, 1995; Daga et al, 1996; Flores et al, 1998; Canon and Banerjee, 2000; Bataillé et 
al, 2005). More recently, a Drosophila genome project revealed two additional runt-related 
Chapter 1 
10 
 
genes, CG42267 and CG34145 (Rennert et al, 2003; Bao and Friedrich, 2008), being 
described so far four runx genes in Drosophila. 
Given the importance of RUNX genes, which play vital roles in the development of various 
species and human diseases, in the last years a large number of groups have focus their 
research in characterizing orthologues of RUNX genes from phylogenetically diverse species, 
trying to achieve a better understanding of their origin and functions. The evolution of RUNX 
genes begins with one more similar to runx3 in invertebrates and then progress to multiple 
RUNX genes in higher species (Cohen, 2009). While primitive metazoans such as sea urchin 
and C. elegans appear to possess a single RUNX family member, so far, three have been 
described in mammals and four in insects, zebrafish and fugu. This can indicate (i) 
evolutionary conserved roles in metazoans and (ii) the necessity for a tight regulation of 
RUNX activity in specifying complex developmental events in higher organisms (Chuang et al, 
2013).  
RUNX proteins are crucial transcription factors that regulate a wide range of biological 
processes to orchestrate proper cell fate determination during the development of 
metazoans (Coffman, 2003). Traditionally described as a DNA-binding protein, RUNX is now 
viewed as a multifaceted protein that associates with diverse proteins to direct biological 
outcomes in a context-dependent manner (Figure 1.2) (Blyth et al, 2005; Chuang et al, 
2013).  
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Figure 1.2 RUNX/CBFβ complexes in the determination of cell fate. This diagram illustrates 
the central role of RUNX/CBFβ complexes in the orchestration of cell fate in response to 
exogenous factors and environmental signals (circles in the left side). A subset of the known 
RUNX target genes is depicted (grey boxes), and these targets have been selected for their 
potential relevance to cancer. Figure adapted from Blyth et al, 2005. 
 
1.6 Runx Aliases - Nomenclature for runt-related (RUNX) proteins 
Since the first runt-related gene has been cloned and studied in Drosophila, there was an 
explosion in the number of independent laboratories focusing their studies in this family of 
transcription factors. So, in the literature, a diversity of family names can be found for these 
genes (Table 1.1 and 1.2) depending on the context of their study (van Wijnen et al, 2004). 
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Table 1.1 – Aliases for the runt-domain class of transcription factors.  
 
Table adapted from (van Wijnen et al, 2004). 
 
Table 1.2 - Common synonyms for each Runx protein.  
 
Table adapted from (http://www.genecards.org/) 
 
Due to the existence of a wild diversity of names for the runt-related family of transcription 
factors, it was difficult to find in the literature all the references existing for this subject. So, 
in 1999, the Nomenclature Committee of the Human Genome Organization (HUGO) adopted 
 
Abbreviation Gene Name Specie described 
Runt  Runt  Drosophila 
Lz Lozenge  Drosophila 
AML Acute myelogenous leukemia Human 
PEBP2alpha Polyomavirus enhancer-binding protein 2 
alpha subunit 
Mouse 
CBFalpha Enhancer core-binding factor α of murine 
leukemia viruses ( i.e SL3-3, AKV and 
Moloney MLV) 
Mouse 
PEA2 Polyoma enhancer A-binding factor 2 Mouse 
SEF1 SL3-3 enhancer factor 1 Mouse 
S/A-CBF SL3-3 and AKV core-binding factor Mouse 
NF-deltaE3A Nuclear factor delta E3A Human 
MyNF1 Myeloid nuclear factor 1 Mouse 
NMP2 Nuclear matrix protein 2 Rat 
OBSC Osteoblast-specific complex  Rat 
OSF2  Osteoblast-specific factor 2 Mouse 
til-1 T-cell tumor integration locus 1 protein Mouse 
run Runt domain-encoding gene Caenorhabditis elegans 
Runt-Related 
Transcription Factor 
1 
RUNX1; AML1; CBFα2; CBFA2; PEBP2αB; PEBP2A2; PEA2αB; 
SL3-3 enhancer factor 1αB subunit; Oncogene AML1; SL3/AKV 
core binding factor αB subunit; AML1-EVI-1; AMLCR1; EVI-1 
Runt-Related 
Transcription Factor 
2 
RUNX2; AML3; CBFα1; CBFA1; PEBP2αA; PEBP2A1; PEA2αA; 
SL3-3 Enhancer Factor 1αA Subunit; Oncogene AML3; SL3/AKV 
core-binding factor αA Subunit; Osteoblast-specific 
transcription factor 2 (OSF-2); CCD 
Runt-Related 
Transcription Factor 
3 
RUNX3; AML2; CBFα3; CBFA3; PEBP2αC; PEBP2A3; PEA2αC; 
SL3-3 Enhancer Factor 1αC Subunit; Oncogene AML2; SL3/AKV 
Core-Binding Factor αC Subunit 
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the use of the term ‘RUNX’ to refer to genes encoding the runt-related proteins. It was 
agreed by the investigators of this field, that any designations can be used to refer to the 
runt-related proteins, but they should be referred as RUNX proteins at least once in the 
Abstract and/or Title of new manuscripts submitted for publication (van Wijnen et al, 2004).  
 
1.7 RUNX gene and protein structures 
There are three RUNX genes described in mammals and all RUNX gene products share many 
structural similarities, but have distinct biological activities. A variety of transcripts have 
been described for all RUNX members, originated from the regulation of transcription from 
two alternative and distantly located promoters (P1 and P2), due to a high number of 
alternative splicing events and the presence of alternative polyadenylation (Miyoshi et al, 
1995; Ahn et al, 1996; Levanon et al, 1996; Geoffroy et al, 1998). The RUNX gene structure is 
well conserved among all vertebrate species analysed (Figure 1.3) (Levanon and Groner, 
2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Phylogenetic illustration of RUNX genes showing the gene number and promoter 
usage in different species. The three lower non-designated branches in the phylogenetic tree 
represent the animal groups (from bottom up) sponges, cnidarians (e.g. jellyﬁsh) and 
acoelomates (e.g. ﬂatworms). The more primitive animals contain one gene regulated by the 
P2 promoter. Figure adapted from Levanon and Groner, 2004. 
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There are two major protein isoforms for each RUNX gene, with a different N-terminal 
sequence depending if it is encoded from the P1-derived or from the P2-derived transcript. 
The gene structure of the three human RUNX genes is represented in Figure 1.4. 
 
Figure 1.4 Genomic organization of the human RUNX genes. The two promoters P1 and P2 
and initiator codons (ATG) are indicated. The P1-derived and P2-derived 5’ UTRs are 
indicated in light and dark grey, respectively, common coding exons are shown in similar 
color and 3’ UTRs are represented in blue. Figure adapted from Levanon and Groner, 2004. 
 
The RUNX proteins that originate from the P2-derived transcripts contain a specific 
N-terminal region of five amino acids – the penta-peptide MRIPV. On the other hand, the 
RUNX isoforms that originate from the P1-derived transcripts contain a specific N-terminal 
region of 19 amino acids, originated by an alternative splicing from exon 1 onto the coding 
region of P2-derived transcript through a conserved in-exon splicing site located 16 bp 
downstream of the P2-ATG codon. This 19 amino acids long specific N-terminal is conserved 
in all P1-derived RUNX proteins, with the highest sequence similarity found between RUNX1 
and RUNX3 (Bangsow et al, 2001). The isoforms are usually designated as isoform 
RUNX3-MA(S/D)NS and RUNX3-M(R/H)IPV, depending if they are encoded from the 
P1-derived or P2-derived transcripts, respectively. 
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1.8 Functional domains of RUNX proteins 
Ito (2004) and, more recently, another report from the same group (Chuang et al, 2013), 
have described the common structure of the RUNX proteins by comparison of the amino 
acid sequences from the three RUNX proteins. They confirmed that all RUNX proteins share 
the same characteristic domains and motifs: runt domain (RD), transactivation domain 
(TAD), inhibitory domain (ID), nuclear localization signal (NLS), PY (or PPxY) motif and the 
VWRPY motif that corresponds to the last five amino acids of the RUNX proteins (Figure 1.5). 
RUNX2 possesses a unique QA domain composed of a stretch of Q and A residues (Ito and 
Miyazono, 2003). The N-terminal part of the molecules comprises the RD, a 128 amino acids 
long domain that is highly conserved between species and has an S-type immunoglobulin 
fold (Warren et al, 2000). The C-terminal part of the RUNX molecule contains the other 
domains (TAD and ID) that play a role in transcription regulation (reviewed in Downing, 
1999; Ito, 1999), and a conserved PY motif, consisting of is a proline-rich peptide, that 
interacts with proteins harbouring the WW domain (Chuang et al, 2013) and a VWRPY motif 
at the end of the C-terminus of RUNX proteins, which mediate the interaction with the co-
repressor Groucho/TLE (Liu et al, 2006; reviewed in Cohen, 2009) (Figure 1.5). 
 
Figure 1.5 Schematic representation of functional domains of RUNX3 protein and examples 
of its interacting proteins. The domains represented are conserved among all RUNX proteins. 
The numbers indicate amino acid positions. TAD, ID, C-term and NLS refer to transactivation 
domain, inhibitory domain, C-terminus and nuclear localization signal, respectively. Figure 
adapted from Chuang et al, 2013. 
 
Traditionally described as a DNA-binding protein that can act as a homodimer or 
heterodimer (with its partner CBFβ) to bind to the promoter of the target genes, RUNX is 
now viewed as a multifaceted protein that associates with a wide variety of proteins to 
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direct biological outcomes in a context-dependent manner. Those proteins can either be 
co-activators or repressors. Examples of some co-factors previously described to interact 
with RUNX proteins (Blyth et al, 2005; Chuang et al, 2013) are represented in Figures 1.5 and 
1.6.  
 
Figure 1.6 Schematic representation of the RUNX factors as organizers of transcription. 
RUNX factors bind to their consensus sequence (PyGPyGGTPy) in the promoter region of the 
target genes as a heterodimer with their binding partner CBFβ. A complex including other 
co-factors is generally formed, determining the outcome of the RUNX regulation on 
transcription of the target genes. CBFβ, core-binding factor-β; C/EBP, CCAAT/enhancer-
binding protein; HDACs, histone deacytylases; nCoR, nuclear receptor corepressor; TLE, 
transducin-like enhancer of split. Figure adapted from Blyth et al, 2005. 
 
The factors affecting the outcome of this interaction on transcription of the target gene 
seem to involve promoter-specific features such as the proximity of binding sites for 
co-activators or repressors as well as the availability of such cofactors in the nucleus. 
 
1.9 Runt domain characteristics 
All RUNX proteins have the characteristic runt domain that is known to have the dual 
function to bind to the promoter of target genes and also to bind to CBFβ protein forming 
the CBFα/β complex. This complex increases allosterically the DNA-binding affinity (Ogawa 
et al, 1993; Miller et al, 2002) and regulates the RUNX proteins turnover by protecting them 
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from ubiquitin-proteasome-mediated degradation (Huang et al, 2001). All RUNX proteins 
heterodimerize with CBFβ and all bind to the same consensus recognition sequence 
(5'-PyGPyGGT-3') (Py is any pyrimidine) found in a number of enhancers and promoters. The 
biological activity of the CBF complex is specified by the α-subunit according to the RUNX 
protein (1, 2 or 3) associated into the complex (Tahirov et al, 2001; Bäckström et al, 2002; 
Lund and van Lohuizen, 2002; Horsfield et al, 2007). The degree of homology between 
invertebrate and vertebrate runt domains is quite high, and this may reflect the 
conservation of dual functions within that domain, as described above.  
There are two types of heterodimeric factors either (i) both subunits bind to specific DNA 
sequences (e.g. Jun/Fos and Myc/Max) or (ii) one subunit binds to DNA and one does not 
(e.g. RUNX/CBFβ). The molecular mechanisms of the DNA binding for the first type of 
heterodimeric factors was already described (Glover and Harrison, 1995), but for the second 
type it is still not well understood how non-DNA binding subunit contribute to DNA binding 
and whether the mechanism by which a non DNA binding subunit stimulates DNA binding is 
shared with different transcription factors (Tahirov et al, 2001).  
Due to the important function of the heterodimeric RUNX/CBFβ complex in different 
developmental processes, regulating different promoters and enhancers of a variety of 
genes in a cell specific manner, different groups have used X-ray crystallography and nuclear 
magnetic resonance (NMR) to determine the tertiary structures of the runt domain and the 
runt/CBFβ heterodimeric complex, and the molecular mechanisms of their interaction 
(Nagata et al, 1999; Tahirov et al, 2001; Bravo et al, 2001; Bäckström et al, 2002). These 
studies revealed that the runt domain adopts the immunoglobulin (Ig)-like fold β-sandwich, 
which is homologous to other DNA-binding domains such as those found in p53, nuclear 
factor-kappa B (NF-kB), nuclear factor of activated T cells (NFAT) and other proteins (Nomura 
et al, 2013).  
Determination of the tertiary structures together with mutational analysis was crucial to the 
identification of regions that are essential to the binding affinity between the runt domain 
and the DNA consensus recognition sequence. One example was the recent identification of 
the three guanines in the DNA consensus recognition sequence (5'-PyGPyGGT-3'), which are 
directly recognized by three arginine residues of the runt domain, as being important for the 
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efficient binding between the runt domain and the recognition element in the DNA (Nomura 
et al, 2013).  
 
1.10 Biological roles of RUNX proteins  
The proteins from the RUNX family show versatile functions being involved in several 
diseases and acting on target genes in a variety of tissues, and exhibiting both transcriptional 
activation and repression activities (Otto et al, 2003). These transcription factors are tissue-
restricted and cancer-related, regulating cell proliferation and growth, as well as 
differentiation (Coffman, 2003; Miyazono et al, 2004; Stein et al, 2004; Young et al, 2007a, 
2007b; Kagoshima et al, 2007). It is clear that each of the three RUNX proteins has different 
roles (Rennert et al, 2003), but since they were found to be co-expressed in some tissues, 
some of their functions may overlap, either synergistically or at different time points (Cohen, 
2009).  
 
1.10.1 The runt-related transcription factor 1 (RUNX1) 
The human RUNX1 was originally cloned from the breakpoint of chromosome 21 in 
t(8;21)(q22;q22) by Miyoshi and collaborators (Miyoshi et al, 1991). This translocation is 
frequently found in patients with acute myeloid leukemia (AML) with maturation (M2 
subtype) (Miyoshi et al, 1991) and has subsequently been shown to be one of the most 
frequent targets of leukemic-associated gene aberrations (Reviewed in Okuda et al, 2001). 
RUNX1 has been proved to regulate, acting as a context-dependent transcriptional activator 
or repressor, a number of target genes, e.g. granulocyte macrophage colony-stimulating 
factor (GM-CSF) (Oakford et al, 2010), receptor for macrophage colony-stimulating factor 
(CSF-1R) (Sauter et al, 2013), tissue inhibitor of metalloproteinase 1 (TIMP1) 
(Bertrand-Philippe et al, 2004), early B-cell factor 1 (Ebf1) (Seo et al, 2012), cyclin D3 
(Bernardin-Fried et al, 2004), CD11 integrin (Puig-Kröger et al, 2000), complement receptor 
type 1 (CR1) (Kim et al, 1999), insulin-like growth factor-binding protein 3 (IGFBP-3) (Iwatsuki 
et al, 2005), type B leukemogenic virus (TBLV) enhancer (Mertz et al, 2001), among others.  
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RUNX1 is expressed in a number of tissues at specific time windows during embryogenesis. 
In the mouse embryo, expression of Runx1 is first detected in definitive hematopoietic stem 
cells (HSC) and in endothelial cells at HSC emergence sites (North et al, 1999; Cai et al, 2000; 
North et al, 2002) and later, Runx1 is highly expressed in several hematopoietic lineages 
including myeloid, B- and T-lymphoid cells (Lorsbach et al, 2004). Runx1 is also highly 
expressed in cranial and dorsal root ganglia (DRG), in the small-diameter nociceptive TrkA 
neurons (Simeone et al, 1995; Levanon et al, 2001, 2002), in the thymus (Satake et al, 1995; 
Komori et al, 1997; Levanon et al, 2001) and in cells of the chondrocyte lineage of the 
developing mouse skeleton (Sato el at, 2008). Tissue sections of the fetal liver or on smear 
preparations of peripheral blood of mutated mice embryos showed an absence of 
hematopoietic elements of definitive origin and analysing the yolk sac the erythropoiesis 
was minimally affected. So, this indicates that the gene targets of RUNX1 are essential for 
the development of all cell lineages of definitive hematopoiesis, but not required for 
erythropoiesis (Okuda et al, 2001). In zebrafish and Xenopus, the expression pattern of runx1 
is well conserved compared to the mammalian pattern, and was shown to be expressed in 
blood progenitors (Tracey et al, 1998; Kalev-Zylinska et al, 2002; Burns et al, 2005). In these 
species, runx1 is also expressed in a few scattered cells within craniofacial cartilages 
(Kalev-Zylinska et al, 2003; Flores et al, 2006; Park and Saint-Jeannet, 2010) and in Rohon-
Beard sensory neurons, that are a population of specialized neurons with mechanoreceptive 
properties only found in fish and amphibians and contribute importantly to the embryonic 
nervous system of these species (Rossi et al, 2009). 
Knockout studies, using different Runx1 deficient mice lines, show that the lack of functional 
Runx1 protein production causes necrosis and haemorrhaging in the central nervous system 
and blocks definitive hematopoiesis resulting in death of the mice during the mid-gestational 
period (Okuda et al, 1996; Wang et al, 1996a). The importance of the heterodimerization of 
CBFβ with RUNX1 is supported by analysis of the disruption of CBFβ that causes a similar 
phenotype as the one obtained for the Runx1 knockout (Wang et al, 1996b). Consistent with 
the Runx1 knockout mice, the zebrafish mutant embryos show normal primitive 
hematopoiesis, but a blockage of the definitive hematopoiesis (Jin et al, 2009). However, the 
RUNX1 role in the generation and maintenance of HSCs during adult hematopoiesis remains 
poorly understood. Recently, Sood and colleagues (2010) reported that a zebrafish runx1-
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deficient mutant line, carrying a truncated version of runx1, is capable of development of 
multilineage adult hematopoiesis (Sood et al, 2010). Apart the numerous reports describing 
the involvement of RUNX1 in hematologic malignancies (Taketani et al, 2003; Podgornik et 
al, 2007; Dicker et al, 2007), there are studies reporting the importance of RUNX1 in a wide 
range of diseases, for example, RUNX1 is involved among others in autoimmune diseases 
(Helms et al, 2003; Shen and Tsao, 2004; Chae et al, 2006), and in cancer (Yang et al, 2005; 
Sakakura et al, 2005; Moosavi et al, 2009). 
 
1.10.2 The runt-related transcription factor 2 (RUNX2) 
RUNX2 has been shown to exert a critical role in normal bone formation and osteoblast 
differentiation. It has been extensively studied and shown to be a key regulator in skeletal 
development in mammals, regulating the switch from cartilage to bone (Otto et al, 1997; 
Inada et al, 1999; Takeda et al, 2001; Ueta et al, 2001). RUNX2 is involved in a variety of 
functions such as in osteoblast differentiation (Komori et al, 1997), chondrocyte maturation 
(Enomoto et al, 2000; Takeda et al, 2001), bone remodelling (Gao et al, 1998; Liu et al, 2001) 
and in the transcriptional regulation of a variety of genes crucial for bone and cartilage 
development including osteocalcin (Ducy et al, 1997; Pinto et al, 2005), matrix Gla protein 
(Fazenda et al, 2010), collagen type X (Zheng et al, 2003; Simões et al, 2006), Indian 
hedgehog (Yoshida et al, 2004; Hecht et al, 2008), sclerosteosis (Sevetson et al, 2004), and in 
its own promoter (Drissi et al, 2000; Yoshida et al, 2002).  
This complex genetic regulation seems to be due to a difference in distribution between 
MASN-Runx2 and MRIPV-Runx2 isoforms, not only resulting from a spatial-temporal 
expression but also due to species specificity (Harada et al, 1999; Li and Xiao, 2007) and to 
the existence of co-regulators that interact with Runx2 enhancing or inhibiting its function 
(Reviewed in Komori, 2005). Studies at cellular level in mice revealed that both Runx2 
isoforms are expressed in osteoblasts and terminal hypertrophic chondrocytes, however, 
MRIPV-Runx2 isoform is also expressed in undifferentiated mesenchymal stem cells, 
preosteoblasts and chondrocyte precursors (Li and Xiao, 2007). Observations at the tissue 
level found that although both isoforms are expressed in bone and lung tissue, MRIPV-Runx2 
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is expressed more widely and can be detected in heart, brain, spleen and skeletal muscles 
(Xiao et al, 2003; Li and Xiao, 2007). 
Komori and colleagues (1997) showed that the ossification is completely blocked in Runx2 
mutated mice. Although the development of cartilage was nearly normal, the mutant mice 
died just after birth and showed a complete lack of bone formation (Komori et al, 1997). 
Diseases associated with RUNX2 include the bone development disorder cleidocranial 
dysplasia (CCD) (Golan et al, 2000; Yamachika et al, 2001), osteosarcoma (San Martin et al, 
2009; Sadikovic et al, 2010), osteoporosis (Khalid et al, 2008) and cancer (Reviewed in Blyth 
et al, 2005). 
 
1.10.3 The runt-related transcription factor 3 (RUNX3) 
The mammalian RUNX3 gene was cloned and localized to human and mouse chromosomes 
1p36.1 and 4, respectively (Levanon et al, 1994; Avraham et al, 1995; Bae et al, 1995). From 
the three mammalian genes belonging to the RUNX family of transcription factors, RUNX3 
gene is the smallest and the one with fewest number of exons (6 exons), compared to 11 
exons and 8 exons in RUNX1 and RUNX2, respectively (Levanon and Groner, 2004). 
Phylogenetic studies of RUNX orthologs from diverse organisms point to RUNX3 as the 
evolutionary founder with one runx3 in invertebrates that progressed to multiple RUNX 
genes in higher species (Bangsow et al, 2001; Reyes et al, 2004, Cohen, 2009).  
RUNX3 has been shown to be a transcriptional regulator, either activating or repressing the 
target genes, by binding to their promoters as a homodimer or heterodimer (with its 
co-factor partner CBFβ). Some examples of described RUNX3 target genes include survivin 
(Liu et al, 2014), thrombospondin-1 (Shi et al, 2013), aggrecan (Wigner et al, 2013), Foxp3 
(Bruno et al, 2009), Runx1 (Brady and Farrell, 2009), osterix (Zheng et al, 2007), Bim 
(Yamamura et al, 2006), CD11a and CD49d integrins (Domínguez-Soto et al, 2005), among 
others.  
Runx3 is the main focus of this report and so it will be described in more detail in the 
following sections. 
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1.10.3.1 Subcellular distribution of RUNX3 protein 
The activity of RUNX is regulated by tissue-speciﬁc expression and post-translational 
modiﬁcations, and is also modulated by subcellular localization (e.g. nuclear localization 
signal and nuclear matrix targeting signal domains) (Pockwinse et al, 2006). As observed for 
Runx1 and Runx2, Runx3 is predominantly a nuclear protein that is punctately organized 
(Pande et al, 2009), however it was also localised in the cytoplasm of gastric cancer cells 
showing the importance of the spatial distribution for proper RUNX function (Ito et al, 2005). 
Pande and co-workers proposed that disruption of Runx3 subnuclear targeting may abrogate 
target gene activation and have important pathological implications for the development of 
gastric tumours (Pande et al, 2009). However, this dynamic shuttle between the nucleus and 
the cytoplasm is still poorly understood. 
 
1.10.3.2 Runx3 expression pattern 
Various groups have published in situ hybridization expression patterns of Runx3 in different 
species, describing detection of Runx3 transcripts in a broad range of tissues, either alone or 
co-expressed with other Runx family members. Levanon and colleagues (2001) showed that, 
in mice, Runx3 is the only Runx family member expressed in a small number of large-
diameter neurons and in cranial and dorsal root ganglia (Levanon et al, 2001). These authors 
also showed Runx3 to be expressed in hematopoietic precursors in the liver, thymus, eyelid 
mesenchyme, superﬁcial cutaneous mesenchyme and mesenchymal element of ﬁliform 
papillae of the tongue, where it is co-expressed with Runx1, and in cartilage, where it was 
expressed in pre-hypertrophic and hypertrophic chondrocytes, co-localized with Runx2 
(Levanon et al, 2001). Runx3 was also shown to be expressed in the ovaries and uteri of mice 
(Tsuchiya et al, 2012), in Meckel's cartilage and other craniofacial cartilages, and in the 
osteogenic regions and ossified bone (Yamashiro et al, 2002). In the developing tooth, Runx3 
expression persisted in odontoblasts and was particularly intense in the dental mesenchyme 
in the cervical loop of continuously growing incisor (Yamashiro et al, 2002). Beside 
mammals, Runx3 spatial-temporal expression pattern has also been analysed by mRNA in 
situ hybridization in other species such as Xenopus (Park and Saint-Jeannet, 2010) and 
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zebrafish (Kataoka et al, 2000; Kalev-Zylinska et al, 2003, Flores et al, 2006) and by RT-PCR in 
a number of other species, for example, in fugu (Ng et al, 2007), elephant shark (Nah et al, 
2014a), Japanese lamprey (Nah et al, 2014b), among others. All together, in situ 
hybridisation results obtained for both zebrafish and Xenopus showed that runx3 is 
expressed in the same cells: hematopoietic lineage, trigeminal ganglia, Rohon-Beard neurons 
and cartilaginous tissues in the head (Kataoka et al, 2000; Kalev-Zylinska et al, 2003; Flores et 
al, 2006; Park and Saint-Jeannet, 2010). runx3 expression has also been detected in zebrafish 
intestinal bulb (Kalev-Zylinska et al, 2003). Although in mouse Runx3 expression has been 
detected in a subset of the DRG sensory neurons, so far in zebrafish it is still not clear if 
runx3 is expressed in these subset of sensory neurons. However, in zebrafish and Xenopus 
the runx3 expression is strongly detected in Rohon-Beard spinal sensory neurons (Kataoka et 
al, 2000; Kalev-Zylinska et al, 2003; Park and Saint-Jeannet, 2010), that as described before, 
are a unique set of primary sensory neurons located in the dorsal spinal cord only present in 
lower vertebrates (Reyes et al, 2004). Rohon-Beard cells are known to derive from the same 
neural plate domain that generates neural crest cells (Cornel and Eisen, 2000). During 
development, these neurons undergo apoptosis and their death coincide with the 
development of the neural crest-derived dorsal root ganglia neurons (Reyes et al, 2004; Park 
and Saint-Jeannet, 2010). Taken together, the runx3 expression pattern in fish and in 
Xenopus seem to be, at least in neural tissues, different from that of the mammalian Runx3 
expression pattern. 
 
1.10.3.2.1 Tissue distribution of Runx3 specific isoforms 
Rini and Calabi (2001) performed a systematic survey (summarized in Table 1.3) for all three 
Runx loci, and showed that the mouse Runx3 is expressed in a wide range of tissues, 
including soft and calcified tissues. In that study, they also showed that each Runx3 
promoter-specific transcript is expressed in the different tissues in a different way, and that 
the Runx3 transcripts can be co-expressed with other Runx members in some tissues (Table 
1.3) (Rini and Calabi, 2001). The expression pattern of the Runx3 P1 and P2 derived 
transcripts suggests that RUNX3 has isoform specific functions since its transcript variants 
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are differentially expressed in the different tissues, with Runx3-P2 been expressed in a broad 
range of tissues and the Runx3-P1 showing a more restricted expression pattern (Table 1.3). 
Table 1.3 – Summary of the expression data for Runx transcripts obtained by Rini and Calabi 
(2001). 
 E BM Sp Th Br Ma Gt Ht Kd Lv Lg Sm Ov Ts 
Runx1 P1 - ++ ++ ++ - + + + - - ± - ± - 
Runx1 P2 + + ± + - + + + - - ++ - + - 
               
Runx2 P1 + + - - - - - - - - - - ++ + 
Runx2 P2 + + - - - - - - - - + - + + 
               
Runx3 P1 - - - + ? - - - - ? - - + - 
Runx3 P2 + + + + ? + + + + ? + + + + 
E, E12.5 embryo; BM, bone marrow; Sp, spleen; Th, thymus; Br, brain; Ma, breast; Gt, gut; 
Ht, heart; Kd, kidney; Lv, liver; Lg, lung; Sm, skeletal muscle; Ov, ovary; Ts, testis. 
 
Groner´s group used a series of overlapping BACs spanning large regions of Runx3 loci to 
identify and characterize the long-range regulatory elements mediating tissue and stage 
specific expression of Runx3 during development and to address the question of how does 
transcription regulation of Runx3 mediate cell-specific expression. Using transgenesis and 
deletions within Runx3 reporter BACs, these authors discovered that Runx3 expression in 
developing sensory neurons is regulated through concerted action of several long-range 
cis-regulatory elements located upstream of the gene (Figure 1.7) 
(http://www.weizmann.ac.il/molgen/Groner/research). However, so far, the expression 
pattern of Runx3 isoform-specific transcripts and the function of each RUNX3 isoform are 
still poorly studied.  
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Figure 1.7 DRG TrkC neuron-specific enhancers are located hundred kb upstream of the P1 
promoter/transcriptional start site. Series of transgenic mouse lines expressing the LacZ 
reporter gene under the regulation of the endogenous Runx3 cis-regulatory elements and 
the different BAC constructs covering ≈0.5 megabase (Mb) around the Runx3 gene. Top: 
Schematic representation of the mouse Runx3 gene and the BAC constructs used to 
generate the transgenic lines and mouse transgenic E14.5 embryos, stained for lacZ, showing 
the spatial-temporal expression pattern of Runx3. Bottom: Table of Runx3 expression 
pattern obtained by LacZ analysis in the transgenic embryos. (Image from 
http://www.weizmann.ac.il/molgen/Groner/research). 
 
  G E, C, A  B, F, D
Hair follicles - ++ +/- 
Vertebrae - +++ + 
Palm - +++ + 
Limbs, ribs ++ +++ + 
Thymus +/- 
(E, C) +/- 
(A) + 
- 
Liver +/- 
(E, C) +/- 
(A) + 
- 
DRG ++ 
(E) ++ 
(A) +/- 
- 
Trigerminal 
ganglion 
++ 
(E) +++ 
(C) ++ 
- 
 
Tissues 
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1.10.3.3 Functional studies to access RUNX3 biological functions 
During mouse embryogenesis Runx3 is expressed in hematopoietic organs, epidermal 
appendages, developing bones, and sensory ganglia (Levanon et al, 2001; Woolf et al, 2003). 
Over the last 15 years several authors have analysed the phenotypic effects of Runx3 
silencing in the developing mouse embryo by analysis of the two currently available 
Runx3-deficient mice strains, obtained by Ito’s and Groner’s groups, and by knockdown 
studies using a morpholino targeting Runx3 (Littman’s group). Although some discrepancies 
in the analysis of the Runx3 KO phenotype associated with gastric neoplasia have been 
observed, probably due to differences in the constructions of the KO mice, all strains show 
similar phenotypic features resulting from the Runx3 loss, with severe congenital limb ataxia 
as the more predominant phenotype, and high mortality soon after birth (Levanon et al, 
2002; Taniuchi et al, 2002; Ito el al, 2003; Levanon and Groner, 2009, among others). Runx3 
was disrupted in these KO mice strains by inserting a LacZ-neomycin cassette into a region 
that affects both P1- and P2-derived RUNX3 isoforms, so the contribution to the phenotype 
of each isoform is still not understood. Based in gain and loss of function studies, Runx3 has 
been shown to be crucial for the regulation of the cell type speciﬁcation of TrkC+ 
proprioceptive dorsal root ganglion (DRG) neurons (Inoue et al, 2002; 2003; Levanon et al, 
2002; Nakamura et al, 2008), to regulate both chondrogenesis and chondrocyte maturation 
(Yoshida et al, 2004; Soung et al, 2007) and to be involved in the regulation of the 
proliferation and survival of various cells including gastric epithelial cells (Li et al, 2002; Ito el 
al, 2008), in T-cell development (Taniuchi et al, 2002; Woolf et al, 2003; Wong et al, 2011) 
and in differentiation of immune cells including natural killer cells (Ohno et al, 2008), 
dendritic cells (Fainaru et al, 2004) and B cells (Watanabe et al, 2010).  
As described above the mice Runx3-/- strains available exhibited high mortality in the first 
few days after birth, making it difficult to completely understand the effect of Runx3 
depletion later on mice development. Zebrafish has been shown to be a powerful model to 
study human diseases and despite several hundred million years of evolutionary separation, 
the genes responsible for some of the teleost and mammalian developmental systems are 
highly conserved (Crosier et al, 2002). So, to overcome some of the difficulties using mouse 
and due to several advantages using zebrafish as a model of study, some researchers used 
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the latter model to analyse the phenotype of Runx3 depletion (Crosier et al, 2002; 
Kalev-Zylinska et al, 2003; Flores et al, 2006). Morpholino knockdown studies showed that 
Runx3 is important for hematopoietic development in zebrafish, as abrogation of Runx3 
function caused abnormalities in hematopoiesis (Croiser et al, 2002; Kalev-Zylinska et al, 
2003). It was observed that morphants preserved development of primitive hematopoietic 
progenitors, however later in development a reduction of circulating blood cells was 
observed, suggesting that Runx3 is required for the maintenance of early blood cell numbers 
and for establishment of definitive hematopoiesis (Crosier et al, 2002; Kalev-Zylinska et al, 
2003). The same group also studied the effect of Runx3 depletion in the onset of 
chondrogenesis in craniofacial endochondral bones, and observed a severe compromised 
craniofacial cartilage formation (Flores et al, 2006). The results obtained for Runx3 
knockdown in zebrafish seem to be in agreement with the results observed for mouse 
knockout studies. However, so far no functional studies reported the effect of zebrafish 
Runx3 depletion in developing DRG sensory neurons, maintaining the role of Runx3 in these 
cells unclear. It is important to note that the importance of the different isoforms in 
zebrafish is still unknown, since the studies using morpholinos to target Runx3 only affected 
the isoforms derived from runx3-P2 and not those derived from the runx3-P1.   
 
1.10.3.4 RUNX3 involvement in disease 
RUNX3, as well as RUNX1, have been shown to be expressed in hematopoietic tissues and 
are frequently associated with leukemias, although the basis for the involvement of RUNX3 
in hematopoiesis and leukemogenesis is still not fully understood (Crosier et al, 2002; Wang 
et al, 2013; 2014). A study published more than a decade ago, where the expression of 
RUNX3 was analysed in a diversity of mammalian cell lines, showed that RUNX3 is expressed 
predominantly in cells of hematopoietic origin, and non-hematopoietic cell lines that either 
do not express or express very low levels of RUNX3 protein (Le et al, 1999). In that report, 
the authors also showed that RUNX3 is induced in a human myeloid leukemia cell line 
through the retinoic acid signalling pathway, suggesting that RUNX3 may play a role in 
hematopoietic cell differentiation (Le et al, 1999). Recently, a Runx3 knockout study 
performed in mouse reveal a mild expansion of myeloid cells and hematopoietic stem cells 
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when aged (Wang et al, 2013) and a study using Runx1/Runx3 double-knockout mice 
showed that disruption of both genes leads to bone marrow failure and leukemia 
predisposition due to transcriptional and DNA repair defects (Wang et al, 2014).  
In thymopoiesis, RUNX3 is known as an important regulator of T-cell differentiation and has 
also been shown to be highly expressed in dendritic cells, where it functions as a component 
of the transforming growth factor β (TGF-β) signalling cascade (Fainaru et al, 2004). 
Functional studies of Runx3 depletion revealed that the dendritic cells of the Runx3 KO mice 
do not respond to TGF-β and that loss of leukocytic cell-autonomous function of Runx3 
results in spontaneous development of inflammatory bowel disease (IBD) and gastric lesion 
(Brenner et al, 2004). Moreover, RUNX3 and TGF-β are down-regulated in peripheral blood 
cells of Crohn’s disease patients, which might suggest involvement of this pathway in the 
human pathogenesis of IBD (Weersma et al, 2008). More recently, RUNX3 has been shown 
to be implicated in the pathogenesis of ankylosing spondylitis (Zeng et al, 2013) and to be an 
additional susceptibility locus for psoriatic arthritis (Apel et al, 2013). 
Similar to the other RUNX family members, RUNX3 has also been implicated in a variety of 
cancers where it can either function as a tumour suppressor or an oncogene, depending on 
the type of cancer (Li et al, 2002; Lund and van Lohuizen, 2002; Reviewed in Subramaniam et 
al, 2009). Although for more than a decade different laboratories have been focusing their 
research in evidences suggesting that lack of RUNX3 expression is related to the 
development of a diversity of cancers, a recent paper that analysed published results based 
on whole-genome and whole-exome DNA sequencing studies on thousands of samples from 
different cancers, did not find RUNX3 to be a gene significantly mutated in cancer (reviewed 
in Lotem et al, 2015). In fact, contradictions about RUNX3 being expressed in gastrointestinal 
tract epithelium and functioning as a tumour suppressor have been disputed over a decade 
between different groups (Normile, 2011; Ito, 2012; Levanon et al, 2012). At the moment it 
is not completely defined how RUNX3 is related to cancer development.  
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1.11 Using zebrafish as a model organism to study gene regulation and function 
Due to an increasing concern about animal welfare, when using animals in research, it is 
important to minimise animal suffering by using the least sentient organism possible to 
answer the question at hand and applying the 3R’s rule (replacement, refinement and 
reduction; https://www.nc3rs.org.uk/). Zebrafish (Danio rerio) is a small (4-5 cm in length) 
tropical fish native from the rivers of northern and eastern India (Engeszer et al, 2007), that 
has long been a common feature in home aquariums, and shown in the last years to be an 
attractive research tool. Zebrafish has revealed several advantages over other models thus 
rapidly becoming an excellent model for biomedical studies, being widely used in research as 
an alternative to mammalian species.  
A fundamental advantage in the use of zebrafish is that they are vertebrates and therefore 
share a considerable amount of genetic identity with mammals, including humans 
(Postlethwait et al, 2000). It was also observed that several zebrafish organ systems are 
remarkably similar to those in humans (Seth et al, 2013) and orthologues of most human 
genes and proteins can be found in zebrafish and show similar patterns of expression and a 
high conservation of amino acid residue sequence (Howe et al, 2013), while maintaining 
their cell biological and developmental processes conserved. Therefore, studies in fish can 
give great insight into human disease processes. The ability to accelerate genetic studies by 
gene knockdown or overexpression have led to the widespread use of zebrafish in the 
detailed investigation of vertebrate gene function and increasingly, the study of human 
genetic diseases (Grunwald and Eisen, 2002). Recently, the development of new 
mutagenesis techniques has increased exponentially the number of available zebrafish 
models of human genetic diseases. That, together with the recent availability of the 
complete zebrafish genome sequence, increased the ability to screen for modifier mutations 
(that suppress or enhance the disease phenotype) and allows dissection of the biological 
processes underlying the disease.  
Other advantages of zebrafish as a model in research, compared to other vertebrate models, 
include their easy and relatively low cost maintenance in laboratory, easy breed and large 
number of offspring that can be obtained from a single spawning and their develop is ex 
utero, allowing easy access to the embryos. Additional advantages are the short generation 
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time and the fact that the young fish are small and relatively transparent which enables 
researchers to make microscopic observations in the living animal (Westerfield, 2000). The 
genetic tractability, the new transgenic and mutagenic tools available and the optical 
transparency of zebrafish makes it the vertebrate model system par excellence for in vivo 
analysis. 
 
 
1.12 Main objectives 
Although in recent years the number of published papers focusing on the study of RUNX3 in 
different aspects of its function has increased substantially, the exact mechanisms of action 
of RUNX3 proteins during development is still not completely understood. Even less clear is 
the mechanism of how RUNX3 transcription is regulated and the implication for function of 
the complex variety of isoforms that are produced by this gene. 
To characterise the variety of transcript variants and the encoded protein isoforms of the 
runx3 gene and to investigate possible roles in zebrafish development, we propose to: (i) 
Identify and clone runx3-P1 and runx3-P2 transcript variants; (ii) Determine the expression 
pattern of runx3 variants both during the embryonic development and in adult tissues; (iii) 
Analyse both runx3 promoter regions using an in silico, in vitro and in vivo approach; (iv) 
Analyse the possibility of cross-regulation of the runx3 promoter regions by Runx2 isoforms, 
as well as the auto-regulation by its own isoforms. 
 
 
 
 
 
 
Chapter 1 
31 
 
1.13 References 
Ahn MY, Bae SC, Maruyama M, Ito Y, 1996. Comparison of the human genomic structure of 
the runt domain-encoding PEBP2/CBFα gene family. Gene. 168:279-280. 
Apel M, Uebe S, Bowes J, Giardina E, Korendowych E, Juneblad K, Pasutto F, Ekici AB, 
McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Böhm B, Traupe H, Lohmann J, Gieger C, 
Wichmann HE, Padyukov L, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, 
Barton A, Reis A, Hüffmeier U, 2013. Variants in RUNX3 contribute to susceptibility to 
psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis. Arthritis 
Rheum. 65:1224-1231. 
Avraham KB, Levanon D, Negreanu V, Bernstein Y, Groner Y, Copeland NG, Jenkins NA, 1995. 
Mapping of the runt domain gene, Aml2, to the distal region of mouse chromosome 4. 
Genomics. 25:603-605. 
Bäckström S, Wolf-Watz M, Grundström C, Härd T, Grundström T, Sauer UH, 2002. The 
RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride 
ions modulate DNA binding. J Mol Biol. 322:259-272. 
Bae S-C, Takahashi E-i, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y, 1995. 
Cloning, mapping and expression of PEBP2aC, a third gene encoding the mammalian runt 
domain. Gene. 159:245-248. 
Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben-
Asher E, Lancet D, Levanon D, Groner Y, 2001. The RUNX3 gene-sequence, structure and 
regulated expression. Gene. 279:221-232. 
Bao R, Friedrich M, 2008. Conserved cluster organization of insect Runx genes. Dev Genes 
Evol. 218:567-574. 
Bataillé L, Augé B, Ferjoux G, Haenlin M, Waltzer L, 2005. Resolving embryonic blood cell fate 
choice in Drosophila: interplay of GCM and RUNX factors. Development. 132:4635-4644. 
Bernardin-Fried F, Kummalue T, Leijen S, Collector MI, Ravid K, Friedman AD, 2004. 
AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-
dependent phosphorylation and induces cyclin D3 gene expression. J Biol Chem. 279:15678-
15687.  
Bertrand-Philippe M, Ruddell RG, Arthur MJ, Thomas J, Mungalsingh N, Mann DA, 2004. 
Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and 
RUNX2. J Biol Chem. 279:24530-24539. 
Blyth K, Cameron ER, Neil JC, 2005. The runx genes: gain or loss of function in cancer. Nat 
Rev Cancer. 5:376-387. 
Chapter 1 
32 
 
Brady G, Farrell PJ, 2009. RUNX3-Mediated Repression of RUNX1 in B Cells. J Cell Physiol. 
221:283-287. 
Bravo J, Li Z, Speck NA, Warren AJ, 2001. The leukemia-associated AML1 (Runx1)-CBF beta 
complex functions as a DNA-induced molecular clamp. Nat Struct Biol. 8:371-378 
Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E, Groner Y, 2004. Loss of 
Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric 
mucosal hyperplasia. Proc Natl Acad Sci U S A. 101:16016-16021.  
Bruno L, Mazzarella L, Hoogenkamp M, Hertweck A, Cobb BS, Sauer S, Hadjur S, Leleu M, 
Naoe Y, Telfer JC, Bonifer C, Taniuchi I, Fisher AG, Merkenschlager M, 2009. Runx proteins 
regulate Foxp3 expression. J Exp Med. 206:2329-2337.  
Burns CE, Traver D, Mayhall E, Shepard JL, Zon L, 2005. Hematopoietic stem cell fate is 
established by the Notch-Runx pathway. Genes Dev. 19:2331-2342. 
Cai Z, de Bruijn M, Ma X, Dortland B, Luteijn T, Downing RJ, Dzierzak E, 2000. 
Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic 
stem cells in the mouse embryo. Immunity. 13:423-431. 
Canon J, Banerjee U, 2000. Runt and Lozenge function in Drosophila development. Semin 
Cell Dev Biol. 11:327-336. 
Carter R, Drouin G, 2009. Structural differentiation of the three eukaryotic RNA polymerases. 
Genomics. 94:388-396. 
Chae SC, Park BL, Park CS, Ryu HJ, Yang YS, Lee SO, Choi YH, Kim EM, Uh ST, Kim YH, Kim KK, 
Oh B, Chung HT, Kimm K, Shin HD, 2006. Putative association of RUNX1 polymorphisms with 
IgE levels in a Korean population. Exp Mol Med. 38:583-588. 
Chuang LSH, Ito K, Ito Y, 2013. RUNX family: Regulation and diversification of roles through 
interacting proteins. Int J Cancer. 132:1260-1271. 
Coffman JA, 2003. Runx transcription factors and the developmental balance between cell 
proliferation and differentiation. Cell Biol Int. 27:315-324. 
Cohen MM Jr, 2009. Perspectives on RUNX genes: An update. Am J Med Genet Part A 
149A:2629-2646. 
Collingwood TN, Urnov FD, Wolffe AP, 1999. Nuclear receptors: coactivators, corepressors 
and chromatin remodeling in the control of transcription. J Mol Endocrinol. 23:255-275. 
Cornell RA, Eisen JS, 2000. Delta signaling mediates segregation of neural crest and spinal 
sensory neurons from zebrafish lateral neural plate. Development. 127:2873-2882. 
Chapter 1 
33 
 
Crosier PS, Kalev-Zylinska ML, Hall CJ, Flores MV, Horsfield JA, Crosier KE, 2002. Pathways in 
blood and vessel development revealed through zebrafish genetics. Int J Dev Biol. 46:493-
502. 
Daga A, Karlovich CA, Dumstrei K, Banerjee U, 1996. Patterning of cells in the Drosophila eye 
by Lozenge, which shares homologous domains with AML1. Genes Dev. 10:1194-1205. 
Dicker F, Haferlach C, Kern W, Haferlach T, Schnittger S, 2007. Trisomy 13 is strongly 
associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid 
leukemia. Blood. 110:1308-1316.  
Domínguez-Soto A, Relloso M, Vega MA, Corbí AL, Puig-Kröger A, 2005. RUNX3 regulates the 
activity of the CD11a and CD49d integrin gene promoters. Immunobiology. 210:133-139. 
Downing JR, 1999. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: 
biology and clinical significance. Br J Haematol. 106(2):296-308. 
Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi JY, Terry A, Hu M, Jones S, Neil JC, 
Lian JB, Stein JL, Van Wijnen AJ, Stein GS, 2000. Transcriptional autoregulation of the bone 
related CBFA1/RUNX2 gene. J Cell Physiol. 184:341-350. 
Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G, 1997. Osf2/Cbfa1: a transcriptional 
activator of osteoblast differentiation. Cell. 89:747-754. 
Duffy JB, Gergen JP, 1991. The Drosophila segmentation gene runt acts as a position-specific 
numerator element necessary for the uniform expression of the sex-determining gene Sex-
lethal. Genes Dev. 5:2176-2187. 
Duffy, JB, Kania MA, Gergen JP, 1991. Expression and function of the Drosophila gene runt in 
early stages of neural development. Development. 1230:1223-1230. 
Engeszer RE, Patterson LB, Rao AA, Parichy DM, 2007. Zebrafish in the wild: a review of 
natural history and new notes from the field. Zebrafish. 4:21-40. 
Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto 
T, Komori T, 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol 
Chem. 275:8695-8702. 
Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D, Negreanu V, Bernstein Y, 
Levanon D, Jung S, Groner Y, 2004. Runx3 regulates mouse TGF-beta-mediated dendritic cell 
function and its absence results in airway inflammation. EMBO J. 23:969-979. 
Fazenda C, Simões B, Kelsh RN, Cancela ML, Conceição N, 2010. Dual transcriptional 
regulation by runx2 of matrix Gla protein in Xenopus laevis. Gene. 450:94-102. 
Flores GV, Daga A, Kalhor HR, Banerjee U, 1998. Lozenge is expressed in pluripotent 
precursor cells and patterns multiple cell types in the Drosophila eye through the control of 
cell-specific transcription factors. Development. 125:3681-3687. 
Chapter 1 
34 
 
Flores MV, Lam EY, Crosier P, Crosier K, 2006. A hierarchy of Runx transcription factors 
modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish. Dev 
Dyn. 235:3166-3176. 
Fickett JW, Wasserman WW, 2000. Discovery and modeling of transcriptional regulatory 
regions. Curr Opin Biotechnol. 11:19-24. 
Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A, 1998. 
Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in 
osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). 
Biochem Biophys Res Commun. 252:697-702. 
Geoffroy V, Corral DA, Zhou L, Lee B, Karsenty G, 1998. Genomic organization, expression of 
the human CBFA1 gene, and evidence for an alternative splicing event affecting protein 
function. Mamm Genome. 9:54-57. 
Gergen JP, Butler BA, 1988. Isolation of the Drosophila segmentation gene runt and analysis 
of its expression during embryogenesis. Genes Dev. 2:1179-1193. 
Glover JNM, Harrison SC, 1995. Crystal structure of the heterodimeric bZIP transcription 
factor c-Fos-c-Jun bound to DNA. Nature. 373:257-261. 
Golan I, Preising M, Wagener H, Baumert U, Niederdellmann H, Lorenz B, Müssig D, 2000. A 
novel missense mutation of the CBFA1 gene in a family with cleidocranial dysplasia (CCD) 
and variable expressivity. J Craniofac Genet Dev Biol. 20:113-120. 
Grunwald DJ, Eisen JS, 2002. Headwaters of the zebrafish - emergence of a new model 
vertebrate. Nat Rev Genet. 3:717-724. 
Gupta BP, Rodrigues V, 1995. Distinct mechanisms of action of the Lozenge locus in 
Drosophila eye and antennal development are suggested by the analysis of dominant 
enhancers. J Neurogenet. 10:137-151. 
Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, 
Nakatsuka M, 1999. Cbfa1 isoforms exert functional differences in osteoblast differentiation. 
J Biol Chem. 274:6972-6978. 
Hart SM, Foroni L, 2002. Core binding factor genes and human leukemia. Haematologica. 
87:1307-1323. 
Hecht J, Stricker S, Wiecha U, Stiege A, Panopoulou G, Podsiadlowski L, Poustka AJ, Dieterich 
C, Ehrich S, Suvorova J, Mundlos S, Seitz V, 2008. Evolution of a core gene network for 
skeletogenesis in Chordates. PLoS Genet. 4:e1000025. 
Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, 
Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM, 2003. A putative RUNX1 binding site 
variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat 
Genet. 35:349-56. 
Chapter 1 
35 
 
Horsfield JA, Anagnostou SH, Hu JK, Cho KH, Geisler R, Lieschke G, Crosier KE, Crosier PS, 
2007. Cohesin-dependent regulation of Runx genes. Development. 134:2639-2649. 
Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, 
McLaren K, Matthews L, McLaren S, Sealy I, Caccamo M, Churcher C, Scott C, Barrett JC, Koch 
R, Rauch GJ, White S, Chow W, Kilian B, Quintais LT, Guerra-Assunção JA, Zhou Y, Gu Y, Yen J, 
et al., 2013. The zebrafish reference genome sequence and its relationship to the human 
genome. Nature. 496:498-503. 
Hu CD, Chinenov Y, Kerppola TK, 2002. Visualization of interactions among bZIP and Rel 
family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 
9:789-798. 
Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y, 2001. Dimerization with PEBP2beta 
protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 20:723-
733. 
Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, 
Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T, 1999. Maturational disturbance 
of chondrocytes in Cbfa1-deficient mice. Dev Dyn. 214:279-290. 
Inoue K, Ozaki S, Ito K, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo 
N, Ito Y. 2003. Runx3 is essential for the target-specific axon pathfinding of trkc-expressing 
dorsal root ganglion neurons. Blood Cells Mol Dis. 30:157-160. 
Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, 
Yamashita N, Itohara S, Kudo N, Ito Y, 2002. Runx3 controls the axonal projection of 
proprioceptive dorsal root ganglion neurons. Nat Neurosci. 5:946-954. 
Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, 
Wang H, Fukamachi H, Ito Y, 2008. RUNX3 attenuates b-catenin/T cell factors in intestinal 
tumorigenesis. Cancer Cell. 14:226-237. 
Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, 
Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y, 2005. RUNX3, a novel tumor 
suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 
65:7743-7750. 
Ito Y, 1999. Molecular basis of tissue-specific gene expression mediated by the runt domain 
transcription factor PEBP2/CBF. Genes Cells. 4:685-696. 
Ito Y, 2004. Oncogenic potential of the RUNX gene family. Oncogene. 23:4198-4208. 
Ito Y, 2012. RUNX3 is expressed in the epithelium of the gastrointestinal tract. EMBO Mol 
Med. 4:541-542. 
Ito Y, Miyazono K, 2003. RUNX transcription factors as key targets of TGF-superfamily 
signaling. Curr Opin Genet Dev. 13:43-47. 
Chapter 1 
36 
 
Iwatsuki K, Tanaka K, Kaneko T, Kazama R, Okamoto S, Nakayama Y, Ito Y, Satake M, 
Takahashi S, Miyajima A, Watanabe T, Hara T, 2005. Runx1 promotes angiogenesis by 
downregulation of insulin-like growth factor-binding protein-3. Oncogene. 24:1129-1137. 
Jin H, Sood R, Xu J, Zhen F, English MA, Liu PP, Wen Z, 2009. Definitive hematopoietic 
stem/progenitor cells manifest distinct differentiation output in the zebrafish VDA and PBI. 
Development. 136:647-54. 
Kagoshima H, Shigesada K, Kohara Y. 2007. RUNX regulates stem cell proliferation and 
differentiation: insights from studies of C. elegans. J Cell Biochem. 100:1119-1130. 
Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P, 1993. 
The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends 
Genet. 9:338-341. 
Kalev-Zylinska ML, Horsfield JA, Flores MV, Postlethwait JH, Chau JY, Cattin PM, Vitas MR, 
Crosier PS, Crosier KE, 2003. Runx3 is required for hematopoietic development in zebrafish. 
Dev Dyn. 228:323-336. 
Kalev-Zylinska ML, Horsfield JA, Flores MV, Postlethwait JH, Vitas MR, Baas AM, Crosier PS, 
Crosier KE, 2002. Runx1 is required for zebrafish blood and vessel development and 
expression of a human RUNX1-CBF2T1 transgene advances a model for studies of 
leukemogenesis. Development. 129:2015-2030. 
Kania MA, Bonner AS, Duffy JB, Gergen JP, 1990. The Drosophila segmentation gene runt 
encodes a novel nuclear regulatory protein that is also expressed in the developing nervous 
system. Genes Dev. 4:1701-1713. 
Kanno Y, Kanno T, Sakakura C, Bae SC, Ito Y, 1998.Cytoplasmic sequestration of the 
polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) 
subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-
mediated transactivation. Mol Cell Biol. 18:4252-4261. 
Kataoka H, Ochi M, Enomoto K, Yamaguchi A, 2000. Cloning and embryonic expression 
patterns of the zebrafish Runt domain genes, runxa and runxb. Mech Dev. 98:139-143. 
Khalid O, Baniwal SK, Purcell DJ, Leclerc N, Gabet Y, Stallcup MR, Coetzee GA, Frenkel B, 
2008. Modulation of Runx2 activity by estrogen receptor-alpha: implications for 
osteoporosis and breast cancer. Endocrinology. 149:5984-5995.  
Kim JH, Lee S, Rho JK, Choe SY, 1999. AML1, the target of chromosomal rearrangements in 
human leukemia, regulates the expression of human complement receptor type 1 (CR1) 
gene. Int J Biochem Cell Biol. 31:933-940. 
Komori T, 2005. Regulation of Skeletal Development by the Runx Family of Transcription 
Factors. J Cell Biochem. 95:445-453.  
Chapter 1 
37 
 
Komori TH, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao 
YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T, 1997. Targeted 
disruption of Cbfa1 results in a complete lack of bone formation owing to maturational 
arrest of osteoblasts. Cell. 89:755-764. 
Le XF, Groner Y, Kornblau SM, Gu Y, Hittelman WN, Levanon D, Mehta K, Arlinghaus RB, 
Chang KS, 1999. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid 
receptor alpha-dependent signaling pathway. J Biol Chem. 274:21651-21658. 
Lee TI, Young RA, 2000. Transcription of eukaryotic protein-coding genes. Annu Rev Genet. 
34:77-137. 
Levanon D, Bernstein Y, Negreanu V, Ghozi MC, Baram I, Aloya R, Goldenberg D, Lotem J, 
Groner Y, 1996. A large variety of alternatively spliced and differentially expressed 
messenger RNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell 
Biol. 15:175-185. 
Levanon D, Bettoun D, Harris-Cerruti C, Woolf E, Negreanu V, Eilam R, Bernstein Y, 
Goldenberg D, Xiao C, Fliegauf M, Kremer E, Otto F, Brenner O, Lev-Tov A, Groner Y, 2002. 
The Runx3 transcription factor regulates development and survival of TrkC dorsal root 
ganglia neurons. EMBO J. 21:3454-3463. 
Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, 
Speck N, Groner Y, 2001. Spatial and temporal expression pattern of Runx3 (Aml2) and 
Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev. 
109:413-417. 
Levanon D, Groner Y, 2004. Structure and regulated expression of mammalian RUNX genes. 
Oncogene. 23:4211-4219.  
Levanon D, Groner Y, 2009. Runx3-deficient mouse strains circa 2008: resemblance and 
dissimilarity. Blood Cells Mol Dis. 43:1-5. 
Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y, 1994. AML1, AML2, and 
AML3, the human members of the runt domain gene-family: cDNA structure, expression, 
and chromosomal localization. Genomics. 23:425-432. 
Levanon D, Negreanu V, Lotem J and Groner Y, 2012. Author reply to: RUNX3 is expressed in 
the epithelium of the gastrointestinal tract. EMBO Mol Med. 4:543-544. 
Levine M, Tjian R, 2003. Transcription regulation and animal diversity. Nature. 424:147-151. 
Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, 
Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, 
Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y, 2002. 
Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:113-
124. 
Chapter 1 
38 
 
Li Y-L, Xiao Z-S, 2007. Advances in Runx2 regulation and its isoforms. Medical Hypotheses. 
68:169-175. 
Liu H, Carlsson L, Grundstrom T, 2006. Identiﬁcation of an N-terminal transactivation domain 
that separates molecular function from global differentiation function. J Biol Chem. 
281:25659-25669. 
Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, 
Komori T, 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and 
causes osteopenia with multiple fractures. J Cell Biol. 155:157-166. 
Liu Z, Zhang X, Xu X, Chen L, Li W, Yu H, Sun Y, Zeng J, Jia J, 2014. RUNX3 inhibits survivin 
expression and induces cell apoptosis in gastric cancer. Eur J Cell Biol. 93:118-126. 
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J, 2000. Molecular Cell 
Biology. 4th edition. New York: W. H. Freeman.  
Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR, 2004. Role of RUNX1 in adult 
hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage 
expression. Blood. 103:2522-2529. 
Lotem J, Levanon D, Negreanu V, Bauer O, Hantisteanu S, Dicken J, Groner Y, 2015. Runx3 at 
the interface of immunity, inflammation and cancer. Biochim Biophys Acta. 1855:131-143.  
Lund AH, van Lohuizen M, 2002. RUNX: a trilogy of cancer genes. Cancer cell. 1:213-215. 
Mertz JA, Mustafa F, Meyers S, Dudley JP, 2001. Type B leukemogenic virus has a T-cell-
specific enhancer that binds AML-1. J Virol. 75:2174-2184. 
Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, Nuckolls GH, Speck NA, 2002. The core-
binding factor β subunit is required for bone formation and hematopoietic maturation. Nat 
Genet. 32:645-649. 
Miyazono K, Maeda S, Imamura T, 2004. Coordinate regulation of cell growth and 
differentiation by TGF-beta superfamily and Runx proteins. Oncogene. 23:4232-4237. 
Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M, 1995. 
Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid 
leukemia. Nucleic Acids Res. 23:2762-2769. 
Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M, 1991. t(8;21) breakpoints on 
chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single 
gene, AML1. Proc Natl Acad Sci USA. 88:10431-10434. 
Moosavi SA, Sanchez J, Adeyinka A, 2009. Marker chromosomes are a significant mechanism 
of high-level RUNX1 gene amplification in hematologic malignancies. Cancer Genet 
Cytogenet. 189:24-28. 
Chapter 1 
39 
 
Nagata T, Gupta V, Sorce D, Kim WY, Sali A, Chait BT, Shigesada K, Ito Y, Werner MH, 1999. 
Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt 
domain. Nat Struct Biol. 6:615-619. 
Nah GS, Lim ZW, Tay BH, Osato M, Venkatesh B, 2014a. Runx family genes in a cartilaginous 
fish, the elephant shark (Callorhinchus milii). PLoS One. 9:e93816. 
Nah GS, Tay BH, Brenner S, Osato M, Venkatesh B, 2014b. Characterization of the Runx gene 
family in a jawless vertebrate, the Japanese lamprey (Lethenteron japonicum). PLoS One. 
9:e113445.  
Nakamura S, Senzaki K, Yoshikawa M, Nishimura M, Inoue K, Ito Y, Ozaki S, Shiga T, 2008. 
Dynamic regulation of the expression of neruotrophin receptors by Runx3. Development. 
135:1703-1711. 
Ng CE, Osato M, Tay BH, Venkatesh B, Ito Y, 2007. cDNA cloning of Runx family genes from 
the pufferfish (Fugu rubripes). Gene. 399:162-173. 
Nomura Y, Tanaka Y, Fukunaga J-i, Fujiwara K, Chiba M, Iibuchi H, Tanaka T, Nakamura Y, 
Kawai G, Kozu T and Sakamoto T, 2013. Solution structure of a DNA mimicking motif of an 
RNA aptamer against transcription factor AML1 Runt domain. J Biochem. 154:513-519. 
Normile D, 2011. Cancer research. Dispute over tumor suppressor gene Runx3 boils over. 
Science. 334:442-443. 
North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, Marin-Padilla M, Speck NA, 1999. 
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 
126:2563-2575.  
North TE, de Bruijn MF, Stacy T, Talebian L, Lind E, Robin C, Binder M, Dzierzak E, Speck NA, 
2002. Runx1 expression marks long-term repopulating hematopoietic stem cells in the 
midgestation mouse embryo. Immunity. 16:661-672.  
Nüsslein-Volhard C, Wieschaus E, 1980. Mutations affecting segment number and polarity in 
Drosophila. Nature. 287:795-801. 
Oakford PC, James SR, Qadi A, West AC, Ray SN, Bert AG, Cockerill PN, Holloway AF, 2010. 
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leuk Res. 
34:1203-1213.  
Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K, 1993. 
Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel 
Drosophila runt-related DNA binding protein PEBP2α. Virology. 194:314-331. 
Ohno S, Sato T, Kohu K, Takeda K, Okumura K, Satake M, Habu S, 2008. Runx proteins are 
involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell 
differentiation. Int Immunol. 20:71-79. 
Chapter 1 
40 
 
Okuda T, Nishimura M, Nakao M, Fujitaa Y, 2001. RUNX1/AML1: A Central Player in 
Hematopoiesis. Int J Hematol. 74:252-257. 
Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR, 1996. AML1, the target of 
multiple chromosomal translocations in human leukemia, is essential for normal fetal liver 
hematopoiesis. Cell. 84:321-330. 
Otto F, Libbert M, Stock M, 2003. Upstream and Downstream Targets of RUNX Proteins. J 
Cell Biochem. 18:9-18. 
Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington 
RS, Mundlos S, Olsen BR, Selby PB, Owen MJ, 1997. Cbfa1, a candidate gene for cleidocranial 
dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 
89:765-771. 
Pande S, Ali SA, Dowdy C, Zaidi SK, Ito K, Ito Y, Montecino MA, Lian JB, Stein JL, van Wijnen 
AJ, Stein GS, 2009. Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic 
association with mitotic chromosomes. J Cell Physiol. 218:473-479. 
Park B-Y, Saint-Jeannet J-P, 2010. Expression analysis of Runx3 and other Runx family 
members during Xenopus development. Gene Expr Patterns. 10: 159-166. 
Patikoglou G, Burley SK, 1997. Eukaryotic transcription factor-DNA complexes. Annu Rev 
Biophys Biomol Struct. 26:289-325. 
Pinto JP, Conceição NM, Viegas CS, Leite RB, Hurst LD, Kelsh RN, Cancela ML, 2005. 
Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing 
osteocalcin gene expression in vitro. J Bone Miner Res. 20:1440-1453. 
Pockwinse SM, Rajgopal A, Young DW, Mujeeb KA, Nickerson J, Javed A, Redick S, Lian JB, 
van Wijnen AJ, Stein JL, Stein GS, Doxsey SJ, 2006. Microtubule-Dependent Nuclear-
Cytoplasmic Shuttling of Runx2. J cellular Physiol. 206:354-362. 
Podgornik H, Debeljak M, Zontar D, Cernelc P, Prestor VV, Jazbec J, 2007. RUNX1 
amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to 
acute myelogenous leukemia. Cancer Genet Cytogenet. 178:77-81. 
Postlethwait JH, Woods IG, Ngo-Hazelett P, Yan YL, Kelly PD, Chu F, Huang H, Hill-Force A, 
Talbot WS, 2000. Zebrafish comparative genomics and the origins of vertebrate 
chromosomes. Genome Res. 10:1890-1902. 
Pugh BF, Tjian R, 1991. Transcription from a TATA-less promoter requires a multisubunit 
TFIID complex. Genes Dev. 5:1935-1945. 
Puig-Kröger A, López-Rodriguez C, Relloso M, Sánchez-Elsner T, Nueda A, Muñoz E, Bernabéu 
C, Corbi AL, 2000. Polyomavirus enhancer-binding protein 2/core binding factor/acute 
myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin 
gene promoter. J Biol Chem. 275:28507-28512. 
Chapter 1 
41 
 
Rennert J, Coffman JA, Mushegian AR, Robertson AJ, 2003. The evolution of Runx genes I. A 
comparative study of sequences from phylogenetically diverse model organisms. BMC Evol 
Biol. 3:4. 
Reyes R, Haendel M, Grant D, Melancon E, Eisen JS, 2004. Slow degeneration of zebrafish 
Rohon-Beard neurons during programmed cell death. Dev Dyn. 229:30-41. 
Rini D, Calabi F, 2001. Identification and comparative analysis of a second runx3 promoter. 
Gene. 273:13-22. 
Roeder RG, 1996. The role of general initiation factors in transcription by RNA polymerase II. 
Trends Biochem Sci. 21:327-335. 
Rossi CC, Kaji T, Artinger KB, 2009. Transcriptional control of Rohon-Beard sensory neuron 
development at the neural plate border. Dev Dyn. 238: 931-943. 
Sadikovic B, Thorner P, Chilton-Macneill S, Martin JW, Cervigne NK, Squire J, Zielenska M, 
2010. Expression analysis of genes associated with human osteosarcoma tumors shows 
correlation of RUNX2 overexpression with poor response to chemotherapy. BMC Cancer. 
10:202. 
Sakakura C, Hagiwara A, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Ito K, 
Yamagishi H, Yazumi S, Chiba T, Ito Y, 2005. Frequent downregulation of the runt domain 
transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer. 
113:221-228. 
San Martin IA, Varela N, Gaete M, Villegas K, Osorio M, Tapia JC, Antonelli M, Mancilla EE, 
Pereira BP, Nathan SS, Lian JB, Stein JL, Stein GS, van Wijnen AJ, Galindo M, 2009. Impaired 
cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-
Cbfbeta in osteosarcoma cells. J Cell Physiol. 221:560-571.  
Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y, 
1995. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic 
development. Mol Cell Biol. 15:1662-1670. 
Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, Ae K, Liu X, Osaki M, Takeuchi Y, 
Fukumoto S, Kawaguchi H, Haro H, Shinomiya K, Karsenty G, Takeda S, 2008. The Distinct 
Role of the Runx Proteins in Chondrocyte Differentiation and Intervertebral Disc 
Degeneration. Arthritis Rheum. 58:2764-2775. 
Sauter KA, Bouhlel MA, O'Neal J, Sester DP, Tagoh H, Ingram RM, Pridans C, Bonifer C, Hume 
DA, 2013. The function of the conserved regulatory element within the second intron of the 
mammalian Csf1r locus. PLoS One. 8(1):e54935. 
Seo W, Ikawa T, Kawamoto H, Taniuchi I, 2012. Runx1-Cbfβ facilitates early B lymphocyte 
development by regulating expression of Ebf1. J Exp Med. 209:1255-1262. 
Chapter 1 
42 
 
Seth A, Stemple DL, Barroso I. 2013. The emerging use of zebrafish to model metabolic 
disease. Dis Model Mech. 6:1080-1088. 
Sevetson B, Taylor S, Pan Y, 2004. Cbfa1/RUNX2 directs specific expression of the 
sclerosteosis gene (SOST). J Biol Chem. 279:13849-13858. 
Shen N, Tsao BP, 2004. Current advances in the human lupus genetics. Curr Rheumatol Rep. 
6:391-398. 
Shi X, Deepak V, Wang L, Ba X, Komori T, Zeng X, Liu W, 2013. Thrombospondin-1 is a 
putative target gene of Runx2 and Runx3. Int J Mol Sci. 14:14321-14332.  
Simeone A, Daga A, Calabi F, 1995. Expression of runt in the mouse embryo. Dev Dyn. 
203:61-70.  
Simões B, Conceição N, Viegas CS, Pinto JP, Gavaia PJ, Hurst LD, Kelsh RN, Cancela ML, 2006. 
Identification of a promoter element within the zebrafish colXalpha1 gene responsive to 
runx2 isoforms Osf2/Cbfa1 and til-1 but not to pebp2alphaA2. Calcif Tissue Int. 79:230-244.  
Sood R, English MA, Belele CL, Jin H, Bishop K, Haskins R, McKinney MC, Chahal J, Weinstein 
BM, Wen Z, Liu PP, 2010. Development of multilineage adult hematopoiesis in the zebrafish 
with a runx1 truncation mutation. Blood. 115:2806-2809 
Soung do Y, Dong Y, Wang Y, Zuscik MJ, Schwarz EM, O'Keefe RJ, Drissi H, 2007. 
Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J Bone Miner Res. 
22:1260-1270. 
Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, Zaidi SK, Young DW, Choi JY, 
Pockwinse SM, 2004. Runx2 control of organization, assembly and activity of the regulatory 
machinery for skeletal gene expression. Oncogene. 23:4315-4329. 
Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M, 2009. Molecular 
pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta. 1796:315-331. 
Tahirov TH, Inoue-Bungo T, Morii H, Fujikawa A, Sasaki M, Kimura K, Shiina M, Sato K, 
Kumasaka T, Yamamoto M, Ishii S, Ogata K, 2001. Structural analyses of DNA recognition by 
the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell. 104:755-767. 
Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G, 2001. Continuous expression of Cbfa1 
in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte 
differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15:467-481. 
Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, 
Hayashi Y, 2003. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired 
trisomy 21, and leukemic transformation in pediatric hematologic malignancies. Genes 
Chromosomes Cancer. 38:1-7. 
Chapter 1 
43 
 
Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR, 2002. 
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing 
during T lymphocyte development. Cell. 111:621-633. 
Tracey WD, Pepling ME, Marko EH, Thomsen GH, Gerben JP, 1998. A Xenopus homologue of 
aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic 
blood. Development. 125:1371-1380. 
Tsuchiya Y, Saito Y, Taniuchi S, Sakuma A, Maekawa T, Fukamachi H, Takeuchi S, Takahashi S, 
2012. Runx3 expression and its roles in mouse endometrial cells. J Reprod Dev. 58:592-598.  
Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto 
H, Nakata K, Takada K, Kurisu K, Komori T, 2001. Skeletal malformations caused by 
overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153:87-
99. 
van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck 
N, 2004. Nomenclature for Runt-related (RUNX) proteins. Oncogene. 23:4209-4210. 
Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY, Nah GS, Du L, Jacob B, Yamashita 
N, Lai SK, Tan TZ, Mori S, Tanuichi I, Tergaonkar V, Ito Y, Osato M, 2014. Disruption of Runx1 
and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional 
and DNA repair defects. Cell Rep. 8:767-782. 
Wang CQ, Motoda L, Satake M, Ito Y, Taniuchi I, Tergaonkar V, Osato M. 2013. Runx3 
deficiency results in myeloproliferative disorder in aged mice. Blood. 122:562-566. 
Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA, 1996a. Disruption of the 
Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks 
definitive hematopoiesis. Proc Natl Acad Sci USA. 93:3444-3449. 
Wang Q, Stacy T, Miller JD Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan 
G, Liu PP, Wynshaw-Boris A, Binder M, Marín-Padilla M, Sharpe AH, Speck NA, 1996b. The 
CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 87:697-708. 
Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA, 1993. Cloning and 
characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-
binding factor. Mol Cell Biol. 13:3324-3339. 
Warren AJ, Bravo J, Williams RL, Rabbitts TH, 2000. Structural basis for the heterodimeric 
interaction between the acute leukaemia-associated transcription factors AML1 and CBFβ. 
EMBO J. 19:3004-3015. 
Watanabe K, Sugai M, Nambu Y, Osato M, Hayashi T, Kawaguchi M, Komori T, Ito Y, Shimizu 
A, 2010. Requirement for Runx proteins in IgA class switching acting downstream of TGF-
beta 1 and retinoic acid signaling. J immunol. 184:2785-2792. 
Chapter 1 
44 
 
Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E, Bok L, 
Peppelenbosch MP, Faber KN, Kleibeuker JH, Dijkstra G, 2008. Runt-related transcription 
factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, 
members 4 and 5. Inflamm Bowel Dis. 14:1615-1622.  
Westerfield M, 2000. The zebrafish book. A guide for the laboratory use of zebrafish (Danio 
rerio). 4th ed., Univ. of Oregon Press, Eugene. 
Wigner NA, Soung do Y, Einhorn TA, Drissi H, Gerstenfeld LC, 2013. Functional role of Runx3 
in the regulation of aggrecan expression during cartilage development. J Cell Physiol. 
228:2232-2242. 
Wong WF, Kohu K, Chiba T, Sato T, Satake M, 2011. Interplay of transcription factors in T-cell 
differentiation and function: the role of Runx. Immunology. 132:157-164.  
Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V, Bernstein Y, Goldenberg D, 
Brenner O, Berke G, Levanon D, Groner Y, 2003. Runx3 and Runx1 are required for CD8 T cell 
development during thymopoiesis. Proc Natl Acad Sci USA. 100:7731-7736. 
Xiao ZS, Simpson LG, Quarles LD, 2003. IRES-dependent translational control of Cbfa1/Runx2 
expression. J Cell Biochem. 88:493-505. 
Yamachika E, Tsujigiwa H, Ishiwari Y, Mizukawa N, Nagai N, Sugahara T, 2001. Identification 
of a stop codon mutation in the CBFA1 runt domain from a patient with cleidocranial 
dysplasia and cleft lip. J Oral Pathol Med. 30:381-383. 
Yamamura Y, Lee WL, Inoue K-I, Ida H, Ito Y, 2006. RUNX3 Cooperates with FoxO3a to Induce 
Apoptosis in Gastric Cancer Cells. J Biol Chem. 281:5267-5276. 
Yamashiro T, Aberg T, Levanon D, Groner Y, Thesleff I, 2002. Expression of Runx1, -2 and -3 
during tooth, palate and craniofacial bone development. Mech Dev. 119:S107-110. 
Yang G, Khalaf W, van de Locht L, Jansen JH, Gao M, Thompson MA, van der Reijden BA, 
Gutmann DH, Delwel R, Clapp DW, Hiebert SW, 2005. Transcriptional repression of the 
Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol. 25:5869-
5879. 
Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, 
Komori T, 2002. Core-binding factor interacts with Runx2 and is required for skeletal 
development. Nat Genet. 32:633-638. 
Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K. Yamana K, Zanma A, Takada K, 
Ito Y, Komori T, 2004. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 
regulates limb growth through induction of Indian hedgehog. Genes Dev. 18:952-963. 
Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, Lee SH, Yang X, Xie R, Javed A, 
Underwood JM, Furcinitti P, Imbalzano AN, Penman S, Nickerson JA, Montecino MA,  
Chapter 1 
45 
 
Young DW, Hassan MQ, Yang X-Q, Galindo M, Javed A, Zaidi SK, Furcinitti P, Lapointe D, 
Montecino M, Lian JB, Stein JL, van Wijnen AJ, Stein GS, 2007b. Mitotic retention of gene 
expression patterns by the cell fate determining transcription factor Runx2. Proc Natl Acad 
Sci USA. 104:3189-3194. 
Zeng Z, Duan Z, Xu S, Pan F, 2013. Is RUNX3 a new player in the pathogenesis of ankylosing 
spondylitis? Rheumatol Int. 33:2449-2450. 
Zheng L, Iohara K, Ishikawa M, Into T, Takano-Yamamoto T, Matsushita K, Nakashima M, 
2007. Runx3 negatively regulates Osterix expression in dental pulp cells. Biochem J. 405:69-
75. 
Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B, 2003. Type X collagen gene 
regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression 
in vivo. J Cell Biol. 162:833-842. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 47 
 
 
Chapter 2 
 
Cloning of Runt-related transcription factor 3 (runx3) 
transcript variants in zebrafish and their expression patterns 
during zebrafish development. 
 
 
 
 
 
 
This chapter is in preparation for publication as a research paper: 
 
Brigite Simões, Natércia Conceição, Robert Kelsh and M Leonor Cancela 
 
 
Author’s contribution: 
All experimental work and writing of the paper was performed by B Simoes, with the 
exception of the pairwise identity analysis and some qPCR experiments performed by N 
Conceição. N Conceição, ML Cancela and RN Kelsh were responsible for the research 
concept and design, critical revision and final approval of the manuscript. 
Chapter 2 
48 
 
2.1 Abstract 
The Runt domain transcription factor is known as polyomavirus enhancer-binding protein 2 
(PEBP2)/core-binding factor (CBF) and is a heterodimer of two different subunits, α and β. In 
humans, three distinct genes, RUNX1, RUNX2 and RUNX3, encode the DNA-binding α 
subunits while the single CBFB gene encodes the shared non-DNA binding β subunit, 
PEBP2β/CBFβ. The RUNX proteins share an evolutionarily conserved 128 amino acid region 
called the Runt domain which is responsible for DNA binding and hetero-dimerization with 
the co-factor CBFβ. This subunit enhances the DNA-binding activity of the RUNX 
transcription factors and regulates their turnover by protecting them from ubiquitin 
proteasome-mediated degradation. All RUNX genes contain two alternative promoters, P1 
(distal) and P2 (proximal). RUNX transcription factors are involved in major developmental 
processes such as hematopoiesis, osteogenesis and neuropoiesis and mutations in these 
genes have been frequently associated with human hereditary diseases and development of 
cancer. 
To improve our understanding of the structure and function of the Runx3 gene, we adopted 
a comparative genomic approach to analyse its domains and degree of conservation. A 
multiple alignment of the RUNX3 proteins from different species revealed high homology of 
the conserved protein domains. We have cloned and characterized several zebrafish runx3 
transcript variants and the corresponding protein isoforms that are derived from alternative 
promoter usage (P1 and P2 promoters) and alternative splicing events. We analyzed the 
temporal expression pattern of zebrafish P1 and P2 derived transcripts by qPCR during 
zebrafish embryonic development and in a variety of adult tissues. Our results show that the 
runx3-P1 and runx3-P2 transcripts are differentially expressed, with the latter showing a 
ubiquitous expression in all tissues analysed and expressed from 24 hpf onwards, in contrast 
to runx3-P1 transcripts that seem to be expressed in a tissue-specific manner and are 
maternally inherited. In addition, mRNA in situ hybridization was performed in whole mount 
zebrafish embryos and runx3 expression was detected in neural and cartilaginous tissues. 
Altogether our data show that zebrafish can be a valuable vertebrate model to gain insight 
about the complex regulation of the runx3 isoforms and to perform functional studies in 
order to clarify the importance of each isoform in development. 
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2.2 Introduction 
The PEBP2/CBF is a small family of heterodimeric transcription factors composed of α and β 
subunits (Ito, 2004). The α-subunit is encoded by the runt domain genes 
(PEBP2α/AML/RUNX) that are characterized by containing a highly conserved 128 amino 
acid region (the runt domain). The runx genes were first described in Drosophila 
melanogaster, and shown to be essential for the formation of segmentation pattern in 
embryos (Gergen and Butler, 1988).  
The RUNX proteins bind as homodimers to the promoter region of target genes recognizing 
the consensus DNA motif TGPyGGTPy (where Py is a pyrimidine) through the runt domain, 
and either act as activators or repressors. They can also heterodimerize with the non-DNA 
binding β-subunit (PEBP2β/CBFβ), that enhances the DNA-binding activity of the α subunit 
and stabilizes their proteins regulating their turnover by protecting them from ubiquitin 
proteasome-mediated degradation (Kagoshima et al, 1996). 
So far, one α subunit has been identified in Caenorhabditis elegans (rnt-1), three in 
mammals (Runx1/AML1/Cbfa2, Runx2/AML3/Cbfa1 and Runx3/AML2/Cbfa3) (Ito, 2004; van 
Wijnen et al, 2004) and four in Drosophila (Runt, Lozenge, CG34145 and CG42267) (Canon 
and Banerjee, 2000; Rennert et al, 2003), in zebrafish (runx1, runx2a, runx2b and runx3) and 
in Fugu (frRunx1, frRunx2, frRunx3, and frRunt). For the β subunit, one gene has been 
described in all species (bro-1 for C. elegans and CBFβ for mammals and fish), except for 
Drosophila, in which two genes were found (Brother and Big-brother) (Golling et al, 1996).  
All RUNX genes are regulated from two distinct promoters, P1 and P2, giving rise to two 
major protein isoforms differing in the first amino acids of the N-terminal (Tighe and Calabi, 
1994; Miyoshi et al, 1995; Geoffroy et al, 1998; Xiao et al, 1998; Levanon et al, 2001; Makita 
et al, 2008). The alternative promoter usage, in combination with alternative splicing 
contribution from exon skipping and multiple poly(A) tail sites, produce a large variety of 
alternatively spliced isoforms, resulting in the complex biological functions of Runx proteins 
(Miyoshi et al, 1995; Terry et al, 2004;  Ng et al, 2007).  
RUNX genes have been functionally characterized in many organisms, and are known to play 
essential roles in metazoan development (Coffman, 2003). Even if expression of the Runx 
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genes can overlap in some tissues (Le et al, 1999), they have distinct roles in tissue 
morphogenesis and homeostasis, controlling critical cell fate decisions in a number of 
different cell lineages (reviewed in Chuang et al, 2013 ) and being involved in the 
transcriptional control of developmental processes (Wheeler et al, 2000; Taniuchi et al, 
2002; Coffman, 2003). Although many studies have been published about Runx genes, their 
biological function and regulation is still not completely understood. It was previously shown 
that RUNX genes are involved in hematopoiesis, neurogenesis and osteogenesis and are also 
implicated in disease and cancer. Runx1 is involved in regulation of hematopoiesis (Ichikawa 
et al. 2004; Komori, 2005; Growney et al, 2005), Runx2 is essential for bone and tooth 
development (Otto et al, 1997; Komori et al, 1997; D’Souza et al, 1999; Maruyama et al, 
2007) and Runx3 is critical for gastric epithelial differentiation, neurogenesis of dorsal root 
ganglia and T cell differentiation (Levanon et al, 2002; Brenner et al, 2004; Komori, 2005; 
Friedrich et al, 2006; Lee et al, 2011; Reis et al, 2013). 
Functional studies in different model organisms showed that alteration in the Runx3 
expression levels affect the hematopoietic lineage (Kalev-Zylinska et al, 2003; de Bruijn and 
Speck, 2004; Wang et al, 2013), chondrocyte maturation (Yoshida et al, 2004; Hecht et al, 
2008; Zhang et al, 2009; reviewed in Komori, 2015), and dorsal root ganglia (DRG) 
development (Inoue et al, 2002, 2003; Nakamura et al, 2008). In zebrafish, a runx3 
orthologue was previously identified and three splicing transcripts, encoding two protein 
isoforms with a different N-terminal, Runx3-MASN and Runx3-MHIPV, were described 
(Kataoka et al, 2000; Kalev-Zylinska et al, 2002). These studies characterized the zebrafish 
runx3 embryonic expression, confirming a broad expression pattern similar to what was 
observed in mammals, and including Rohon-Beard neurons, trigeminal ganglia, craniofacial 
cartilage and hematopoietic cells. Some knockdown studies demonstrated that a reduction 
in the runx3 transcript levels affect hematopoietic cells, neurons and craniofacial cartilage. It 
is still not clear whether the runx3 transcripts are differentially expressed and if the encoded 
protein isoforms have different roles in development.  
Here we describe the cloning of 12 new zebrafish runx3 splicing transcript variants, derived 
from a combination of different promoter usage and alternative splicing. We analysed the 
expression pattern of the runx3-P1 and runx3-P2 derived transcripts in both zebrafish adult 
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tissues and developmental stages, using quantitative real-time PCR (qPCR) targeting the 
transcript-specific 5’ UTR sequence, and the results confirm that they are differentially 
expressed. The mRNA expression pattern was also analysed by in situ hybridization, using a 
riboprobe that recognized the common region of both transcript variants, or a riboprobe 
that recognized the 5’ UTR region specific to each transcript. The expression of the runx3-P2 
derived transcripts appeared to overlap with that of the riboprobe recognizing the common 
region, but no conclusion could be taken about the expression of the runx3-P1 derived 
transcripts.  
 
2.3 Material and Methods 
2.3.1. Ethics statement 
All zebrafish (Danio rerio) studies were conducted using the wild type (AB) strain, both at the 
aquarium at the University of Algarve (Faro, Portugal) or at the University of Bath (Bath, UK). 
The experiments were conducted following the legislation for animal experimentation and 
welfare either in Portugal, in accordance with the Portuguese law (Portaria 1005/02 and 
Portaria 1131/97) which transcribes the European Guideline 86/609/EC, and in UK, according 
to the Animals (Scientific Procedures) Act 1986 - Scientific Procedures on Living Animals, 
under a personal Home Office licence. 
 
2.3.2. Zebrafish maintenance 
Embryos were obtained from natural spawning and maintained according to each fish facility 
standard procedures. The embryos were collected in embryo medium (Westerfield, 2000), 
raised up to 5 days post fertilization (dpf) in an incubator with a constant temperature of 
28.5°C and staged according to Kimmel et al (1995) (occasionally, their development was 
slowed down or speeded up at 23°C or 33°C, respectively, if needed for a specific 
experiment). For some experiments, embryos were treated with 0.003% 1-phenyl-2-thiourea 
(PTU; Sigma) to inhibit pigment formation and thus facilitating imaging and staining for 
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whole-mount in situ hybridization (ISH). All specimens were deeply anesthetised in Tricane 
(3-amino benzoic acid ethyl ester also called ethyl 3-aminobenzoate) (Sigma-Aldrich) before 
manipulation as described (Westerfield, 2000).  
 
2.3.3 Sequence alignment and analysis 
BLAST facilities at NCBI (National Center for Biotechnology Information, 
www.ncbi.nlm.nih.gov) and Ensembl (http://www.ensembl.org/) databases were used to 
search for sequences showing similarity with zebrafish runx3 gene and protein.  
Alignments for Runx3 sequences were created using ClustalW (Thompson et al, 1994) or 
T-Coffee multiple sequence alignment software (Notredame et al, 2000; 
http://www.ebi.ac.uk/Tools/msa/tcoffee/) with parameters set to the default. Sequence 
logos were then created by T-Coffee from multiple alignments using WebLogo facilities at 
weblogo.berkeley.edu (Schneider and Stephens, 1990).  
Percentage protein identity was calculated using the Sequence Manipulation Suite (Stothard, 
2000) available at http://www.bioinformatics.org. 
 
2.3.4 RNA preparation 
Total RNA was prepared from different adult tissues using the acid guanidium thiocyanate 
procedure (Chomczynski and Sacchi, 1987). Due to the low weight of the individual 
embryonic and larvae samples RNA was extracted from pools of zebrafish embryos at 
different stages of development using the TRIzol Reagent (Sigma-Aldrich) as recommended 
in the manufacturer’s protocol. RNA integrity was assessed through 1% (w/v) 
agarose/MOPS-formaldehyde gel electrophoresis with ethidium bromide staining (Sambrook 
et al, 1989) and RNA quantity was determined through spectrophotometry (NanoDrop 1000; 
Thermo Scientific). Total RNA (1 μg) was then treated with RQ1 RNase‐free DNase I 
(Promega) for 30 min at 37°C, and reverse‐transcribed at 37°C for 1 h using the 
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Moloney-murine leukemia virus (MMLV) reverse transcriptase, RNaseOUT (both from 
Invitrogen) and oligo(dT)‐adapter or a gene specific primer (DrRunx3_R2, Table 2.S1). 
 
2.3.5 Construction of cDNA library 
Total RNA from a pool of embryos at different developmental stages (2 dpf, 20 dpf, 25 dpf, 
40 dpf and adult male) was extracted as described in section 2.3.4. High-quality Poly A+ RNA 
was purified using the Oligotex mRNA Midi Kit (Qiagen) and used in the construction of a 
Marathon cDNA library (Clontech) according to manufacturer’s instructions. Briefly, the 
cDNAs were transcribed from 1 µg of purified Poly A+ RNA blunt ends were created and the 
Marathon adaptors were ligated to both ends of the double-stranded cDNA.  
 
2.3.6. cDNA Cloning 
The zebrafish runx3 sequences for P1-derived transcripts (AB043789 and AB043790) and 
P2-derived transcript (AB043788) were used as templates to design zebrafish runx3 gene 
specific primers. All primer sequences used for cloning are shown in Table 2.S1.  
 
2.3.6.1. Rapid amplification of cDNA ends (RACE) 
The 5’ ends of zebrafish runx3-P1 and runx3-P2 transcripts were amplified by RACE-PCR 
using gene specific reverse primers Runx3_R2 and Runx3_R4 and Marathon AP1 and AP2 
adaptor primers (Table 2.S1), respectively in a primary and nested reaction, and the 
zebrafish Marathon cDNA library described in section 2.3.5. Amplifications were performed 
using the Advantage cDNA polymerase mix (Clontech) as suggested by the supplier. The 
resulting cDNA fragments were size-separated by electrophoresis on an agarose gel, purified 
using GeneJET Gel Extraction Kit (Thermo Scientific), cloned into pCRII-TOPO (Life 
technologies) and sequenced on both strands to confirm their identity. 
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2.3.6.2. Amplification of full-length cDNA 
Amplification of the different zebrafish runx3 transcripts was performed by two steps PCR 
with gene specific primers (Table 2.S1) and either with the Taq DNA polymerase (Life 
technologies) or the KOD Hot Start DNA Polymerase (Novagen), in a GeneAmp 2400 
thermocycler (Perkin-Elmer), under conditions suggested by the suppliers. The template 
cDNA used was obtained, using the specific reverse primer DrRunx3_R2, from RNA obtained 
either from 48 hours post fertilization (hpf) embryos or adult male zebrafish, as described in 
section 2.3.4.  
runx3 P1-derived isoforms 1 to 5 were amplified using cDNA from 48 hpf zebrafish embryos, 
in a primary PCR with primers DrRunx3II_F2 and DrRunx3_R8, and then used as template in a 
semi-nested PCR with the same sense primer and with the antisense primer DrRunx3_R6, 
and cloned into pCR-BluntII-TOPO vector (Life technologies). 
runx3 P2-derived isoform 6 and isoforms 9 to 12 were amplified using cDNA from 48 hpf 
zebrafish embryos, in a primary PCR with primers DrRunx3I_F5 and DrRunx3_R8, and then in 
a nested PCR with primers DrRunx3I_F4 and DrRunx3_R6, and cloned into pCR-BluntII-TOPO 
vector. runx3 P2-derived isoforms 7 and 8 were amplified using cDNA from an adult male 
zebrafish, in a primary PCR with primers DrRunx3I_F2 and DrRunx3_R2, and then a nested 
PCR using primers DrRunx3_F5 and DrRunx3_R6, and cloned into pCRII-TOPO vector.  
Cloned fragments were identified by restriction digestion and sequenced on both strands to 
confirm their identity. 
 
2.3.7 Measurement of relative gene expression by quantitative real-time PCR 
Gene expression was performed by qPCR for runx3 isoform specific transcripts using primers 
designed from 5’-unique sequences. For P1-derived transcripts we used the primers 
DrRunx3II&III_F1/DrRunx3II&III_R2 and for P2-derived transcripts we used the primers 
DrRunx3I_F3/DrRunx3I_R2 (Table 2.S1). RNA was prepared as described in section 2.3.4. 
qPCR was performed in a StepOnePlus apparatus (Applied Biosystems, Invitrogen). PCR 
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reactions, set up in duplicates, were carried out using SsoFast EvaGreen Supermix (Bio-Rad) 
according to manufacturer’s instructions. Melting profiles and gel electrophoresis of each 
reaction were performed to check for unspecific product amplification. Levels of gene 
expression were calculated using the comparative method (ΔΔCt) and normalized using gene 
expression levels of 18S ribosomal RNA or elongation factor 1-alpha (ef1α) housekeeping 
genes.  
 
2.3.8 Probe synthesis and whole mount ISH staining 
A fragment of 995 bp of zebrafish runx3 transcript was PCR amplified with primers 
DrRunx3_F3/DrRunx3_R2 (Table 2.S1), using 2x BioMix (Bioline) solution as recommended 
by the manufacturer, and cDNA synthesized from 33 hpf zebrafish (as described in section 
2.3.4). Then it was inserted into pGEM-T-easy vector (Promega) by standard TA-cloning. 
runx3-P1 and runx3-P2 specific fragments were amplified (178 bp and 589 bp, respectively) 
with primers DrRunx3II_F1/DrRunx3II&III_R1 and DrRunx3I_F2/DrRunx3I_R1 (Table 2.S1) 
respectively, using the Taq DNA polymerase as recommended by the manufacturer, and 
cDNA synthesized from adult male zebrafish (as described in section 2.3.4), and cloned into 
pCRII-TOPO. All fragments were sequenced on both strands to confirm their orientation and 
identity. Those constructs were used as templates to each probe synthesis. The plasmids 
were linearized using the appropriated enzyme (Table 2.1). Then, digoxigenin (DIG)-labeled 
antisense RNA probes were synthesized using either T7 or SP6 RNA polymerases (Table 2.1) 
according to the manufacturer’s specifications (Roche). Whole-mount RNA ISH was 
performed as previously described (Thisse et al, 1993). After the hybridization, some 
embryos were embedded in paraffin, cut into 5 µm-thick sections, and imaged in an Eclipse 
E800 (Nikon) microscope.   
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Table 2.1 Information for ISH probe synthesis. 
probe Plasmid Enzyme Polymerase size Notes 
runx3 (+runt) pCRII-TOPO 
ApaI SP6 anti-sense 
sense 
1175 bp 
SacI T7 
runx3 (-runt) pGEM-T-Easy 
SacI T7 anti-sense 
sense 
995 bp 
ApaI SP6 
P1-runx3 pCRII-TOPO 
SacI T7 anti-sense 
sense 
178 bp 
XhoI SP6 
P2-runx3 pCRII-TOPO 
SacI T7 anti-sense 
sense 
589 bp 
XhoI Sp6 
 
2.4 Results 
2.4.1 Molecular characterization of zebrafish runx3 gene 
Kataoka and colleagues (2000) have previously published the cloning of three zebrafish 
runx3 transcripts (that they designated runxb) generated by alternative promoter usage and 
alternative splicing (Kataoka et al, 2000). In order to amplify the corresponding zebrafish 
open reading frames (ORFs) we used the runx3 transcripts (Accession Numbers: AB043788, 
AB043789 and AB043790) previously described as templates to design our primers. First we 
performed BLAST analysis against the zebrafish genome (Danio rerio strain Tuebingen 
chromosome 13, GRCz10) in NCBI database to determine the gene structure and the 
transcript variations. The zebrafish runx3 gene was found on chromosome 13 in the reverse 
orientation (position 44960717 - 45064151) with a length of approximately 103.4 kb and it is 
organized in 7 exons and 6 introns (Figure 2.1), showing a structure slightly different from 
the runx3 genomic structures known for other species, where the gene is organized in 6 
exons and 5 introns.  
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Figure 2.1 Schematic representations of the zebrafish runx3 gene, the cDNA splicing variants 
and corresponding protein structure. In gene structure, exons are represented by black 
boxes and introns by solid black lines. Exon sizes are indicated inside the boxes and the 
intron sizes indicated above the lines. Exons are in scale but the introns are not. The two 
alternative promoter regions are also indicated (arrow). In cDNA structure, black represents 
the coding sequence and white the 5’ and 3’ untranslated regions. The ATG translation start 
and TAA stop codons are also indicated. In the protein structure, the Runx protein 
characteristic domains are represented as well as their corresponding region in the cDNA 
(dot lines). Box with horizontal and vertical lines indicates specific N-terminal from P1- and 
P2-derived isoforms, respectively. RHD – runt homology domain; NLS – nuclear localization 
signal; TAD – transactivation domain; ID – inhibition domain; PPPY -  short proline-rich motif; 
NMTS - nuclear matrix targeting signal; VWRPY – Runx conserved penta-peptide motif. 
 
The sites of exon-intron borders were deduced by comparison of the transcript sequences 
with the genomic sequence and it was observed that all exon-intron splicing junctions match 
consensus sequences for donor and acceptor sites (result not shown). The runx3 transcripts 
are transcribed from two alternative promoters (P1/distal and P2/proximal) and encode two 
Runx3 protein isoforms that differ only in their N-terminal sequence (Figure 2.1). The P1-
derived transcripts (AB043789 - type II and AB043790 - type III) generate a 438 amino acids 
protein containing a specific N-terminal of 19 amino acids (MASNSIFDTFSSYSPSLLR) present 
only in the P1-derived isoforms. The P2-derived transcript (AB043788 - Type I) does not 
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contain exon 1, been transcribed from an alternative promoter in intron 1, and so it is 
translated from a different ATG codon present in exon 2, generating a 424 amino acids 
protein containing a specific N-terminal of five amino acids (MHIPV) present only in the P2-
derived isoforms (Kataoka et al, 2000). Due to their N-terminal sequences, in this work these 
isoforms are also referred as Runx3-MASN or Runx3-MHIPV isoform, depending if we are 
referring to a P1-derived or P2-derived isoform, respectively.  
From the cDNA deduced primary structure and by comparative analysis between all RUNX 
proteins, we identified the typical domains present in all Runx proteins characteristic of this 
family of proteins: the runt domain (RHD), transcription activation domain (TAD), inhibition 
domain (ID), nuclear localization signal (NLS), nuclear matrix target signal (NMTS) and PPPY 
and VWRPY domains (Figure 2.1). 
 
2.4.2 in silico analysis of Runx3 protein isoforms 
Sequence databases at NCBI (www.ncbi.nlm.nih.gov) and Ensembl (www.ensembl.org) were 
searched for annotated RUNX3 sequences. A total of 23 RUNX3 sequences were collected 
(Table 2.S2). The full collection of sequences represents 18 species, from most classes of 
vertebrates (actinopterygii, chondrichthyes, amphibian and mammalia). We have calculated 
the pairwise percentage identities with Manipulation Suite facilities among RUNX3 isoform 
protein sequences of different species, observing that the amino acid sequence of zebrafish 
Runx3 has higher identity to those of grass carp (94%) and fugu (74%) and a sequence 
identity of 61-64% compared to mammals (including human) (Figure 2.2).  
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Figure 2.2 Pairwise percent identities among RUNX3 (A) P1-derived (MASN) and (B) 
P2-derived (M(H/R)IPV) isoforms. From light grey to black: actinopterygii, chondrichthyes, 
amphibia, mammalia. Hsa, Homo sapiens (human); Mmu, Macaca mulata (rhesus macaque); 
Bta, Bos Taurus (bovine); Mmus, Mus musculus (mouse); Rno, Rattus norvegicus (rat); Dre, 
Danio rerio (zebrafish); Cid, Ctenopharyngodon idella (grass carp); Oni, Oreochromis niloticus 
(tilapia); Loc, Lepisosteus oculatus (Spotted gar); Pfo Poecilia formosa (Amazon molly); Xma, 
Xiphophorus maculatus  (Southern platyfish); Cmi, Callorhinchus milii (elephant shark); Xla, 
Xenopus laevis (African clawed frog);  Tni, Tetraodon nigroviridis (spotted green pufferfish); 
Tru, Tetraodon rubripes (torafugu); Sca, Scyliorhinus canicula (lesser spotted catshark); Laf, 
Loxodonta africana  (elephant); Pan, Papio anubis (Olive baboon). Diagonal grey values are 
sequence lengths. 
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As the overall Runx3 protein sequence identity between zebrafish and the mammals was not 
very high, we decided to analyse the degree of conservation between the domains of the 
RUNX3 proteins. The RUNX3 sequences (Table 2.S2) were aligned using T‐Coffee and the 
result submitted to WebLogo software that generates sequence logos, a graphical 
representation of the patterns within a multiple sequence alignment (Figure 2.3). In the 
webLogo graph, the amino acid similarity is represented by the height of the each letter 
(logos that represent amino acid residues) that is directly proportional to the probability of 
the corresponding amino acid, so the conservation can be easily assessed (Figure 2.3).  
 
Figure 2.3 Schematic representation of the conservation in RUNX3 protein domains. The 
characteristic domains found in all RUNX proteins are indicated to show their relative 
positions along the protein. The multiple sequence alignment (using T-Coffee and WebLogo) 
using 23 RUNX3 proteins from 18 different species was used to determine the amino acid 
conservation in the different protein domains. NLS - nuclear localization signal, TAD - 
transactivation domain, ID - inhibitory domain, PY - short proline-rich motif, P -residue 
targeted for phosphorylation, VWRPY – Runx conserved penta-peptide motif. 
 
As expected, we could observe a high degree of conservation of the runt domain as well as a 
100% conservation of the NLS, PY and VWRPY motifs (Figure 2.3). The TAD and ID domains 
showed more variation, however some residues are still 100% conserved, indicating that 
they probably have a major contribution to the function of that domain (Figure 2.3). 
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2.4.3. Cloning of new zebrafish runx3 transcript variants 
In an attempt to amplify the zebrafish transcripts that derived from alternative promoter 
usage (P1/Distal or P2/Proximal) that generates different Runx3 isoforms, we hereby 
identified and cloned 12 different transcripts (Figure 2.4), 10 of each are new transcript 
variants that are described in this study for the first time, and found to have a structure 
different from that of any previously reported isoform of zebrafish runx3 cDNAs. Two of the 
transcripts are similar to the P1-derived and P2-derived isoforms previously described (runx3 
isoform 1 and runx3 isoform 6, respectively), four correspond to splicing variants of 
P1-derived transcripts (runx3 isoform 2 to 5) and six correspond to splicing variants of 
P2-derived transcripts (runx3 isoforms 7 to 12). These transcripts result from alternative 
exon skipping, generating different protein isoforms, depending on the splicing event. The 
identity of the runx3 cDNA sequences obtained was confirmed using blast searches against 
GenBank (NCBI) database. The nucleotide sequences of these new spliced variants were 
deposited in GenBank as runx3 isoforms 1 to 12 (GenBank ID: KP866665, KP866666, 
KP866667, KP866668, KP866669, KP866670, KP866671, KP866672, KP866673, KP866674, 
KP866675, KP866676, respectively). 
The ORF sequence of the runx3 isoform 1 and isoform 6 transcripts are similar to the ORF 
sequence of the runx3 transcripts (AB043789 and AB043788, respectively) previously 
published in Kataoka et al (2000) (Figure 2.4). Comparison between both sequences shows 
that the runx3 isoform 1 and the isoform 6 have nine nucleotides different from the 
published sequences, causing an ORF with two amino acid substitutions.  
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Figure 2.4 Schematic representation of zebrafish alternatively spliced runx3 cDNA 
transcripts. (A) Schematic representation of the runx3 gene structure. The exons are 
represented by black boxes, and the lines represent the introns and intergenic sequences. 
The exons are scale represented, but the introns are not. (B) Schematic representation of 
the alternative spliced runx3 transcripts cloned. Black boxes represent coding exons, grey 
boxes represent spliced exons and white boxes represent UTRs. Start and stop codons are 
represented. Arrows represent the location of primers used for the amplification of the 
ORFs. 
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The transcripts of runx3 isoforms 2 to 5 are splicing variants of isoform 1 that have a splicing 
event that eliminates one or more exons (Figure 2.4). Isoform 2 is a splicing variant that 
loses exon 5, and we predicted that it loses the NLS and part of the TAD domain, but keeps 
the coding region for the runt domain intact. On the other hand, transcripts of isoforms 3 to 
5 have a splicing event that eliminates multiple exons: isoform 3 has a splicing from 
nucleotide 803 in exon 2 to nucleotide 122 in exon 6; isoform 4 has a splicing that eliminates 
exons 2 to 4; and isoform 5 has a splicing that eliminates exons 2 to 6a (Figure 2.4). The 
transcripts of runx3 isoforms 7 to 12 are splicing variants of isoform 6, and all have multiple 
exons eliminated by alternative splicing events (Figure 2.4). The isoform 7 loses its exons 5 
and 5a that corresponds to the coding of NLS and part of the TAD domains, but maintains its 
runt domain intact, suggesting that can be a functional isoform. The isoforms 8 and 9 have a 
splicing from nucleotide 52 of exon 4 to nucleotide 65 of exon 6 (isoform 8) and from 
nucleotide 725 of exon 2 to nucleotide 296 of exon 6 (isoform 9), causing a frame shift that 
produces a premature stop codon (Figure 2.4). On the other hand, the isoforms 10 to 12 
have an extensive splicing event that eliminates the majority of the exons including the start 
codon ATG. As a consequence, these runx3 transcripts are likely to result in loss-of-function 
mutants. 
 
2.4.4 Molecular structure of zebrafish runx3 5’ UTR regions  
We employed RACE analyses to map the transcription-start sites (TSSs) downstream the two 
promoters, runx3-P1 and runx3-P2. A new putative TSS was mapped by 5’-RACE for the 
P1-transcript, and contains 642 bp of 5’-untranslated region from the translation initiation 
ATG codon (Figure 2.5). The sequence of this new P1-5’ UTR splicing variant, named runx3 
isoform 14 (GenBank ID: KP866678) corresponds to the AB043789 transcript described by 
Kataoka et al (2000) carrying the 221 bp splicing event (nucleotides -277 to -57) but with 
more 182 bp of 5´ UTR region (Figure 2.5). Besides this, we also found a new P1-5’ UTR 
regions splicing variant, named runx3 isoform 13 (GenBank ID: KP866677), obtained from 
cDNA of an adult zebrafish speciemen (as described in section 2.3.6.2), that corresponds to 
the AB043789 transcript previously described by Kataoka et al (2000) but with more 313 bp 
of 5’ UTR region (Figure 2.5). Regarding the P2-TSS, we also amplified and sequenced one 
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major DNA fragment that placed the major P2-TSS 562 bp upstream of the initiator ATG 
codon, matching the sequence available in the NCBI database (AB043788) (Results not 
shown). 
 
Figure 2.5 Schematic representations of the splicing events within the runx3 exon 1 affecting 
the 5’ UTR of the P1-derived transcripts. (Top) Representation of the runx3 exon 1. White 
box represents 5’ UTR region, black box represents coding region. ATG codon is also 
represented. The A from the ATG codon of the runx3 P1-derived transcripts is represented as 
+1. (Bottom) Representation of the different 5’ UTRs of the P1-derived transcripts described 
and the new transcripts obtained in this work, originated by alternative splicing. The 
rectangles represent transcript sequences and lines represent spliced sequences. 
 
The analysis of both 5’ UTR regions of runx3 transcripts, revealed several ATG nucleotide 
triplets upstream of the ATG codon that is known to initiate Runx3 protein isoforms. Using a 
translation program (http://web.expasy.org/translate/), we could predict some putative 
upstream open reading frames (uORFs) in both 5’ UTR regions, that can vary in size from 
very small (just one amino acid long) to longer peptides (70 amino acids long) (Figure 2.S1). 
The presence of one or more uORFs has been shown to repress the translation of the 
downstream ORF and this feature has been associated with tissue-specific gene regulation 
and developmental control (van der Velden and Thomas, 1999). 
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2.4.5 qPCR analysis of runx3 P1 and P2 transcript variants 
The gene expression of runx3-P1 and runx3-P2 derived transcripts has been evaluated in a 
variety of adult zebrafish tissues (including calcified and non-calcified soft tissues) by qPCR, 
using specific primers and normalized using the ef1α as housekeeping gene (Figure 2.6). The 
expression of P1-derived transcripts was detected mainly in the calcified tissues analysed, 
with the highest levels observed in the pectoral fins (≈6 fold) and in the branchial arches 
(≈15-fold), and with a similar relative expression in the brain, heart and skin and its 
expression in the liver and muscle is barely detectable (Figure 2.6A). P2-derived transcripts 
expression was detected in all tissues analysed, with the highest levels of expression in the 
calcified tissues (between ≈15-fold to ≈37-fold) compared to the expression in the soft 
tissues (between ≈1.7-fold to ≈12-fold) (Figure 2.6B).  
 
Figure 2.6 Levels of runx3-P1 and runx3-P2 derived transcripts in adult zebrafish tissues. 
Levels of gene expression were determined by qPCR in adult soft and calcified tissues and 
normalized using ef1α as housekeeping gene. The level in female gonads (Gn) was used as a 
reference and set to 1. Gn – female gonads; Br – brain; Ht – heart; Lv – liver; Ms – muscle; Sk 
– skin; BA – branchial arches; MO – mandibular operculum; PF – pectoral fins; Ra – rays; Te – 
teeth; TV – trunk vertebrae. Values are the mean of at least three replicates with error bars 
representing ± standard deviation (S.D.).  
 
To analyse the temporal expression of runx3-P1 and runx3-P2 derived transcripts during 
zebrafish embryogenesis, mRNAs collected at seven different time points between 1-cell and 
13 dpf were analysed by qPCR using specific primers and normalized using the 18S as 
housekeeping gene. A different expression pattern was observed for runx3-P1 and runx3-P2 
derived transcripts during the initial stages of zebrafish development (Figure 2.7).  
 
A B 
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Figure 2.7 Levels of runx3-P1 and runx3-P2 derived transcripts in embryonic zebrafish 
development. Levels of gene expression were determined by qPCR in different embryonic 
developmental stages and normalized using 18S as housekeeping gene. S means somites. An 
arbitrary unit was used as reference. Values are the mean of two replicates with error bars 
representing S.D. 
 
While runx3-P1 derived transcripts are detected already at 1 cell (Figure 2.7A), runx3-P2 
transcripts can only be detected from 24 hpf onwards, showing its highest expression at 72 
hpf (Figure 2.7B). Interestingly, the expression of runx3-P1 derived transcripts decreases 
until 24 hpf and then it increases again until 13 dpf (Figure 2.7A). 
 
2.4.6 Expression patterns of zebrafish runx3 gene expression 
To determine the spatial and temporal expression pattern of runx3, whole-mount ISH time 
course was performed in wild-type zebrafish embryos. A runx3 specific riboprobe (995 bp), 
which is complementary to the 3’ of the runx3 cDNA, including part of the sequence that 
codes for the runt domain (common part of all runx3 transcripts) was used. Zebrafish wild 
type specimens, from 24 hpf up to 4 dpf were collected, fixed and submitted to whole 
mount ISH (Figure 2.8, A-F) and posterior cross-sections at 24 hpf and 36 hpf were also 
analysed (Figure 2.8, G-H).  
 
A B 
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The results of the ISH confirmed the runx3 expression pattern previously published (Kataoka 
et al, 2000; Kalev-Zylinska et al, 2003). We observed runx3 in the first stage analysed, at 18 
hpf, in the trigeminal ganglions and in the Rohon-Beard neurons (rb), that are primary 
sensory neurons located dorsally in the embryos (Figure 2.8A, A’ to E, E’). The expression in 
the rb neurons is still very strong at 24 hpf, but then gradually decreases being the number 
of rb expressing cells much lower at 60 hpf and almost non-existent at 4 dpf This is in 
agreement with previous studies showing that rb sensory neurons die over a protracted 
period of time (Williams et al, 2000; Cole and Ross, 2001; Reyes et al, 2004). Reyes and 
colleagues, showed that in zebrafish embryos rb neurons begin to show signs of 
programmed cell death as early as 1 dpf and that most rb cells died by 4 dpf (Reyes et al, 
2004). At 24 hpf runx3 expression is also detected in the lateral line primordia (llp), that 
migrates along the trunk (Figure 2.8B, C, D’). We also observed runx3 expression at the 
cranial sensory ganglia from 48 hpf, as well as, in the base of the pectoral fins and in the 
cranial cartilages at 4 dpf (Figure 2.8D, E, F). The same expression pattern was observed 
using a probe spanning 1175 bp (Table 2.1), containing all sequence that codes for the runt 
domain (results not shown). However, we fail to detect runx3 expression in the 
hematopoietic tissues, suggesting that maybe our protocol needs to be improved to increase 
sensitivity. Posterior cross-sections of the trunk at 24 hpf and 36 hpf confirmed the 
expression in the Rohon-Beard neurons (Figure 2.8G, G’, H; arrow) and at 36 hpf we 
observed expressing cells that seems to lay outside of the neural tube and that may be part 
of the dorsal root ganglia (Figure 2.8H, H’; arrowhead). 
To further assess the sites of expression for each runx3-P1 or runx3-P2 transcript variant, 
whole-mount ISH was performed using specific riboprobes for the 5’ UTR of the P1-derived 
and P2-derived transcripts (Table 2.1; Figure 2.8I, I’, J, K, K’). In the stages analysed we could 
not identify any structure expressing the P1-derived transcripts (Figure 2.8I, I’), but when a 
specific riboprobe for the P2-derived transcripts was used we could detect expression in 
trigeminal ganglions, Rohon-Beard neurons of neural tube, lateral line primordial, base of 
the developing pectoral fins, and cranial sensory ganglia (Figure 2.8J, K, K’), the same tissues 
that were detected when we used a riboprobe for the common part of runx3 (Figure 2.8A-F).  
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Figure 2.8 Analysis of runx3 transcripts localization during early zebrafish developmental stages by ISH. Lateral (A, A’, B, B’, C, C’, D’, E, E’, F’, I, 
I’, J, K and K’) and dorsal (B’’, C’’, D and F) views of zebrafish embryos. In all pictures embryos are oriented anterior to the left and dorsal to the 
top. Transversal cross-sections of the trunk after whole mount ISH (G, G’, H, H’) showing runx3 expression in Rohon-Beard cells (arrows in G’ G’, 
H) and expressing cells that lay outside the neural tube (arrowheads in H, H’). runx3 probe complementary to the common region of the 
different runx3 transcripts (A-H’), runx3-P1 transcripts specific probe (I, I’) and runx3-P2 transcripts specific probe (J, K, K’).  hpf – hours 
post-fertilization; dpf – days post-fertilization. tg - trigeminal ganglions; rb - Rohon-Beard neurons; llp - lateral line primordial; bpf - base of the 
developing pectoral fins; csg - cranial sensory ganglia; cc – cranial cartilages.  
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2.5 Discussion 
Prior to this work, there were three major transcripts described for zebrafish runx3 that are 
transcribed from two promoters and give rise to two proteins that differ in their N-terminal 
sequence. The runx3 P2-derived transcript (named type I variant) is derived from the 
proximal (or P2) promoter and encodes the 424 amino acid P2-Runx3 protein isoform, also 
called the Runx3-shorter or Runx3-MHIPV isoform. On the other hand, due to 5’ UTR splicing 
events two major transcripts are transcribed from the Distal (or P1) promoter (named runx3 
Type II and Type III variants) and encoding the 438 amino acid P1-Runx3 protein isoform, 
also called the Runx3-longer or Runx3-MASN isoform. The only difference between the two 
isoforms is the N-terminal – the first five amino acids of the Runx3-MHIPV isoform and the 
first 19 amino acids of the Runx3-MASN isoform are specific to each isoform. After that, both 
isoforms have exactly the same amino acid sequence and the alignment of the P1 and P2 
full-length isoforms of RUNX3 proteins revealed several highly conserved protein domains. 
As expected, the 128 amino acid runt domain that is critical for DNA binding and 
heterodimerisation is highly conserved in all RUNX proteins. The NLS, VWRPY and PY motifs 
are also highly conserved. Our in silico results comparing the zebrafish Runx3 and vertebrate 
orthologs are in agreement with previous reports that have also studied the conservation of 
the RUNX3 proteins through evolution (Rini and Calabi, 2001; Ng et al, 2007; Nah et al, 
2014). 
The RUNX family of transcription factors have been extensively studied over the last years, 
due to their involvement in a variety of biological processes and disease, and they have been 
shown to be regulated by two alternative promoters that generated different transcript 
variants, and those are also subject to alternative splicing events generating a variety of 
RUNX protein isoforms (Coffman, 2003; Komori, 2005; Cohen, 2009; Wang et al, 2010; 
Chuang et al, 2013; among others). Although they are highly similar in respect to their 
genomic organization, DNA sequence and transcriptional regulation, functional studies have 
shown that the disruption of each RUNX gene causes different phenotypes, indicating tissue-
specific roles Coffman, 2003; Chuang et al, 2013). The regulation of genes by alternative 
promoters and the existence of multiple alternative splicing variants have been associated 
with complex regulation of gene expression (Ayoubi and Van De Ven, 1996). RUNX3 is the 
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less studied of the RUNX family members. In zebrafish Runx3 has been shown to be required 
for hematopoietic development (Kalev-Zylinska et al, 2003) and to be involved in craniofacial 
development (Flores et al, 2006), but the importance of each of the P1-Runx3 and P2-Runx3 
isoforms is not described. 
In this study we investigated the expression pattern of each runx3 isoform in different stages 
of zebrafish development and in different adult tissues, in order to identify if the isoforms 
are differentially regulated. In an attempt to clone the runx3 ORFs, we identified and cloned 
multiple transcript variants. Besides the three different transcripts previously described for 
zebrafish runx3 (Kataoka et al, 2000) we cloned 10 additional variants obtained by 
alternative splicing. Of the new variants cloned, four are P1-derived (isoforms 2 to 5) and six 
are P2-derived (isoforms 7 to 12). Interestingly, in contrast to the other RUNX family 
members, relatively few isoforms have been described for RUNX3. Moreover, the zebrafish 
runx3 isoform 2 described in this study with a splice of exon 5 has already been described for 
human RUNX3 (Puig-Kroger et al, 2010). These alternatively spliced transcript variants that 
generate protein isoforms with one or more domains partially or totally absent, suggest that 
probably Runx3 splicing isoforms have different functions. In fact, Puig-Kroger and co-
workers have shown that transcriptional activities of the human RUNX3/p33 isoform, 
generated by splicing a runt DNA-binding domain-encoding exon, differ from those of the 
non-spliced isoform (Puig-Kroger et al, 2010). Although some of these alternative spliced 
isoforms may have important modulatory functions in development or in critical cell fate 
decisions, others may not be translated due to the process of nonsense-mediated mRNA 
decay (NMD) that causes degradation of mRNAs containing premature translation 
termination codons. The NMD process was identified and studied also in zebrafish, and was 
shown to be essential for zebrafish embryonic development, preventing accumulation of 
potentially detrimental truncated proteins (Wittkopp et al, 2009). In this study, isoforms 8 to 
12 showed splicing across multiple exons, generating either premature termination codons 
or splicing of the initiation codon, and thus may be potential targets for the NMD pathway, 
and not likely to be translated into proteins.  
The runx3 isoforms 13 and 14 correspond to transcripts with splicing events in the 5’ UTR 
regions of the runx3-P1 transcript. The isoform 13 is similar to the AB043789 transcript 
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previously described (Kataoka et al, 2000) but with more 313 bp of 5´ UTR, that seems to 
correspond to an intron retention. Interestingly, one isoform similar to this was cloned for 
human RUNX1 (type I isoform; Zhang et al, 1997). A new TSS was identified from the 
P1-runx3 transcript, isoform 14, that contains an extra 182 bp of the 5´ UTR region and 
carries the 221 bp splicing event observed in the previously described isoform AB043789 
(Kataoka et al, 2000). Analysis of both runx3 5’ UTR regions revealed the presence of several 
ATG nucleotide triplets upstream the ATG codon (uATG) that can generate several putative 
upstream open reading frames (uORFs) that can vary sizes. uATGs and uORFs are common 
features of mRNAs that encode regulatory proteins and have been shown to profoundly 
influence translation of the main ORF (Wang and Rothnagel, 2004). Although we did not test 
for the existence of these uORFs and their effect in the translation of the Runx3 proteins, it 
would be interesting to analyse if the regulation of the runx3 isoforms is affected by their 
complex 5’ UTR region.  
We analysed the expression of runx3-P1 and runx3-P2 transcripts both in zebrafish adult 
tissues and during zebrafish embryonic development by qPCR. We observed that the relative 
expression of both variants is higher in the calcified tissues compared to the soft tissues. 
However, the variants showed a different expression pattern in the adult tissues analysed, 
with runx3-P1 showing a relatively similar expression in all tissues analysed, except in the 
liver and muscle where the expression was barely detectable, and in the pectoral fins and 
branchial arches where it showed the highest expression. In contrast, the runx3-P2 variant 
showed a more variable relative expression between the tissues analysed with the brain, 
heart and liver presenting the lowest expression values, and the pectoral fins, mandibular 
operculum and trunk vertebrae presenting the highest values. These observations are in 
agreement with a previously published report, where it was shown by S1 nuclease 
protection assay using RNA from mouse tissues that Runx3-P2 is nearly ubiquitously 
expressed, although Runx3-P1 is restricted to few lineages/physiological states (Rini and 
Calabi, 2001). These differences between the expression patterns of both runx3-P1 and 
runx3-P2 transcripts are also observed during the zebrafish embryonic development as the 
runx3-P1 variant showed to be expressed maternally as well as zygotically, in contrast to the 
runx3-P2 variant where the expression was first detected in the stage 24 hpf. In a previous 
report from Kataoka and colleagues, runx3 transcript 1 and transcript 2 were detected 
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maternally, as well as zygotically and the expression of runx3 transcript 3 was detected from 
the three somite stage (Kataoka et al, 2000). It is important to note that their nomenclature 
is somewhat confusing, since transcript 1 derives from the P2 promoter and transcripts 2 
and 3 derive from the P1 promoter.  
To identify the spatial-temporal expression of the runx3 transcripts we performed ISH at 
different zebrafish developmental stages, using RNA specific probes to the common region 
of all variants, and to the 5’ UTR specific of each variant. Using a probe that recognizes a 
common region of the runx3 transcripts we confirmed the runx3 expression previously 
reported (Kataoka et al, 2000; Burns et al, 2002; Kalev-Zylinkska et al, 2003; Flores et al, 
2006) in neural and cartilaginous tissues in the developing embryo. Kalev-Zylinkska and co-
workers (2003) have previously shown runx3 to be expressed in hematopoietic tissues, 
however we and other authors (Kataoka et al, 2000; Burns et al, 2002) failed to detect this 
expression. Using the specific probes to each variant we always obtained a high background 
signal, making it very difficult to reach any conclusion. We could observe that the runx3-P2 
specific probe reproduces at least partially the expression pattern obtained with the probe 
to the common region of the runx3; in contrast using a runx3-P1 specific probe it was not 
possible to identify any site of expression, since the background signal was always very 
intense. These high background levels of expression can be due to the small size of the 
probes (≈180 bp and ≈500 bp, respectively for P1- and P2-derived probes) or due to a low 
copy number of the transcripts, so optimization to find the better conditions need to be 
done or, alternatively new ISH techniques should be used. For example, to detect alternative 
spliced RNA variants that differ only in a short region, the locked nucleic acids (LNAs) probes 
that exhibits superior specificity, hybridization kinetics and stability (Darnell et al, 2010), are 
probably a better option. For the detection of low-copy number molecules the amplification 
of the signal can be essential for its detection, so the use of the recent technique, RNAscope, 
that uses a unique probe that enables simultaneous signal amplification and background 
suppression (Wang et al, 2012), may be an alternative. This technique has been recently 
used to successfully detect multiple RNA molecules in a high resolution and quantitatively 
manner in zebrafish whole-mount embryos (Gross-Thebing et al, 2014). Together, our qPCR 
and ISH results suggest that the runx3-P2 variants are probably expressed in higher levels 
and in a variety of tissues, but on the other hand, the runx3-P1 variants are likely expressed 
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in a tissue-specific way and/or in low levels, so that the sensitivity of this technique is not 
sufficient to detect that expression. In fact, knockdown analysis in zebrafish embryos using 
an antisense morpholino specific to the Runx3-P2 isoform has been reported to affect the 
hematopoietic and craniofacial cartilage development (Kalev-Zylinkska et al, 2003; Flores et 
al, 2006), but no studies have been reported where the Runx3-P1 isoform has been targeted.  
For this reason, we attempted a knockdown analysis in zebrafish embryos, using antisense 
morpholinos specific to each Runx3 isoform to analyse if the resulting morphants have 
different phenotypes. Levanon and co-workers (2002) reported that Runx3 is expressed in 
the dorsal root ganglia (DRG) sensory neurons, specifically in a subset of neurons called the 
tyrosine kinase receptor C (TrkC) proprioceptive neurons, and these authors showed that 
Runx3-deficient mice develop severe limb ataxia due to disruption of monosynaptic 
connectivity between intra spinal afferents and motoneurons (Levanon et al, 2002). Using 
translation-blocking morpholinos targeting Runx3-P1 or Runx3-P2 protein isoforms we 
explored isoform-specific gene function in DRG development using the generic neuronal 
marker anti-Hu. Our preliminary results suggest that targeting the Runx3-P1 protein isoform 
resulted in a reduced number of DRG sensory neurons and in the presence of ectopic 
neurons in a position directly dorsal to the spinal cord. In contrast, the results targeting the 
Runx3-P2 protein isoform, showed no effect in DRGs (Appendix 2.1). However, we are aware 
of the increasing reports showing that morpholinos can cause artefacts due to the 
non-specific minority of morpholinos efficiently mimic mutant phenotypes (Eisen and Smith, 
2008; Kok et al, 2015). So, at the moment our results must be treated as preliminary and 
more work has to be developed. Recently, new techniques to generate targeted mutations 
in genes of interest have been successfully used in zebrafish, namely transcription activator-
like effector nucleases (TALENs; Cade et al, 2012; Xiao et al, 2013) and clustered regularly 
interspaced short palindromic repeats (CRISPR) RNA-guided Cas9 nuclease system (Hwang et 
al, 2013a; 2013b; Xiao et al, 2013; Jao et al, 2013; among others). As the latter system has 
been shown to be simple, robust and a very efficient reverse genetic tool, we intend to use it 
to confirm our preliminary results using morpholinos and to analyse in more detail the effect 
of depletion of the Runx3 isoforms in the zebrafish development.  
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In conclusion, we cloned for the first time new zebrafish runx3 transcript variants that are 
generated by alternative splicing and derived from the alterative P1 and P2 promoters. We 
analysed the specific runx3-P1 and runx3-P2 spatial-temporal analysis either by qPCR or by 
ISH, and showed that the transcript variants are differentially expressed in zebrafish adult 
tissues and also during the development, where the runx3-P1 variant is maternally and 
zygotically expressed in contrast to the runx3-P2 variant that is only expressed after the 
zygotic transcription started. These results together with our preliminary results of Runx3 
knockdown analysis strongly suggest that Runx3 protein isoforms are differently regulated 
and play different roles in the developing embryo.  
 
Acknowledgments 
This research was partially supported by the European Regional Development Fund (ERDF) 
through the COMPETE - Operational Competitiveness Program and national funds through 
FCT – Foundation for Science and Technology, under the project “PEst-C/MAR/LA0015/2011. 
NC and BS are supported, respectively, by a post-doctoral and doctoral grant from FCT 
(SFRH/BPD/48206/2008 and SFRH/BD/38083/2007). 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
76 
 
2.6 Supplementary Tables 
 
Table 2.S1 PCR primers used in this chapter. 
Sense primers Primer sequence (5’ to 3’)# 
DrRunx3_F3 GGCAGGAGCGGCAGAGGAAAGA 
DrRunx3_F5 TGTGATGCATATTCCCGTAGACCCG 
DrRunx3I_F1 CACAACGGACTTTCTGTAGCCT 
DrRunx3I_F2 GCGGCGTTCGCGTAGTCG 
DrRunx3I_F4 GTATTAACGCTTCTGCATCTGCATTG 
DrRunx3I_F5 TGACAGGACGGAAAGTAACTGAATGA 
DrRunx3II_F1 TGACCTCGGATACCTCAGACA 
DrRunx3II_F2 GCAACCACTTCTGGAGAGAGAGAGAC 
DrRunx3II&III_F1 AAGACGGTACGACGGCGGAGAGGC 
DrRunx3I_F1_XhoI CCGGAGCTCGAGCACAACGGACTTTCTGTAGCCT 
DrRunx3II&III_F1_XhoI CCGGAGCTCGAGGGCTGAAGATGGTACGACGG 
  
Antisense primers Primer sequence (5’ to 3’)# 
DrRunx3_R2 TGCATCATGCGCAACTCTTCTGG 
DrRunx3_R4 CGTCTGCTCGTGCTCGGGTCT 
DrRunx3_R6 ATCTTAGTACGGCCTCCAGACAGACTC 
DrRunx3_R8 ATGCAAGACGTTTCACCTCTTCTCTT 
DrRunx3I_R1 CTCGTGCTCGGGTCTACGGGAA 
DrRunx3II&III_R1 CGCAGCAAACTGGGCGAGTAG 
DrRunx3I_R1_KpnI CACGCGGTACCCTCGTGCTCGGGTCTACGGGAA 
DrRunx3II&III_R1_KpnI CACGCGGTACCCGCAGCAAACTGGGCGAGTAG 
  
qPCR primers Primer sequence (5’ to 3’) 
DrRunx3II&III_F1 AAGACGGTACGACGGCGGAGAGGC 
DrRunx3II&III_R2 CGCAGCAAACTGGGCGAGTAGCTAGAGA 
DrRunx3I_F3 ACGCATTCATTTGGAAAGAACGCTTGAC 
DrRunx3I_R2 CAGCAGGTGTGAGCTGCTCCTGAATATCAGT 
DrEf1α_F1 ACGCCCTCCTGGCTTTCACCC 
DrEf1α_R1 TGGGACGAAGGCAACACTGGC 
Dr18s_F1 ACCACCCACAGAATCGAGAAA 
Dr18s_R1 GCCTGCGGCTTAATTTGACT 
  
Universal primers Primer sequence (5’ to 3’) 
Adaptor Primer 1 (AP1) CCATCCTAATACGACTCACTATAGGGC 
Adaptor Primer 2 (AP2) ACTCACTATAGGGCTCGAGCGGC 
oligo(dT)‐adapter primer ACGCGTCGACCTCGAGATCGATGTTTTTTTTTTTTT 
# indicates the recognition sequence for the restriction enzyme named on the primer. 
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Table 2.S2 Accession numbers of all Runx3 protein sequences used for the in silico analysis. 
Species 
Protein 
isoform 
N-Terminal Acession number 
Amazon molly P1-Runx3 MASN ENSPFOT00000030105 
Callorhinchus milii P1-Runx3 MASN AHW58145.1 
Danio rerio P1-Runx3 MASN BAB17904.1 
Homo sapiens P1-Runx3 MASN NP_001026850.1 
Lepisosteus oculatus P1-Runx3 MASN ENSLOCT00000003239 
Loxodonta africana P1-Runx3 MASN ENSLAFT00000008382 
Mus musculus P1-Runx3 MASN NP_062706.2 
Olive baboon P1-Runx3 MASN ENSPANT00000016693 
Scyliorhinus canicula P1-Runx3 MASN ABL68117.1 
Takifugu rubripes P1-Runx3 MASN AAU14193.1 
Tetraodon nigroviridis P1-Runx3 MASN ENSTNIT00000001252 
Bos taurus P2-Runx3 MRIPV NP_001180087.1 
Ctenopharyngodon idella P2-Runx3 MRIPV AHJ59933.1 
Danio rerio P2-Runx3 MHIPV BAB17903.1 
Homo sapiens P2-Runx3 MRIPV NP_004341.1 
Macaca mulatta P2-Runx3 MRIPV AFH34424.1 
Mus musculus P2-Runx3 MRIPV EDL29993.1 
Oreochromis niloticus P2-Runx3 MHIPV ENSONIT00000010344 
Rattus norvegicus P2-Runx3 MRIPV NP_569109.1 
Scyliorhinus canicula P2-Runx3 MRIPV ABL68116.1 
Takifugu rubripes P2-Runx3 MHIPV NP_001092121.1 
Xenopus laevis P2-Runx3 MLIPV NP_001182313.1 
Xiphophorus maculatus P2-Runx3 MHIPV ENSXMAT00000018904 
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2.7 Supplementary Figures 
 
> AB043788 
GCGCGGCGTTCGCGTAGTCGTATGTCTGACTAACACAAACCACTTTTCTCGTTTTAACTCACTTTTACGCATTCATTTGGAAAGAACGCTTGACA
GCTGAAAGGGACTTTGCTGCAGAAACTCTTCTGAAACTGAGGGATTAATTTGTTTGGACTTTATTTTCCGAGACTCTGGATTGACAGGACGGAA
AGTAACTGAATGAAAGTAAAACTGATATTCAGGAGCAGCTCACACCTGCTGTACACGCTCTGGGATGAATTCAGTTTCATAAATAACTCTTAAA
TAGTAGTTGTATATGCTTTGAGAAGCATACAAGACTCAGTTTTTATGCCTTACTTTCATCTATCGTGCAGCACGAGATTGTATGTGCTTGCGTG
TGTGTGTGTGGCTAAAGTCAGTGGGGAACTCGCTCTGTATTAACGCTTCTGCATCTGCATTGCAACACAAAGTAAACGGTCACCGAGGAGTTTT
TTCCACTCTCCAACACAACGGACTTTCTGTAGCCTACTCAACCAACTGGGTTGCCCGAGCTTTTCACGAGGACTCATTTGAAATCTGTTGTGATG 
 
 
5'3' Frame 1 
ARRSRSRMSDStopHKPLFSFStopLTFTHSFGKNAStopQLKGTLLQKLFStopNStopGINLFGLYFPRLWIDRTESNStopMKVKLIFRSSSHLLYTLWDEFSFI
NNSStopIVVVYALRSIQDSVFMPYFHLSCSTRLYVLACVCVAKVSGELALYStopRFCICIATQSKRSPRSFFHSPTQRTFCSLLNQLGCPSFSRGLIStopNLLSto
p 
 
5'3' Frame 2 
RGVRVVVCLTNTNHFSRFNSLLRIHLERTLDSStopKGLCCRNSSETEGLICLDFIFRDSGLTGRKVTEStopKStopNStopYSGAAHTCCTRSGMNSVSStopITL
KStopStopLYMLStopEAYKTQFLCLTFIYRAARDCMCLRVCVWLKSVGNSLCINASASALQHKVNGHRGVFSTLQHNGLSVAYSTNWVARAFHEDSFEICCD 
 
5'3' Frame 3 
AAFAStopSYVStopLTQTTFLVLTHFYAFIWKERLTAERDFAAETLLKLRDStopFVWTLFSETLDStopQDGKStopLNESKTDIQEQLTPAVHALGStopIQFH
KStopLLNSSCICFEKHTRLSFYALLSSIVQHEIVCACVCVCGStopSQWGTRSVLTLLHLHCNTKStopTVTEEFFPLSNTTDFLStopPTQPTGLPELFTRTHLKS
VVM 
 
 
> AB043789 
GATACCGCGGGAGCTGTGACCTCGGATACCTCAGACATGCGACTGACAGGCCTTTACCACGGTGATCACCACTGTAAGAGCGTCAGACACCTGAC
ATTTCAACTCTCTGACTGAAGGCACGTAGACTCTACAGCAACCACTTCTGGAGAGAGAGAGACGCACAGAAGTGTCCATCAACAAAGGCTGAAG
ATGGTACGACGGCGGAGAGGCCAGCTCTTTTCCCTTCAGAGCGGGACACATG 
 
5'3' Frame 1 
DTAGAVTSDTSDMRLTGLYHGDHHCKSVRHLTFQLSDStopRHVDSTATTSGERETHRSVHQQRLKMVRRRRGQLFSLQSGTH 
 
5'3' Frame 2 
IPRELStopPRIPQTCDStopQAFTTVITTVRASDTStopHFNSLTEGTStopTLQQPLLERERRTEVSINKGStopRWYDGGEASSFPFRAGHM 
 
5'3' Frame 3 
YRGSCDLGYLRHATDRPLPRStopSPLStopERQTPDISTLStopLKARRLYSNHFWRERDAQKCPSTKAEDGTTAERPALFPSERDT 
 
 
>AB043790 
AAACCCCAAATTCTTGGTTGCAGGCTGTCTATGTAGTTTCTGTATTTCTCTTTCTCCGACTGTCATTCTCTCAGGCTGAAGATGGTACGACGGCG
GAGAGGCCAGCTCTTTTCCCTTCAGAGCGGGACACATG 
5'3'Frame 1 
KPQILGCRLSMStopFLYFSFSDCHSLRLKMVRRRRGQLFSLQSGTH 
 
5'3'Frame 2 
NPKFLVAGCLCSFCISLSPTVILSGStopRWYDGGEASSFPFRAGHM 
 
5'3'Frame 3 
TPNSWLQAVYVVSVFLFLRLSFSQAEDGTTAERPALFPSERDT 
 
>Runx3_iso13 
TGACCTCGGATACCTCAGACATGCGACTGACAGGCCTTTACCACGGTGATCACCACTGTAAGAGCGTCAGACACCTGACATTTCAACTCTCTGAC
TGAAGGCACGTAGACTCTACAGCAACCACTTCTGGAGAGAGAGAGACGCACAGAAGTGTCCATCTACAAAGGTGAGTCCATTTCTATGAGACTT
AGTGCTGTCCTCACTTTGTCTTTCAGTCTTTCTCTCTTTCTCTCTTACTCTCGCTCGCTCTCACCACACGGCACATATGCTGTTCTGTTAGTCGGC
TTGTGGCGAAAGATTCCTGTGGCACTCTCAAACCCCAAATTCTTGGTTGCAGGCTGTCTATGTAGTTTCTGTATTTCTCTTTCTCCGACTGTCAT
TCTCTCAGGCTGAAGACGGTACGACGGCGGAGAGGCCAGCTCTTTTCCCTTCAGAGCGGGACACATG 
 
5'3'Frame 1 
StopPRIPQTCDStopQAFTTVITTVRASDTStopHFNSLTEGTStopTLQQPLLERERRTEVSIYKGESISMRLSAVLTLSFSLSLFLSYSRSLSPHGTYAVLLVGLW
RKIPVALSNPKFLVAGCLCSFCISLSPTVILSGStopRRYDGGEASSFPFRAGHM 
 
5'3'Frame 2 
DLGYLRHATDRPLPRStopSPLStopERQTPDISTLStopLKARRLYSNHFWRERDAQKCPSTKVSPFLStopDLVLSSLCLSVFLSFSLTLARSHHTAHMLFCSto
pSACGERFLWHSQTPNSWLQAVYVVSVFLFLRLSFSQAEDGTTAERPALFPSERDT 
 
5'3'Frame 3 
TSDTSDMRLTGLYHGDHHCKSVRHLTFQLSDStopRHVDSTATTSGERETHRSVHLQRStopVHFYETStopCCPHFVFQSFSLSLLLSLALTTRHICCSVSRLVA
KDSCGTLKPQILGCRLSMStopFLYFSFSDCHSLRLKTVRRRRGQLFSLQSGTH 
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>Runx3_iso14 
CTCTTCAAGAAGGTCCCATCATCTTCTGGGAAACTCTTCAAACACCAGCCATGGGCCAATCAGATGAGTGAGAAAGGCACTGGGAAGAAAAGGA
GAACTTGAATGCATGCAAGCGAGGGAGAGAGAGAACGTCATGTGACTGGAGTTCCACCTATCAGATCATGGGATTGGCGAGCAGCAGTGATACC
GCGGGAGCTGTGACCTCGGATACCTCAGACATGCGACTGACAGGCCTTTACCACGGTGATCACCACTGTAAGAGCGTCAGACACCTGACATTTCA
ACTCTCTGACTGAAGGCACGTAGACTCTACAGCAACCACTTCTGGAGAGAGAGAGACGCACAGAAGTGTCCATCAACAAAGGCTGAAGATGGTA
CGACGGCGGAGAGGCCAGCTCTTTTCCCTTCAGAGCGGGACACATG 
5'3'Frame 1 
LFKKVPSSSGKLFKHQPWANQMSEKGTGKKRRTStopMHASEGERERHVTGVPPIRSWDWRAAVIPRELStopPRIPQTCDStopQAFTTVITTVRASDTStop
HFNSLTEGTStopTLQQPLLERERRTEVSINKGStopRWYDGGEASSFPFRAGHM 
 
5'3'Frame 2 
SSRRSHHLLGNSSNTSHGPIRStopVRKALGRKGELECMQARERENVMStopLEFHLSDHGIGEQQStopYRGSCDLGYLRHATDRPLPRStopSPLStopERQTP
DISTLStopLKARRLYSNHFWRERDAQKCPSTKAEDGTTAERPALFPSERDT 
 
5'3'Frame 3 
LQEGPIIFWETLQTPAMGQSDEStopERHWEEKENLNACKRGRERTSCDWSSTYQIMGLASSSDTAGAVTSDTSDMRLTGLYHGDHHCKSVRHLTFQLSDSto
pRHVDSTATTSGERETHRSVHQQRLKMVRRRRGQLFSLQSGTH 
 
> AB043788 
CGCGGCGTTCGCGTAGTCGTATGTCTGACTAACACAAACCACTTTTCTCGTTTTAACTCACTTTTACGCATTCATTTGGAAAGAACGCTTGACAG
CTGAAAGGGACTTTGCTGCAGAAACTCTTCTGAAACTGAGGGATTAATTTGTTTGGACTTTATTTTCCGAGACTCTGGATTGACAGGACGGAAA
GTAACTGAATGAAAGTAAAACTGATATTCAGGAGCAGCTCACACCTGCTGTACACGCTCTGGGATGAATTCAGTTTCATAAATAACTCTTAAAT
AGTAGTTGTATATGCTTTGAGAAGCATACAAGACTCAGTTTTTATGCCTTACTTTCATCTATCGTGCAGCACGAGATTGTATGTGCTTGCGTGT
GTGTGTGTGGCTAAAGTCAGTGGGGAACTCGCTCTGTATTAACGCTTCTGCATCTGCATTGCAACACAAAGTAAACGGTCACCGAGGAGTTTTT
TCCACTCTCCAACACAACGGACTTTCTGTAGCCTACTCAACCAACTGGGTTGCCCGAGCTTTTCACGAGGACTCATTTGAAATCTGTTGTGATG 
 
5'3' Frame 1 
R G V R V V V C L T N T N H F S R F N S L L R I H L E R T L D S Stop K G L C C R N S S E T E G L I C L D F I F R D S G L T G R K V T 
E Stop K Stop N Stop Y S G A A H T C C T R S G M N S V S Stop I T L K Stop Stop L Y M L Stop E A Y K T Q F L C L T F I Y R A A R D C M C L R V C V 
W L K S V G N S L C I N A S A S A L Q H K V N G H R G V F S T L Q H N G L S V A Y S T N W V A R A F H E D S F E I C C D 
 
5'3' Frame 2 
A A F A Stop S Y V Stop L T Q T T F L V L T H F Y A F I W K E R L T A E R D F A A E T L L K L R D Stop F V W T L F S E T L D Stop Q D G K Stop L N 
E S K T D I Q E Q L T P A V H A L G Stop I Q F H K Stop L L N S S C I C F E K H T R L S F Y A L L S S I V Q H E I V C A C V C V C G Stop S Q W G T R S V 
L T L L H L H C N T K Stop T V T E E F F P L S N T T D F L Stop P T Q P T G L P E L F T R T H L K S V V M 
 
5'3' Frame 3 
R R S R S R M S D Stop H K P L F S F Stop L T F T H S F G K N A Stop Q L K G T L L Q K L F Stop N Stop G I N L F G L Y F P R L W I D R T E S 
N Stop M K V K L I F R S S S H L L Y T L W D E F S F I N N S Stop I V V V Y A L R S I Q D S V F M P Y F H L S C S T R L Y V L A C V C V A K V S G E L A 
L Y Stop R F C I C I A T Q S K R S P R S F F H S P T Q R T F C S L L N Q L G C P S F S R G L I Stop N L L Stop 
 
Figure 2.S1 Both runx3-P1 and runx3-P2 5’ UTR regions show the presence of multiple ATG 
nucleotide triplets upstream the ATG codon that initiates translation of the Runx3 proteins. 
The described ATG codon and respective Methionine is highlighted in black and the 
upstream ATG nucleotide triplets and respective putative uORFs are highlighted in grey. 
Putative uORFs were predicted using the Translate tool available in the ExPASy Portal 
(http://web.expasy.org/translate/). 
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Appendix 1 - Knockdown zebrafish Runx3 protein function to investigate effect on DRG 
sensory neurons 
 
Methods 
 
Zebrafish Runx3 protein function knockdown by morpholinos 
Antisense morpholinos complementary to the 5’ UTR near the ATG translation start codon of 
each Runx3 isoform and to the exon 3-intron 3 splice junction were designed and 
synthesised by Gene Tools LLC (www.gene-tools.com/). Runx3 morpholino sequences were 
as follows: Mo-L, 5’- AGATGCTGTTTGAAGCCATGTGTCC-3’; Mo-S, 5’ 
CACAACAGATTTCAAATGAGTCCTC-3’; Mo-Sp, 5’- TGTTTAGATGTGGCACCTCTGCCGC-3’; 
Mo-M, 5’- AGATCCTCTTTCAAGCGATGTCTCC3’ (mismatched bases are underlined).  
 
EGFP fusion constructs  
(Runx3-MASNS):EGFP and (Runx3-MHIPV):EGFP constructs were generated by PCR 
amplification using as template 24 hpf cDNA, prepared as described in section 2.3.4, in a 
primary reaction with sense primers (DrRunx3II&III_F1 and DrRunx3I_F1, respectively) and 
the same antisense primer (DrRunx3_R4). Then, a nested PCR was performed, using the 
amplified primary PCR as template, and the sense primers (Runx3II&III_F1_XhoI and 
Runx3I_F1_XhoI) and the antisense primers (RunxII&III_R1_KpnI and Runx3I_R1_KpnI) for 
isoforms Runx3-MASN and Runx3-MHIPV, respectively. All primer sequences are described 
in Table 2.S1 DNA fragments were digested with XhoI and KpnI restriction enzymes and 
cloned into pEGFP-N1 vector (Clontech) previously digested with the same enzymes. 
Constructs were verified by double stranded DNA sequence analysis and prepared for 
injection using the GFXTM Micro Plasmid Prep kit (GE Healthcare). 
 
Zebrafish microinjection 
Injected DNA or morpholinos were diluted to the desired concentration (100 ng/µl and 5 
µg/µl, respectively) in 1X Danieau solution (Westerfield, 2000) with 0.025% phenol red to 
help visualization. Morpholinos solution was heated at 65ºC prior to use to reduce 
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secondary structure and to dissolve any precipitation. Very thin needles were created by 
melting 31/2’’ Drummond glass capillaries (Drummond Scientific Co., Broomall, PA) in a 
Narishige, PC-10 64 needle puller (heater 1 at 63, all weights on) and 1-cell stage zebrafish 
embryos were injected using a Drummond Nanoject II injector apparatus (Drummond 
Scientific Co.). The embryos and larvae were examined and imaged using an Eclipse E800 
(Nikon) microscope. 
 
Immunohistochemistry in whole mount zebrafish embryos 
Whole-mount immunohistochemistry was performed as previously described (Ungos et al, 
2003). The mouse monoclonal antibody [16A11] to Hu protein was used (1-700, Abcam, 
Cat#ab14370) and for fluorescent detection was used the AlexaFluor 488 goat anti-mouse 
IgG (1:700, Molecular Probes, Cat# A31619). Embryos were kept and imaged in 70% glycerol, 
in an Eclipse E800 (Nikon) microscope. 
 
 
Results 
 
Morpholino test using a tagged protein construct  
Based in the analysis of all runx3 transcripts, four morpholino were designed. Two 
translation morpholinos – Mo-L morpholino, that blocks the translation of Runx3-P1 derived 
isoform (Longer-isoform), Mo-S morpholino, specific to block the translation of Runx3-P2 
derived isoform (Shorter-Isoform); one splicing morpholino – Mo-Sp morpholino that blocks 
the splicing of intron 3; and one control morpholino – Mo-M morpholino with five bases 
mismatch compared to Mo-L (Figure 2.A1A). 
To test the efficiency of both translation morpholinos, Mo-L and Mo-S, two tagged protein 
constructs were made for both Runx3 isoforms, as GFP fusion proteins in pEGFP-N1 vector, 
and then microinjected into zebrafish 1-cell stage embryos in the presence or absence of the 
testing morpholinos (Figure 2.A1B).  
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Figure 2.A1 Qualitative evaluation of the knockdown efficiency of translation Runx3 
Morpholinos in zebrafish embryos using a Mo-target:GFP fusion assay. (A) Representation of 
the runx3 gene structure with localization of the morpholinos target sequences and 
schematic representation of the runx3-GFP fusion constructs used in the assay. The runx3 
sequence placed upstream of the EGFP gene is indicated by the dotted lines. (B) Part of the 
nucleotide sequences of the zebrafish runx3 region used in the fusion constructs. The Mo-L 
and Mo-S target sequences are indicated by the boxes and the start codons are also 
indicated in red. (C) Qualitative observation of the inhibition levels caused by the 
microinjection of Runx3-MOs using fluorescence microscopy.  
 
We observed that the embryos injected with the tagged cDNA:GFP construct (100 
pg/embryo) in the absence of morpholinos have high expression of GFP driven by the CMV 
promoter, in contract to the embryos co-injected with the tagged cDNA:GFP construct and 
the testing morpholinos (11.5 ng/embryo), that showed an almost complete blocking of the 
GFP expression (Figure 2.A1C). These results, confirm the inhibitory effect of the Runx3 
morpholinos on the translation of the corresponding mRNA, whereas the control 
morpholinos with five nucleotides substitution (MoM) did not have a significant affect (data 
not shown). 
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Morpholino-mediated knockdown of specific zebrafish runx3 isoforms to assess the 
function 
We used three different runx3 morpholinos to protein knockdown studies. Zebrafish injected 
with runx3 testing morpholinos were compared with zebrafish at the same embryonic stage 
injected with the Danieau’s solution and the negative control Mo-M, and the effects of both 
morpholinos on DRG development were observed at 5 dpf. As the morpholinos can have 
different efficiencies, a range of dilutions between ≈2 to 23 ng/embryo were tested to 
optimize the best concentration of each morpholino to use.  
After injection, the embryos were raise as described previously and the embryos that were 
apparently normal were selected and fixed at 5 dpf for further analysis of the morpholinos 
effect in sensory neurons, analysed by immunohistochemistry using the neural marker 
Anti-Hu (Figure 2.A2).  
Figure 2.A2 Knockdown of runx3 Longer-isoform causes a decrease in DGR number. (A) 
Lateral views of part of the trunk of 5 dpf embryos, showing staining for neurons with Hu 
specific antibody. (B, C, D) Quantitative measurement of Hu+ DRG sensory neurons and 
ectopic Hu+ cells in control and morphant zebrafish embryos (* P<0.05, Student’s t-test). 
Arrowheads represent DRG sensory neurons; asterisks represent missing DRG sensory 
neurons; arrows represent ectopic neurons. Mo-S – Translation morpholino specific to block 
Runx3 Shorter-isoform (Runx3-P2); Mo-L – Translation morpholino specific to block 
Longer-isoform (Runx3-P1); Mo-Sp – Splicing morpholino; Mo-M – Mismatch morpholino (5-
base mismatch). 
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Our preliminary results show that knockdown of Runx3-P2 isoform, using a morpholino 
specific to this isoform (Mo-S), does not affect the total number of DRG sensory neurons 
(Figure 2.A2A-C), obtaining a total number of DRG sensory neurons similar to the number 
observed in control embryos (Danieu’s and Mo-M; Figure 2.A2A-C). On the other hand, 
knockdown of Runx3-P1 isoform, using the specific morpholino Mo-L, resulted in a 
significant decrease in total number of DRG sensory neurons (Figure 2.A2A-C) and in the 
appearance of extra ectopic neuronal cells in a position directly dorsal to the spinal cord 
(Figure 2.A2A, D). The same phenotype was observed when a splicing morpholino (Mo-Sp) 
was used (Figure 2.A2A-D). 
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3.1 Abstract 
RUNX3 encodes a member of the runt domain family of transcription factors. In mammals 
this family includes three genes (RUNX1-3) and their protein products function as 
context-dependent transcription factors, either transcriptional activators or repressors, 
during developmental processes such as hematopoiesis, neurogenesis, and osteogenesis; all 
are proto-oncogenes or tumour suppressors. All three genes were shown to be transcribed 
from two promoters, giving rise to protein products bearing either the P1 or the P2 
N-termini, translated respectively from transcripts originating from the distal (P1)- or the 
proximal (P2)-promoters. Understanding their differential regulation and interaction may 
help explain how RUNX factors contribute to such different and often opposing biological 
processes. In this study we have identified putative molecular players affecting zebrafish 
runx3 gene transcription by using a computational approach to search for cis-regulatory 
transcription factor binding sites (TFBSs) in the promoter regions of the runx3 gene from 
zebrafish (Danio rerio) and fugu (Takifugu rubripes). From the data obtained it was possible 
to identify the sites most likely involved in regulating expression of runx3 in zebrafish. Our 
comparative approach reduced substantially the number of putative TFBSs in the runx3 
promoter regions; reassuringly, published TFs identified as transcriptional regulators of 
Runx3 are confirmed by our in silico analysis. Our data now provides the basis for focused in 
vitro and/or in vivo experimental tests of the transcriptional regulatory activities of strong 
candidate regulators of zebrafish runx3.  
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3.2 Introduction 
RUNX3 encodes a member of the runt domain family of transcription factors which also 
include RUNX1 and RUNX2. RUNX proteins can bind DNA as a monomer to the core 
sequence 5'-PyGPyGGT-3' found in a number of enhancers and promoters, but their affinity 
for DNA is enhanced when the RUNX protein forms a heterodimer with its non-DNA binding 
partner CBFβ (Ogawa et al, 1993; Bae et al, 1994). The RUNX proteins also interact with 
other transcription factors, thus modulating their activity. Despite the recognized 
importance of this family in gene transcription, little is known about the factors regulating 
transcription of the RUNX3 gene itself. Like the other two RUNX genes, RUNX3 was shown to 
be transcribed from two promoters (Ghozi et al, 1996; Xiao et al, 1998; Rini and Calabi, 
2001), giving rise to Runx3 protein products bearing either the P1 or the P2 N-termini, 
resulting from transcripts derived from the distal (P1) or the proximal (P2) promoters 
respectively (Bangsow et al, 2001; Rini and Calabi, 2001). The identification of several RUNX 
binding sites in the RUNX promoter regions (Ghozi et al, 1996; Levanon et al, 2001; Bangsow 
et al, 2001) led to the demonstration that auto- and cross-regulation of RUNX expression by 
RUNX proteins was likely to contribute to their regulation (Drissi et al, 2000; Spender et al, 
2005). However, little work has addressed the regulatory processes that determine when 
RUNX proteins bind to the promoters of the genes of the other two family members to 
inhibit their expression in a kind of intrafamilial competition, nor when each RUNX protein 
acts mainly on its own promoter either promoting or inhibiting its own transcription, for 
example, to stabilise its levels of expression. Spender et al (2005) have shown that in human 
B lymphoid cell lines, RUNX3 represses RUNX1 expression, thus contributing to their 
mutually exclusive expression in those cells. In this case, RUNX3 represses the RUNX1 P1 
promoter by binding specifically to the conserved RUNX sites located near the transcription 
start site of that promoter, thus confirming that cross-regulation between different RUNX 
family members is a means of controlling RUNX expression (Spender et al, 2005). The 
demonstration that RUNX transcription factors can be regulated by other members of the 
RUNX family may help explain their diverse functions and has important implications for the 
interpretation of pathologies associated with RUNX gene knockout or amplification. RUNX 
family proteins can function as context-dependent transcription factors during diverse 
developmental processes such as hematopoiesis (de Bruijn and Speck, 2004), neurogenesis 
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(Li et al, 2002; Fainaru et al, 2004), and osteogenesis (Karsenty, 2000; Komori, 2005). RUNX2 
and RUNX3 have also been shown to regulate chondrocyte differentiation and maturation 
(Yoshida et al, 2004). In zebrafish, was shown that loss of function of runx3 leads to severe 
reduction of head cartilage at 4 dpf (Flores et al, 2006; Dalcq et al, 2012). Furthermore, it 
was shown that a regulatory cascade formed by Runx3-Egr1-Sox9b controls late 
chondrogenesis by reducing expression of Follistatin A, a BMP inhibitor (Dalcq et al, 2012). 
This down-regulation allows the correct activation of BMP signalling required for expression 
of runx2b in developing chondrocytes (Dalcq et al, 2012). These observations were further 
investigated by Larbuisson et al (2013) using loss of function studies observed cartilage 
defects in Fgfr1a or Fgfr2 morphants that could be rescued by expression of exogenous 
Runx3 or Egr1. Recently, it was also shown using RNA-sequencing of Atlantic salmon 
notochord during segmentation that runx3 was one of the genes expressed during and 
implicated in tissue mineralisation, alongside other genes such as the chondroblast-specific 
sox6, sox5 and sox9 (Wang et al, 2014). 
Recently, we have cloned the full-length cDNA sequences of the zebrafish runx3, observed 
the tissue distribution pattern and analyzed their bioinformatic features. With the aim to 
characterize the genomic structure and to analyze the promoter activities, we have cloned 
the 5′-flanking regions of the runx3 (P1 and P2) (Chapter 4). In this study we have analysed 
the promoter activities of the 5′-flanking regions of the zebrafish runx3 (P1 and P2) and 
identified putative transcriptional regulators of zebrafish runx3 by using a computational 
approach to search for cis-regulatory transcription factor binding sites (TFBSs) in the 
promoter regions (P1 and P2) of the runx3 gene from zebrafish (Danio rerio) and fugu 
(Takifugu rubripes). Our in silico strategy provides a quick way to identify the most promising 
candidates among the large number of TFs that might potentially regulate zebrafish runx3 in 
vivo. Testing the functionality of these sites in vitro and in vivo will then be the priority for 
future studies. 
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3.3 Materials and Methods 
3.3.1 Cell culture, transient transfection and luciferase assay 
C6 cells (rat glioma cell line) were maintained in F-12K Nutrient Mixture Medium 
supplemented with 2.5% fetal bovine serum, 15% horse serum and 1% 
penicillin/streptomycin. U2OS cells (human osteosarcoma cell line) were maintained in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal bovine serum, 
2mM L-Glutamine and 1% penicillin/streptomycin. For both cell lines, incubation was carried 
out at 37 °C in a humidified atmosphere containing 5% CO2. The media, FBS, antibiotics and 
glutamine were obtained from Invitrogen. For all transfections, the C6 and the U2OS cells 
were seeded into 24-well plates at the density of 5 x 104 cells/well and 3 × 104 cells/well, 
respectively. Following 16 h of incubation, when the cells were about 70-80% confluent, 
transient transfection of the plasmids was carried out using Lipofectamine® LTX with Plus™ 
Reagent (Invitrogen) for C6 cells and X-tremeGENE HP DNA Transfection Reagent (Roche) for 
U2OS cells. To normalize the transfection efficiency, the pRL-null vector (Promega) encoding 
Renilla luciferase was co-transfected at the ratio of 1:10 relative to pGL3-basic vector. After 
incubation for 48 h, cells were harvested. The luciferase activities were measured by the 
Dual-luciferase Reporter Assay System (Promega). The data were normalized by calculating 
the ratio of the specific activity of firefly luciferase to that of Renilla luciferase. 
 
3.3.2 Sequence collection 
Sequence databases at GenBank (www.ncbi.nlm.nih.gov) and Ensembl (release v72; 
www.ensembl.org) were searched for annotated Runx3 sequences derived from zebrafish 
and fugu. The promoter sequences from these two genes were extracted for analysis by 
selecting 5000 base pairs (bp) upstream of the known translation start sites giving rise to 
both isoforms, P1 and P2. This length of sequence provided a reasonable assurance of 
containing the target gene’s TFBSs. The promoter sequences were masked for repetitive 
elements by the program RepeatMasker (www.repeatmasker.org) with the default mode. 
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3.3.3 Comparative promoter TFBSs analysis 
For each zebrafish-fugu orthologous promoter pair, the DNA Block Aligner (DBA) software 
(www.ebi.ac.uk/Tools/psa/promoterwise/) was used to extract blocks of aligned sequence 
using the default parameter settings based on the postulation that conserved regulatory 
blocks may be regions important for regulation of the gene. DBA alignments between 
orthologous promoters vary substantially, in many cases having no significant alignment, but 
others having several large sections of aligning sequences. This also clearly shows that many 
genes have multiple aligning blocks, sometimes spaced quite widely apart in the 5 kb region. 
With this software it is possible to obtain four different types of conserved blocks of a 
certain degree of similarity: type A, 60-70%; type B, 70-80%; type C, 80%-90%; and type D, 
90-100%.  
The promoter sequences (P1 and P2) of the zebrafish runx3 genes were then assessed for 
TFBSs by running MatInspector (http://www.genomatix.de/) against TF binding site position 
weight matrices (PWM). For this study we used the default settings for the core similarity 
0.75 and for matrix similarity 0.80. 
For the multiple alignment plus prediction of TFBSs in the set of identified conserved blocks 
present within the promoters, we used the DiAlignTF software (http://www.genomatix.de/). 
We retained the same settings as used for the TFBSs prediction in the promoters (score 
similarity 0.75 and matrix similarity 0.8) and all the common TFBS matches located in aligned 
regions were determined. Then we used MatInspector for quantification of TFBSs common 
to all input sequences. The percentage of retention of putative TFBSs was calculated 
comparing the number of a given TFBS in the promoter to that from the conserved blocks in 
both zebrafish and fugu promoters. 
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3.4 Results 
3.4.1 Promoter activity analysis and prediction of transcription factor binding sites in 
zebrafish runx3 
To investigate the promoter activity of the promoter regions (P1 and P2) of the zebrafish 
runx3 gene, we performed luciferase assays following the transient transfection of the 
human osteosarcoma U2OS cells and rat C6 glioma cells (Figure 3.1). The U2OS cell line was 
shown to express low levels of RUNX3 (Lai and Mager, 2012) and it was previously reported 
that RUNX3 expression is significantly decreased in human glioma (Mei et al., 2011). We 
have used P1 (from -5094 to -17 of the translation start site starting as MASN) and P2 
(from -3930 to -474 of the translation start site starting as MHIPV) reporter constructs 
generated by inserting PCR fragments into the pGL3-basic vector (Chapter 5). Both the 
constructs exhibited higher luciferase activities than negative control of the pGL3-basic 
vector (Figure 3.1). The P2 promoter construct showed about 36-fold and 26-fold higher 
luciferase activities than pGL-3-basic in U2OS and C6 cells respectively, while the P1 
promoter construct showed about 7-fold and 5-fold higher activity than the empty vector in 
U2OS and C6 cells respectively. Therefore, we expect that differences in the sequences of 
each promoter could affect their ability to function as a promoter. 
Figure 3.1 Relative transcriptional activity of zebrafish runx3 promoter constructs in U2OS 
and C6 cell lines. The results represent the ratio between firefly and Renilla luciferase 
determined. The mean and the SD for at least three independent transfections are shown. 
 
In order to verify the relationship between sequence variation and promoter activity, we 
analyzed transcription factor binding sites (TFBSs) in the zebrafish runx3 promoter regions by 
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using TRANSFAC® Public 6.0. We observed a huge number of putative TFBSs in both 
promoters, some of which were identified in both P1 and P2, while others were specifically 
found either in P1 or P2 promoter regions. To identify from this list of TFBSs which ones are 
more likely to be involved in the regulation of each promoter we decided to perform a 
comparative promoter analysis. 
 
3.4.2 Zebrafish and fugu runx3 promoter regions comparison 
To identify the likely regulatory regions, we analyzed the conservation of the promoter 
regions of the zebrafish and fugu runx3 genes using the DBA (DNA Block Aligner) web server. 
The output of DBA not only identifies discrete conserved blocks but also classifies them into 
four levels of conservation (A-D category, A showing lowest (60-70%) and D showing highest 
(90-100%) conservation). Among the 5 kb promoter sequences upstream of the translation 
start sites, an average of ten per cent of the total length of the P1 promoter region from 
zebrafish and fugu could be aligned by DBA; 0.7%, 3.2%, 1.9%, and 3.9% being of the A-D 
category, respectively. For the P2 promoter region only 3.3% was aligned by DBA; 0.5%, 0.9% 
and 1.9% being of the B-D categories, respectively. We plotted the sequence conservation as 
a function of the distance from the zebrafish runx3 translation start sites (Figure 3.2). 
Sequence conservation in the first 1000 bp was distinctly higher (Figure 3.2C), a finding fully 
consistent with the typical pattern for protein coding genes (Conceição et al, 2009). 
Furthermore, in addition to being more abundant, conserved blocks in the first 1000 bp 
tended to be more conserved (i.e. Type D, with 90-100% sequence identity) in both 
promoters (Figure 3.2). Interestingly, we observed that the P1 promoter region shows more 
conserved blocks (23 blocks) than the P2 promoter (eight blocks) (Table 3.1), suggesting that 
the P1 promoter sequence is more conserved compared with P2 and that there are more 
conserved cis-acting regulatory elements in the P1 than in the P2 promoter region. 
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Figure 3.2 Distribution of percentage of base-pairs located in block A, B, C, or D located in 
zebrafish and fugu promoters, for each of five 1000 bp segments spanning up to -5000 bp 
upstream of translation start signal (TSS) in (a) P1, (b) P2 and (c) P1 and P2 runx3 promoter 
regions. 
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3.4.3 Analysis of regulatory elements using MatInspector 
To analyze the conservation of the cis elements between the zebrafish and fugu 5 kb runx3 
promoter regions, the zebrafish promoter sequences and the set of identified conserved 
blocks presented within the zebrafish and fugu promoters were compared for TFBSs. Our 
comparison reveals the conservation of multiple potential cis elements between fugu and 
zebrafish promoters (Figure 3.S1). Although TFBSs are abundant in all sequences assessed, 
relatively few show conservation between zebrafish and fugu. Thus, for zebrafish, this 
criterion reduces the 3478 TFBSs in the P1 promoter sequence to only 142 in the conserved 
blocks, and the 8544 TFBSs in the P2 promoter sequence to only 104 in the conserved 
blocks. Thus, by identifying and analysing only conserved blocks, an average of 96% and 99% 
of all TFBSs in, respectively, the P1 and P2 promoter regions were eliminated (Figure 3.3). 
Likewise, this approach also substantially reduces the number of TF families implicated in 
runx3 regulation, (from 170 to 66 (a reduction of 61 %) and from 175 to 49 (a reduction of 72 
%), in P1 and P2 promoters, respectively).  
To determine whether our comparative screening of TFBSs was likely to have identified TFs 
(Table 3.1) with roles in runx3 regulation, we searched our lists for the presence of TFs 
previously characterized as regulating RUNX3. Key roles have been shown for signal 
transducer and activator of transcription STAT (Park et al, 2010), Sp1 transcription factor 
/TEA domain family member 2 (Sp1/ETF) (Bangsow et al, 2001), T helper transcription factor 
(Th-POK) (Egawa et al, 2009), CBF1/Suppressor of Hairless/Lag1 (CSL) (Fu et al, 2011), 
interferon regulatory factor 4 (IRF4) (Cao et al, 2010), E-twenty-six (Ets1) (Zamisch et al, 
2009), cAMP-response element-binding protein (Creb) (Lim et al, 2011), microphthalmia-
associated transcription factor (Mitf) (Hoek et al, 2008), Twist subfamily of class B bHLH 
transcription factors (Scl/Tal1) (Landry et al, 2008), Brn POU domain factor (Brn3a) (Dykes et 
al, 2010; 2011), recombination signal binding protein-J kappa (Rbpj) (Fu et al, 2011) and 
runt-related transcription factors (Runx) (Drissi et al, 2000) in regulation of mammalian 
RUNX3. Of these eight TFs, Ets1, Stat, Creb, Mitf, Scl, Brn3a, Rbpj and Runx show conserved 
binding sites in the conserved sequence blocks in the runx3 promoter sequences analysed 
here, consistent with them having a functional role in the regulation of runx3 in fish. 
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These TFs are then prime candidates for future functional studies assessing their ability to bind to and regulate activity of runx3 in vivo. 
 
Figure 3.3 Retention of putative TFBSs after comparative analysis. For each TF listed along the x-axis, corresponding bars represent the 
percentage (y-axis) of putative TFBSs originally identified by MatInspector that also survived after DiAlignTF comparative analysis. The dashed 
line indicates the minimum percent chosen to consider TFBSs as most frequent. 
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Table 3.1 Transcription factor families conserved in each block obtained from the alignment 
of P1 and P2 runx3 promoter regions between zebrafish and fugu. 
Pr 
Block 
Number 
Block Position 
Block Type 
Conserved TF Families 
A B C D 
P1 
1 
Dr: -3636 to -3620 
  X  V$OCT1; O$PTBP 
Fr: -3044 to -3060 (-) 
2 
Dr: -3557 to -3545 
   X V$ZF35; V$RUSH 
Fr: -1271 to -1259 
3 
Dr: -3512 to -3494 
   X V$RU49; V$ZF03; V$HASF 
Fr: -4874 to -4894 (-) 
4 
Dr: -3202 to -3194 
   X No common TF matches found 
Fr: -3149 to -3157 (-) 
5 
Dr: -3084 to -3071 
   X V$RUSH; V$SMAD 
Fr: -3776 to -3789 (-) 
6 
Dr: -3042 to -3032 
   X V$TCFF 
Fr: -1084 to -1094 (-) 
7 
Dr: -2979 to -2967 
   X No common TF matches found 
Fr: -4396 to -4384 
8 
Dr: -2957 to -2895 
 X   
V$CSEN; O$INRE; V$PAX6; V$AP1R; V$HAND; 
V$MYOD; V$SORY; V$NKXH; V$BRN5; VHOXF; 
V$YY1F; V$BRNF; V$ABDB; V$SF1F; V$LTFM; V$RBP2 Fr: -1688 to -1626 
9 
Dr: -1532 to -1503 
  X  
V$FKHD; V$NFAT; V$ABDB; V$BRNF; V$CDXF; 
V$ZF35; V$ARID; O$VTBP; V$SATB 
Fr: -1274 to -1247 
10 
Dr: -1189 to -1171 
  X  V$HAML; V$NFKB; V$ZFHX; V$ZF08; V$SAL2 
Fr: -3275 to -3293 (-) 
11 
Dr: -1110 to -1100 
   X No common TF matches found 
Fr: -1494 to -1504 (-) 
12 
Dr: -1073 to -1036 
X    
V$CEBP; V$OCT1; V$PAX6; V$BRAC; V$HASF; 
V$RUSH Fr: -4416 to -4379 
13 
Dr: -1021 to -1006 
  X  V$CIZF; V$CHRF 
Fr: -3085 to -3100 (-) 
14 
Dr: -852 to -803 
 X   
V$BRN5; V$SORY; V$BRNF; V$CLOX; V$GATA; 
V$HAND; V$HOMF; V$EBOX; V$HIFF; V$MYOD; 
V$HESF; V$MITF; V$NKXH; V$SREB; V$CAAT; 
V$NEUR; V$KLFS; O$INRE; V$CARE; V$SAL2; V$MIZ1 Fr: -1037 to -1086 (-) 
15 
Dr: -778 to -763 
   X V$HAML; V$ZF35; V$BPTF; V$ZFHX; V$CABL 
Fr: -499 to -516 (-) 
16 
Dr: -701 to -684 
   X V$RUSH; V$CIZF; V$CABL 
Fr: -1249 to -1267 (-) 
17 
Dr: -625 to -604 
  X  
V$STAT; V$XBBF; V$CEBP; V$RBPF; V$IKRS; V$MZF1; 
V$MYT1; V$ZF03; V$ZFHX Fr: -3027 to -3006 
18 
Dr: -510 to -484 
   X V$TCFF 
Fr: -544 to -518 
19 
Dr: -472 to -463 
   X No common TF matches found 
Fr: -3549 to -3540 
20 
Dr: -454 to -443 
   X V$SMAD 
Fr: -1597 to -1608 (-) 
21 
Dr: -202 to -188 
   X V$MZF1 
Fr: -3392 to -3378 
22 
Dr: -162 to -98 
 X   
V$HASF; V$HAML; V$ZF08; V$GFI1; V$CLOX; V$ETSF; 
V$GATA; V$GUCE; V$EBOX; V$IKRS; V$KLFS; 
V$AP2F; V$HOMF; V$BRNF; V$SORY; V$STAT; 
V$PAX6; V$XBBF Fr: -179 to -118 
23 
Dr: -80 to -61 
   X V$TALE; V$CSEN; V$TCFF 
Fr: -5053 to -5074 (-) 
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Pr 
Block 
Number 
Block Position 
Block Type 
Conserved TF Families 
A B C D 
P2 
1 
Dr: -5505 to -5479 
 X   
O$VTBP; V$CDXF; V$PARF; V$FKHD; 
V$BRNF; V$HOMF; V$PAXH; V$RUSH Fr: -294 to -320 (-) 
2 
Dr: -4930 to -4913 
   X V$RUSH; O$VTBP; V$PAXH; V$CHRF 
Fr: -2187 to -2205 (-) 
3 
Dr: -4466 to -4446 
  X  V$ARID 
Fr: -3630 to -3650 (-) 
4 
Dr: -3926 to -3908 
   X V$MYBL; V$XBBF; V$OSRF 
Fr: -2808 to -2790 
5 
Dr: -3900 to -3873 
  X  
V$CSEN; V$KLFS; V$TALE; V$AP2F; 
V$HAND; V$MYOD; V$EBOX; V$HESF; 
V$E2FF; V$ZF5F; O$TF2B Fr: -2773 to -2745 
6 
Dr: -3862 to -3838 
   X 
V$CART; V$CREB; V$EBOX; V$HIFF; 
V$LHXF; V$ARID; V$NKXH; V$PAX3; 
V$SIX3; V$HOBX; V$HOMF; V$HOXF; 
V$PAX6; V$SATB; V$BCDF; V$BRNF; 
O$VTBP; V$DLXF; V$PIT1; V$NKX6; 
V$PAXH; V$HOXC; V$ABDB; V$OCT1; 
V$ZF35; O$INRE; V$TCFF 
Fr: -2713 to -2689 
7 
Dr: -2982 to -2964 
   X 
V$BRNF; V$FKHD; O$VTBP; V$SATB; 
V$SAL1 Fr: -2517 to -2535 (-) 
8 
Dr: -974 to -950 
   X 
V$CART; V$HOMF; V$MEF2; V$ABDB; 
V$LHXF; O$PTBP; V$BRNF; V$CHRF; 
V$CLOX; V$FKHD; V$HOXC; O$VTBP; 
V$STAB 
Fr: -2322 to -2347 (-) 
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Figure 3.4 Representation of a DBA block obtained from the alignment of P1 (a) and P2 (a’) 
runx3 promoter regions between zebrafish and fugu and overview of TFBS families detected 
by DiAlignTF on the conserved blocks analysed for P1 (b) and P2 (b’) promoters. (a, a’) 
Example of an alignment of one of the 23 blocks obtained for P1 and 8 blocks obtained for 
P2 using the DBA software. The block position in the respective promoter sequence is 
shown, considering the A of the translation initiation codon as +1. The block type is also 
represented as a bold letter next to the consensus sequence identified between the two 
blocks. (b, b’) Overview of the TFBS conserved in the block showed as (a) or (a’), respectively 
for P1 or P2, detected by MatInspector using DiAlignTF program. Only upper-case letters are 
considered to be aligned. The colour code for each specific TFBS is shown above the 
alignment. 
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3.5 Discussion 
In the present study we provide evidence for the transcriptional activity of zebrafish runx3 
promoters in two different cell lines, using in vitro transient transfection experiments. These 
findings support an earlier report from our laboratory. To gain insight into the regulatory 
mechanism of the runx3 gene, the sequences of the genomic fragments (named P1 and P2) 
were analyzed in silico for potential recognition sites to transcription factors. Our analysis 
identified numerous putative cis regulatory elements that may serve as targets for 
sequence-specific enhancer/silencer transcription factors.  
We have then used the DBA algorithm to obtain comparative alignment between zebrafish 
and fugu runx3 promoter regions in order to detect conserved sequence blocks and then 
used MatInspector to determine putative TFBSs in those blocks, so as to enrich for likely 
functionally relevant TFBSs. Our in silico analysis of zebrafish runx3 P1 and P2 promoter 
regions provides important clues as to factors likely to be involved in regulation of runx3 
expression. Although MatInspector can find most true positive TFBS matches in a promoter 
region (Cartharius et al, 2005), not all sites found are necessarily functional in a particular 
biological context. A first step in examining functionality is a comparative promoter analysis. 
The alignment obtained with DBA was then assessed for conserved TFBSs by DiAlignTF, a 
combination of MatInspector with the multiple alignment program DiAlign (Morgenstern et 
al, 1998). DiAlignTF displays TFBSs located at the same position within the alignment and 
then it can be used to reduce the list of potential TFBSs to the most likely functional 
matches. From the data obtained it was possible to identify the sites most likely involved in 
regulating expression of runx3 in zebrafish. While a number of pathways regulating RUNX 
activity have been delineated, transcription factors binding to RUNX promoters are only 
beginning to be identified. From the list of 86 putative TFBSs families retained after the 
comparative analysis, CREB (family V$CREB) (Lim et al, 2011), Mitf (family V$MITF) (Hoek et 
al, 2008), Brn3a (family V$BRNF) (Dykes et al, 2010; 2011), Rbp-j (family V$RBPF) (Fu et al, 
2011), Scl/Tal1 (family V$HAND) (Landry et al, 2008), Ets1 (family V$ETSF) (Zamisch et al, 
2009), Stat (family V$STAT) (Park et al, 2010) and Runx (family V$HAML) (Drissi et al, 2000; 
Spender et al, 2005) are described in the literature as regulating the RUNX3 gene. In addition 
to these data indicating likely conservation of a regulatory function for these TFs between 
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mammals and fish, our in silico analysis identified a number of novel potential regulatory TFs 
for the zebrafish runx3 promoters (Figure 3.3). As described in Materials and Methods, 
several TFs were found to be retained within the conserved blocks (between zebrafish and 
fugu promoters) analysed (Figure 3.4). By focusing only on those, we selected a set having a 
retained score of 15 % or higher (Figure 3.3), which included Brn-5 POU domain factors 
(family V$BRN5), Cas interacting zinc finger (family V$CIZF), Runx or Human acute 
myelogenous leukemia factors (family V$HAML), PAX-4/PAX-6 paired domain binding sites 
(family V$PAX6), Spalt-like transcription factor 2 (family V$SAL2) and Sterol regulatory 
element binding proteins (family V$SREB) for P1 promoter and TFIIB or RNA polymerase II 
transcription factor II B (family O$TF2B) for P2 promoter. Interestingly, available data links 
some of these with either skeletal or neuronal development. In the context of the P1 
promoter, five of these TFs have a function in neurogenesis and two in skeletogenesis. Brn-5 
POU domain factors (Brn-5) is expressed in many central nervous system (CNS) neuron 
populations and may function as a transcriptional regulator involved in specifying the 
mature phenotype of CNS neurons (Cui and Bulleit, 1998). Spalt-like transcription factor 2 
(Sall2) also plays a role in neuronal development (Pincheira et al, 2009) and is the only 
member of the family suggested to act as a tumor suppressor (Li et al, 2001; Ma et al, 2001). 
Sterol regulatory element binding protein 2 (Srebp2) was shown to interact with the 
acetoacetyl-CoA synthetase (AACS) promoter and knockdown experiments showed that 
SREBP-2 regulates AACS expression during neurite outgrowth in the neuroblastoma Neuro-
2a cell line (Hasegawa et al, 2012). Paired box 6 (Pax6) also is expressed during neurogenesis 
(Gan et al, 2013), and it functions as a transcription factor with a major role in eye and brain 
development from Drosophila to humans (Callaerts et al, 1999; van Heyningen and 
Williamson, 2002). Lleras-Forero et al (2013) showed CNS Pax6b expression in zebrafish. The 
human acute myelogenous leukemia factors (Haml; also known as a runt-related Runx/AML 
protein) function as context-dependent transcription factors during developmental 
processes such as hematopoiesis, neurogenesis, and osteogenesis (Westendorf and Hiebert, 
1999). Runx expression was shown in subtypes of dorsal root ganglion (DRG) neurons, 
suggesting their involvement in lamina-specific afferent differentiation and maturation 
(Inoue et al, 2003) and Runx2 and Runx3 have also been shown to regulate chondrocyte 
differentiation and maturation (Yoshida et al, 2004; Komori, 2005). In zebrafish, we have 
shown that Runx2 was able to transactivate the promoter of osteocalcin, an osteoblastic 
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marker gene (Pinto et al, 2005), as well as the promoter of collagen Xα1, a chondrocyte 
marker gene (Simões et al, 2006). Zebrafish runx3 expression was observed in neuronal 
tissues including the trigeminal ganglia and Rohon-Beard neurons (Kalev-Zylinska et al, 2003) 
and also in the craniofacial region (Flores et al, 2006). Cas-interacting zinc finger protein (CIZ) 
is one of the suppressors of BMP signaling in osteoblastic differentiation (Shen et al, 2002). 
Besides these last two highly conserved TFBSs, our data shows the occurrence in the 
conserved sequences of binding sites for many more TFs that are described as having a role 
in skeletogenesis. These factors include NF-kB (Wu et al, 2011), NF-YB (Chen et al, 2009), 
NFATc1 (Lambertini et al, 2008), Ets-1 (Wenke et al, 2006), and Sox5 and Sox9 (Yang et al, 
2011). Curiously, all these TFBSs are only detected in the P1 promoter and not in the P2 
promoter.  
Of the two putative TFBSs more conserved in the P2 promoter, that for the odd-skipped 
related (Osr) zinc finger transcription factor is notable since it has suggested to be involved 
in bone formation (Kawai et al, 2007). The other relates to TFIIB, a component of the basal 
transcription complex. Several other TFs identified in our analysis for the P2 promoter are 
known to play critical roles in zebrafish development, e.g. dlx (distal-less homeodomain; 
family V$DLXF) genes play a key role in the patterning of the forebrain, in peripheral 
structures of the head, and in the fins (Akimenko et al, 1994); mef2 (myocyte enhancer 
factor 2; family V$MEF2) genes are essential for heart development (Hinits et al, 2012) and 
in cranial neural crest for proper head skeletal patterning (Miller et al, 2007); CREB (cAMP 
response element-binding protein; family V$CREB) have a role in neural development 
(Dworkin et al, 2007); Nkx6 (NK6 homeobox; family V$NKX6) proteins specify one zebrafish 
primary motoneuron subtype (Hutchinson et al, 2007); Pax3 (paired box 3; family V$PAX3) is 
induced early during neural development in progenitors of the dorsal spinal cord (Moore et 
al, 2013), and Six3 (sine oculis homeobox homolog 3; family V$SIX3) are involved in the 
left-right brain patterning (Inbal et al, 2007). 
Since it is known that all Runx protein family members bind to the same DNA core sequence, 
their temporal and/or spatial expression has to be tightly regulated. Other investigators have 
reported that the two promoter regions, P1 and P2, regulate Runx3 expression in a cell 
type-specific manner (Bangsow et al, 2001; Egawa, 2009). Soung et al (2007) showed that 
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both Runx3 isoforms in mice are expressed and regulated during chondrocyte 
differentiation, while Yoshida et al (2004) showed that Runx3 mRNA was detected in both 
mouse CD8+ and CD4+ T cells, but only the CD8+ population expressed the P1 transcript 
isoform and detectable levels of RUNX3 protein. 
Comparison of the zebrafish runx2b proximal promoter sequence that we identified and 
cloned previously (Pinto et al, 2005) with both those of zebrafish runx3 showed some 
common consensus binding motifs, namely for NFAT, CREB, Runx, and CBF1. They are thus 
possible candidates for regulating expression of runx3. Of interest are the two putative 
RUNX-binding sites present at the beginning of the 5’UTR of the P1 promoter of all three 
RUNX genes perfectly conserved in mammals. These RUNX-binding sites were previously 
been shown by independent studies to have an effect on the transcriptional regulation of 
Runx genes, either positively or negatively, through the binding of RUNX proteins (Levanon 
et al, 1998; Ducy et al, 1999; Drissi et al, 2000; Bangsow et al, 2001; Levanon and Groner, 
2004; Spender et al, 2005). In our present analysis we also found two Runx-binding sites in 
the runx3 P1 promoter that are conserved between zebrafish and fugu. Taken together this 
may indicate important regulatory roles such as cross-regulation and/or auto-regulation. 
In conclusion, our comparative in silico analysis of zebrafish runx3 gene promoter regions, 
using the DBA and DiAlignTF softwares, predicts strong candidates TFBS likely to contribute 
to regulation of runx3 transcription. These TFBSs include binding sites for TFs already known 
from work in mammals as transcriptional regulators of Runx3, but also include novel TFs. 
Thus, our data likely provide a powerful tool to guide future dissection of runx3 
transcriptional regulation in vitro and/or in vivo. 
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3.6 Supplementary Figures 
 
(a) Promoter P1 
 
>P1_Block_1 
 
Dr: -3636    AATCTAATTTATATCTG    -3620 
       C  AATCTAAT  ATAT TG 
Fr: -3044    AATCTAATAAATATGTG    -3060 
 
V$OCT1  O$PTBP  
alignment position   1 . . . . . . . . .   1 1 . . . . . 
Dr 1   A A T C T A A T T T   A T A T C T G 
Fr 1   A A T C T A A T A A   A T A T G T G 
 
 
>P1_Block_2 
 
Dr: -3557    CCAGAAAATAAAA    -3545  
       D  CCAGAAAATAAAA 
Fr: -1271    CCAGAAAATAAAA    -1259  
 
V$ZF35  V$RUSH  
alignment position   1 . . . . . . . . .   1 1 . 
Dr 1   C C A G A A A A T A   A A A 
Fr 1   C C A G A A A A T A   A A A 
 
 
>P1_Block_3  
 
Dr: -3512    CATTTCAGTACACA--TTTCA    -3494  
       D  CATT CAGTACACA  TTTCA 
Fr: -4874    CATTGCAGTACACACATTTCA    -4894 
 
V$RU49  V$ZF03  V$HASF 
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 
Dr 1   C A T T T C A G T A   - - C A C A T T T C   A 
 
Fr 1   C A T T G C A G T A   c a C A C A T T T C   A 
 
 
 
>P1_Block_4 
 
Dr: -3202    TATCCTGTT    -3194  
       D  TATCCTGTT 
Fr: -3149    TATCCTGTT    -3157 
 
No common TF matches found. 
alignment position   1 . . . . . . . . 
Dr 1   T A T C C T G T T 
Fr 1   T A T C C T G T T 
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>P1_Block_5 
 
Dr: -3084    TGTGTGTATGTGTG    -3071 
       D  TGTGTGT TGTGTG 
Fr: -3776    TGTGTGTCTGTGTG    -3789 
 
V$RUSH  V$SMAD  
alignment position   1 . . . . . . . . .   1 1 . . 
Dr 1   T G T G T G T A T G   T G T G 
Fr 1   T G T G T G T C T G   T G T G 
 
 
>P1_Block_6 
 
Dr: -3042    GAAGTCATTCT    -3032  
       D  GAAGTCATTCT 
Fr: -1084    GAAGTCATTCT    -1094 
 
V$TCFF  
alignment position   1 . . . . . . . . .   1 1 
Dr 1   G A A G T C A T T C   T 
 
Fr 1   G A A G T C A T T C   T 
 
 
 
>P1_Block_7 
 
Dr: -2979    CACACACACATAG    2967  
       D  CACACACACATAG 
Fr: -4396    CACACACACATAG    -4384 
 
No TF matches found. 
alignment position   1 . . . . . . . . .   1 1 . 
Dr 1   C A C A C A C A C A   T A G 
Fr 1   C A C A C A C A C A   T A G 
 
 
 
>P1_Block_8 
 
Dr: -2957    GTGTCATTTTCCCTGGGCTGCCGGCTGAC-CAACACACAAGTGCTCATT    -2910  
       B  GTGTCATTT   C   GCTGCCG CT AC CAAC   CAA TGCTCATT       
Fr: -1688    GTGTCATTTAGGCCATGCTGCCGCCTAACTCAACGG-CAACTGCTCATT    -1641  
 
 
Dr: -2909    TTCATGGCACTGTGG    -2895  
       B  T CA GGCA TG GG 
Fr: -1640    TACAGGGCAGTGCGG    -1626  
 
 
V$CSEN  O$INRE  V$PAX6  V$AP1R  V$HAND  V$MYOD  V$SORY  V$NKXH  V$BRN5  V$HOXF  V$YY1F  V$BRNF  
V$ABDB  V$SF1F  V$LTFM  V$RBP2  
        
alignment 
position 
  1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . .   3 1 . . . . . . . .   4 1 . . . . . . . . 
Dr 1   G T G T C A T T T T   C C C T G G G C T G   C C G G C T G A C -   C A A C a c a C A A   G T G C T C A T T T 
Fr 1   G T G T C A T T T A   G G C C A T G C T G   C C G C C T A A C t   C A A C g g - C A A   C T G C T C A T T T 
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alignment 
position 
  5 1 . . . . . . . .   6 1 . . 
                                       
Dr 50   T C A T G G C A C T   G T G G 
                                       
Fr 50   A C A G G G C A G T   G C G G 
                                       
 
 
>P1_Block_9 
 
Dr: -1532    AAACCAGCAAATAAACAAGCTAGCTAAAAC    -1503  
       C  AA CCAG AAATAAA AAG T GC AAAAC  
Fr: -1274    AACCCAGAAAATAAAAAAG-T-GCAAAAAC    -1247  
 
V$FKHD  V$NFAT  V$ABDB  V$BRNF  V$CDXF  V$ZF35  V$ARID O$VTBP  V$SATB  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . . 
Dr 1   A A A C C A G C A A   A T A A A C A A G c   t a G C T A A A A C 
Fr 1   A A C C C A G A A A   A T A A A A A A G t   - - G C A A A A A C 
 
 
>P1_Block_10 
 
Dr: -1189    ACTATAGAAACCACCCAGA    -1171  
       C  ACT T GAAACCAC CAGA  
Fr: -3275    ACTGTGGAAACCACACAGA    -3293 
 
V$HAML  V$NFKB  V$ZFHX  V$ZF08  V$SAL2  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . 
Dr 1   A C T A T A G A A A   C C A C C C A G A 
Fr 1   A C T G T G G A A A   C C A C A C A G A 
 
 
>P1_Block_11 
 
Dr: -1110    AAACTGCTTCA    -1100  
       D  AAACTGCTTCA  
Fr: -1494    AAACTGCTTCA    -1504 
 
 
 
No common TF matches found. 
alignment position   1 . . . . . . . . .   1 1 
Dr 1   A A A C T G C T T C   A 
 
Fr 1   A A A C T G C T T C   A 
 
 
 
>P1_Block_12 
 
Dr: -1073    TACACATATATGCACACCTAAATACACATATAGATAGT    -1036  
       A  TA ACA   ATGCACA  T  A ACACA ATAG TA T  
Fr: -4416    TAGACACCAATGCACAGATGCACACACACATAGGTAAT    -4379  
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V$CEBP  V$OCT1  V$PAX6  V$BRAC  V$HASF V$RUSH  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . .   3 1 . . . . . . 
Dr 1   T A C A C A T A T A   T G C A C A C C T A   A A T A C A C A T A   T A G A T A g t 
Fr 1   T A G A C A C C A A   T G C A C A G A T G   C A C A C A C A C A   T A G G T A a t 
 
 
>P1_Block_13 
 
Dr: -1021    ATTTGTTTTTAACCAG    -1006  
       C  ATT GTTTTTAAC AG  
Fr: -3085    ATTAGTTTTTAACGAG    -3100 
 
V$CIZF V$CHRF  
alignment position   1 . . . . . . . . .   1 1 . . . . 
Dr 1   A T T T G T T T T T   A A C C A G 
Fr 1   A T T A G T T T T T   A A C G A G 
 
 
>P1_Block_14 
 
Dr: -852    TTTTAATGAGGCTAACATCGAGATAATATCAAGTGGTGAGTGAGGGTGGA    -803  
      B  TT TAAT AG CTA  AT   GATA TATCAAGTGGT AGTGAGGGTGGA       
Fr: -1037   TTCTAATAAGACTATGATTATGATACTATCAAGTGGTAAGTGAGGGTGGA    -1086 
 
 
V$BRN5  V$SORY  V$BRNF  V$CLOX  V$GATA  V$HAND  V$HOMF  V$EBOX  V$HIFF  V$MYOD  V$HESF  V$MITF  
V$NKXH  V$SREB  V$CAAT V$NEUR  V$KLFS  O$INRE  V$CARE V$SAL2  V$MIZ1  
   
alignment 
position 
  1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . .   3 1 . . . . . . . .   4 1 . . . . . . . . 
Dr 1   T T T T A A T G A G   G C T A A C A T c g   a G A T A A T A T C   A A G T G G T G A G   T G A G G G T G G A 
Fr 1   T T C T A A T A A G   A C T A T G A T t a   t G A T A C T A T C   A A G T G G T A A G   T G A G G G T G G A 
 
 
>P1_Block_15 
 
Dr: -778    CCAC-CA-AAACACACTC    -763  
      D  CCAC CA AAACACACTC  
Fr: -499    CCACACAGAAACACACTC    -516 
 
V$HAML  V$ZF35  V$BPTF  V$ZFHX  V$CABL  
alignment position   1 . . . . . . . . .   1 1 . . . . . . 
Dr 1   C C A C c a - - A A   A C A C A C T C 
Fr 1   C C A C a c a g A A   A C A C A C T C 
 
 
>P1_Block_16 
 
Dr: -701    TTTTGTACTTTTTT-TTTT    -684  
      D  TTTTG ACTTTTTT TTTT  
Fr: -1249   TTTTGCACTTTTTTATTTT    -1267 
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V$RUSH  V$CIZF V$CABL  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . 
Dr 1   T T T T G T A C T T   T T T T T T T T - 
Fr 1   T T T T G C A C T T   T T T T A T T T t 
 
 
>P1_Block_17 
 
Dr: -625     ATCATCTTCTGGGAAACTCTTC    -604  
       C  ATCA CT  TGGGAAACT TTC  
Fr: -3027    ATCACCTCATGGGAAACTTTTC    -3006  
 
V$STAT  V$XBBF  V$CEBP  V$RBPF  V$IKRS  V$MZF1  V$MYT1  V$ZF03  V$ZFHX  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 
Dr 1   A T C A T C T T C T   G G G A A A C T C T   T C 
Fr 1   A T C A C C T C A T   G G G A A A C T T T   T C 
 
 
>P1_Block_18 
 
Dr: -510    CATGTGAC-TGGAGTTCCACCTA-TCAGA    -484  
      D  CATGTGAC TGG GTTC ACC A TCAGA  
Fr: -544    CATGTGACGTGG-GTTCGACC-ACTCAGA    -518  
 
V$TCFF  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . 
Dr 1   C A T G T G A C T G   G A G T T C C A C C   T A T C A G A 
Fr 1   C A T G T G A C G T   G G G T T C G A C C   A C T C A G A 
 
 
>P1_Block_19 
 
Dr: -472     GCGAGCAGCA    -463  
       D  GCGAGCAGCA  
Fr: -3549    GCGAGCAGCA    -3540  
 
No common TF matches found. 
alignment position   1 . . . . . . . . . 
Dr 1   G C G A G C A G C A 
Fr 1   G C G A G C A G C A 
 
 
>P1_Block_20 
 
Dr: -454    GCGGGAGCTGTG    -443  
      D  GCGGGAGCTGTG  
Fr: -1597   GCGGGAGCTGTG    -1608 
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V$SMAD  
alignment position   1 . . . . . . . . .   1 1 
Dr 1   G C G G G A G C T G   T G 
Fr 1   G C G G G A G C T G   T G 
 
 
>P1_Block_21 
 
Dr: -202     CTCGCTCTCACCACA    -188  
       D  CTCGCTC CACCACA  
Fr: -3392    CTCGCTCCCACCACA    -3378  
 
V$MZF1  
alignment position   1 . . . . . . . . .   1 1 . . . 
Dr 1   C T C G C T C T C A   C C A C A 
Fr 1   C T C G C T C C C A   C C A C A 
 
 
 
>P1_Block_22 
 
Dr: -162    GGCTTGTGGCGAAAGATTCCTGTGGCACTCTCAAACCCCAAATTCTTGG -114  
      B  GGCTTGTGGC    GATTCCTGTGG   TC CAAACC  A  TTCT GG       
Fr: -179    GGCTTGTGGCTCTGGATTCCTGTGGTGGTCACAAACCG-A--TTCTCGG -134  
 
 
Dr: -113    TTGCAGGCTGTCTATG    -98  
      B  TTGC  GC  TCT TG  
Fr: -133    TTGCGCGCCATCTCTG    -118  
 
V$HASF V$HAML  V$ZF08  V$GFI1  V$CLOX  V$ETSF  V$GATA  V$GUCE  V$EBOX  V$IKRS  V$KLFS  V$AP2F  
V$HOMF  V$BRNF  V$SORY  V$STAT  V$PAX6  V$XBBF  
      
alignment 
position 
  1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . .   3 1 . . . . . . . .   4 1 . . . . . . . . 
Dr 1   G G C T T G T G G C   G A A A G A T T C C   T G T G G C A C T C   T C A A A C C c c a   a A T T C T T G G T 
Fr 1   G G C T T G T G G C   T C T G G A T T C C   T G T G G T G G T C   A C A A A C C g - -   - A T T C T C G G T 
alignment 
position 
  5 1 . . . . . . . .   6 1 . . . 
                                      
Dr 51   T G C A G G C T G T   C T A T G 
                                      
Fr 48   T G C G C G C C A T   C T C T G 
                                      
 
 
>P1_Block_23 
 
Dr: -80     TTTC-TCC-GACTGTCATTCTC    -61  
      D  TTTC TCC GA TGTCATTCTC  
Fr: -5053   TTTCCTCCAGAATGTCATTCTC    -5074  
 
V$TALE  V$CSEN  V$TCFF  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 
Dr 1   - T T T C T C C - G   A C T G T C A T T C   T C 
Fr 1   t T T C C T C C a G   A A T G T C A T T C   T C 
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(b) Promoter P2 
 
>P2_Block_1 
 
Dr: -5505    TCATTTAAAAAAATAATTCCAAAGTTA    -5479 
       B  TC TTTAAAAAAA AA T  AAA TTA  
Fr: -294     TCTTTTAAAAAAAAAAATTTAAAATTA    -320 
 
O$VTBP  V$CDXF  V$PARF  V$FKHD  V$BRNF  V$HOMF  V$PAXH  V$RUSH  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . 
Dr 1   T C A T T T A A A A   A A A T A A T T C C   A A A G T T A 
Fr 1   T C T T T T A A A A   A A A A A A A T T T   A A A A T T A 
 
 
>P2_Block_2 
 
Dr: -4930    AATAAAT-ATTTTAAAATA    -4913   
       D  AATAAAT ATTTTAAAATA   
Fr: -2187    AATAAATGATTTTAAAATA    -2205 
 
V$RUSH  O$VTBP  V$PAXH  V$CHRF  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . 
Dr 1   A A T A A A T - A T   T T T A A A A T A 
Fr 1   A A T A A A T g A T   T T T A A A A T A 
 
 
>P2_Block_3  
 
Dr: -4466    TTTTTTTTTCCTTCTGTAAAT    -4446  
       C  TTTTTTTTT  TTCTGT AAT   
Fr: -3630    TTTTTTTTTTTTTCTGTGAAT    -3650 
 
V$ARID 
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 
Dr 1   T T T T T T T T T C   C T T C T G T A A A   T 
 
Fr 1   T T T T T T T T T T   T T T C T G T G A A   T 
 
 
 
>P2_Block_4 
 
Dr: -3926    CTGTAACCGTAGAAACTGC    -3908  
       D  CTG AACCGTAGAAACTGC    
Fr:  2808    CTGAAACCGTAGAAACTGC    -2790  
 
V$MYBL  V$XBBF  V$OSRF  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . 
Dr 1   C T G T A A C C G T   A G A A A C T G C 
Fr 1   C T G A A A C C G T   A G A A A C T G C 
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>P2_Block_5 
 
Dr: -3900    GTCTGAATTTGACAGGCGCGCGGAG-TCA    -3873  
       C  GTCT AAT TGACAGGCGC C GAG TCA   
Fr: -2773    GTCTAAATGTGACAGGCGCCCAGAGCTCA    -2745  
 
V$CSEN  V$KLFS  V$TALE  V$AP2F  V$HAND  V$MYOD  V$EBOX  V$HESF  V$E2FF  V$ZF5F  O$TF2B  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . . . . 
Dr 1   G T C T G A A T T T   G A C A G G C G C G   C G G A G - T C A 
Fr 1   G T C T A A A T G T   G A C A G G C G C C   C A G A G c T C A 
 
>P2_Block_6 
 
Dr: -3682    GTGCGGTCACGTATTAATAATGAAC    -3838  
       D  GTG GGTCACGTATTAATAATGAAC   
Fr: -2713    GTGTGGTCACGTATTAATAATGAAC    -2689  
 
V$CART V$CREB  V$EBOX  V$HIFF  V$LHXF  V$ARID V$NKXH  V$PAX3  V$SIX3  V$HBOX  V$HOMF  V$HOXF  
V$PAX6  V$SATB  V$BCDF  V$BRNF  O$VTBP  V$DLXF  V$PIT1  V$NKX6  V$PAXH  V$HOXC  V$ABDB  V$OCT1  
V$ZF35  O$INRE  V$TCFF  
         
algnment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . 
Dr 1   G T G C G G T C A C   G T A T T A A T A A   T G A A C 
Fr 1   G T G T G G T C A C   G T A T T A A T A A   T G A A C 
 
 
>P2_Block_7 
 
Dr: -2982    TTAAAATAAA-TAAATAAAT    -2964  
       D  TTAAAATAAA TAA TAAAT   
Fr: -2517    TTAAAATAAAATAA-TAAAT    -2535 
 
V$BRNF  V$FKHD  O$VTBP  V$SATB  V$SAL1  
alignment position   1 . . . . . . . . .   1 1 . . . . . . . 
Dr 1   T T A A A A T A A A   T A A A T A A A T 
Fr 1   T T A A A A T A A A   A T A A T A A A T 
 
 
>P2_Block_8 
 
Dr: -974    ATAACTAT-TTTAAATAGATTATTTA    -950 
      D  ATAA TAT TTTAAATAGA TATTTA  
Fr: -2322   ATAAATATATTTAAATAGAATATTTA    -2347 
 
V$CART V$HOMF  V$MEF2  V$ABDB  V$LHXF  O$PTBP  V$BRNF  V$CHRF  V$CLOX  V$FKHD  V$HOXC  O$VTBP  
V$SATB  
           
alignment position   1 . . . . . . . . .   1 1 . . . . . . . .   2 1 . . . . 
Dr 1   A T A A C T A T - T   T T A A A T A G A T   T A T T T A 
Fr 1   A T A A A T A T a T   T T A A A T A G A A   T A T T T A 
 
Figure 3.S1 TFBS families detected by DiAlignTF that are common in all conserved blocks 
obtained from the alignment of runx3 P1 (a) and P2 (b) promoter regions between zebrafish 
and fugu. In each block is represented the alignment obtained by DBA software (upper 
alignment) and the DiAlignTF output (lower alignment) showing the TFBSs conserved in each 
block. The colour code for each specific TFBS is shown above the alignment. 
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4.1 Abstract 
The CBFβ gene encodes a transcription factor that, in combination with CBFα (also called 
Runx, runt-related transcription factor) regulates expression of several target genes. CBFβ 
interacts with all Runx family members, such as RUNX2, a master-regulator of bone-related 
gene transcription that contains a conserved DNA-binding domain (Runt domain). CBFβ 
stimulates DNA binding of the Runt domain, and is essential for most of the known functions 
of RUNX2. 
A comparative analysis of the zebrafish cbfβ gene and protein, and of its orthologous 
identified homologous proteins in different species indicates a highly conserved function. 
We cloned eleven transcripts of the zebrafish cbfβ gene, one resulting in the known Cbfβ 
protein (with 187 amino-acids (aa)), and three additional variants resulting from skipping 
exon 5a (resulting in a protein with 174 aa) or exon 5b resulting in a protein with 201 aa), 
both observed for the first time in zebrafish, and a completely novel isoform containing both 
exon 5a and 5b (and resulting in a protein with 188 aa). Functional analysis of these isoforms 
provides insight into their role in regulating gene transcription. From the other seven 
variants two correspond to premature early termination of Cbfβ forms, while the others 
show in-frame exon-skipping causing changes in the Cbfβ domain that may affect its 
function.  
 
4.2 Introduction 
Chondrocytes, osteoblasts, and osteoclasts are the major cell types that contribute to the 
development and maintenance of the skeleton (Erlebacher et al, 1995). Vertebrate skeletons 
are constructed by the formation of bone and cartilage structures that can occur via two 
distinct mechanisms: intramembranous and endochondral ossification. During 
intramembranous (or dermal) ossiﬁcation, mesenchymal cells condense and diﬀerentiate 
into osteoblasts, the bone-forming cells. In contrast, during chondral ossiﬁcation, 
mesenchymal cells condense and diﬀerentiate into chondrocytes to form a cartilage 
template. Subsequently, this template is either replaced by bone (endochondral ossiﬁcation) 
or it becomes surrounded by bone (perichondral ossiﬁcation) (Spoorendonk et al, 2010).  
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The importance of runt-related transcription factor 2 (RUNX2), in skeletal development was 
first suggested by studies of the autosomal dominant disease cleidocranial dysplasia (CCD) 
(Mundlos et al, 1995; reviewed in Martin et al, 2011). RUNX2 is a known master 
transcription factor for bone and hypertrophic cartilage formation expressed very early in 
bone development and continues to be present through the later phases of development 
(Ducy et al, 1997). It is essential for osteoblast differentiation as well as a critical regulator 
for chondrocyte maturation (Komori et al, 1997; Kishimoto et al, 1997; Otto et al, 1997; Kim 
et al, 1999; Inada et al, 1999; Takeda et al, 2001; Hinoi et al, 2006). RUNX2 belongs to the 
Runt-related transcription factor (RUNX) family of genes which are also called core binding 
factor-α (CBFα). The other two members identified are RUNX1 (AML1/CBFα2/PEBP2αB) and 
RUNX3 (AML2/CBFα3/PEBP2αC). The RUNX proteins can bind DNA as a monomer in vitro, 
but their affinity for DNA is enhanced when binding to the DNA as a CBFα:β heterodimers 
(Ogawa et al, 1993; Wang et al, 1993). Unlike CBFα, the CBFβ subunit does not contact DNA 
directly, but rather stabilizes and enhances in vitro DNA binding of the runt domain of the α 
subunit (Ogawa et al, 1993; Wang et al, 1993), which is a DNA binding domain conserved 
amongst the Runx family (Ogawa et al, 1993). Earlier studies have indicated that CBFβ and 
RUNX2 can cooperatively activate transcription (Harada et al, 1999; Zhang et al, 2000). 
Kundu et al (2002) carried out a series of experiments to determine whether CBFβ and 
Runx2 could interact physically and function in a cooperative manner, and have shown that 
the addition of CBFβ strongly induced the DNA binding of Runx2 (Kundu et al, 2002).  
Runx2 initiates and mediates the entire process of hypertrophic differentiation of 
chondrocytes (Stricker et al, 2002; Smith et al, 2005) by regulating the transcription of genes 
important for this process, e.g. collagen type X gene (Col10α1) (Enomoto et al, 2000; Zheng 
et al, 2003; Higashikawa et al, 2009). RUNX2 regulation of cell-specific Col10α1 expression 
may impact the process of chondrocyte maturation and represent the major mechanistic 
basis of multiple skeletal pathologies, such as CCD, fracture healing, and osteoarthritis 
(Higashikawa et al, 2009; Zheng et al, 2005; Kamekura et al, 2006; Tu et al, 2007). Zheng et al 
(2005) have previously reported abnormal endochondral ossiﬁcation in a fetal case of CCD, 
possibly due to altered RUNX2 regulation of chondrocyte hypertrophy and down-regulation 
of its target genes, including type X collagen. The above observations clearly demonstrate 
that both Runx2 and Col10α1 genes play important roles upon chondrocyte maturation 
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during endochondral bone formation. The interaction between Runx2 and the Col10α1 
proximal or core promoters in different species has previously been described extensively 
(Dourado and LuValle, 1998; Zheng et al, 2003; Simões et al, 2006; Higashikawa et al, 2009). 
Most studies in the areas of osteogenesis and mineral research have been performed in 
mice and chicken, or using in vitro cell culture systems. Although it has been shown that 
there are some characteristics in teleost bones that differ from mammals (Witten and 
Huysseune, 2009), the origin of cells that contribute to the various bone elements and the 
key regulators of bone formation are highly conserved between mammals and teleosts. 
Furthermore, the corresponding orthologs share signiﬁcant sequence similarities and an 
overlap in expression patterns (Flores et al, 2004; Yan et al, 2005; Li et al, 2009) when 
compared to mammals. As a result of this finding, in the last few years zebraﬁsh was 
demonstrated to be a powerful model especially in forward genetics to identify novel gene 
functions and to study their role in numerous processes including osteogenesis. Accordingly, 
zebraﬁsh can be used as a tool to complement genetic and embryological studies in mice 
and chicken in order to clarify the molecular mechanisms underlying bone development and 
disease. In addition, zebraﬁsh and medaka are ideally suited and currently the only model 
systems available to allow visualization of chondrocytes and osteoblasts in vivo over time.  
Thus far, different CBFβ isoforms have been described in mammals, but just one zebrafish 
Cbfβ protein has been reported. Here we report the cloning and characterization of ten 
novel zebrafish isoforms, which are generated by alternative splicing. A structural 
conservation during evolution from fish to mammals was confirmed, by a comparative 
analysis between zebrafish cbfβ gene and protein and its orthologs in different species. 
Previously, we have shown that zebrafish col10α1 expression is up-regulated by Runx2 
(Simões et al, 2006) through its binding to specific motifs within the col10α1 promoter 
region. So, we tested the ability of some of these newly identified Cbfβ isoforms to enhance 
Runx2-dependent up-regulation of col10α1 promoter. The transcriptional activity 
determined by luciferase reporter assays was enhanced by transfection of Runx2-MASN 
isoform and increased even more potently by the co-transfection of both Runx2-MASN and 
the co-activator Cbfβ (isoforms 1 and 2) as compared with the control. Furthermore, this 
indicates that Cbfβ exon 5a is not required for interaction with Runx2-MASN and 
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transcription activation. Moreover, we analysed the expression pattern of the Cbfβ isoforms 
1-4 in various adult tissues and at different embryonic developmental stages. 
 
4.3 Material and Methods 
4.3.1 Zebrafish RNA extraction and RNA reverse transcription 
Total RNA was extracted from ZFB1 cell line as described by Vijayakumar et al (2013) and 
from pools of zebrafish embryos at different stages of development and from a variety of 
adult zebrafish tissueswith TRIzol (Sigma Aldrich) as recommended in the manufacturer’s 
protocol. RNA integrity was assessed through 1% (w/v) agarose/formaldehyde gel 
electrophoresis and RNA quantity was determined through spectrophotometry (NanoDrop 
1000; Thermo Scientific). Total RNA (1 μg) was then treated with RQ1 RNase‐free DNase I 
(Promega) for 30 min at 37ºC, and reverse‐transcribed at 37°C for 1 h using the Moloney‐
murine leukemia virus (MMLV) reverse transcriptase, RNaseOUT (both from Invitrogen) and 
oligo(dT)‐adapter primer (Table 4.1). 
Table 4.1 Oligonucleotides used for PCR amplification. 
Name Sequence 
ZfCBFbFw1 GAGCGTCTGTTGTCAGCAGTCGGA 
ZfCBFbFw2 
ZfCBFbFw3 
ZfCBFbFw4 
ZfCBFbRev1 
ZfCBFbRev2 
ZfCBFbRev3 
ZfCBFbRev5 
Gapdh_F 
Gapdh_R 
CGTTCAAGATGCCTCGGGTGGTCC 
GAGGACTCGTGATTTCGAGGACAG 
GGAGCAGATGCCGATGGCACAGCT 
CCCCAAAACTCCCCCAGCGGTGTG 
CTGCCCACTTTGGTGAATGCCGCT 
GTGATCATCAGTGTTGCCCATGTT 
GTCCTTGAAGGCCATCAGTCCCAGA 
GTGGAGTCTACTGGTGTCTTC 
GTGCAGGAGGCATTGCTTACA 
Oligo(dt) primer ACGCGTCGACCTCGAGATCGATG(T)13 
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4.3.2 Zebrafish cbfβ cDNA cloning using RT-PCR 
The primer sequences used for cloning are shown in Table 4.1 and were synthesized and 
purchased from Sigma-Aldrich. Specific primers (zfCBFbFw1, zfCBFbFw2, zfCBFbRev1 and 
zfCBFbRev2) were designed to amplify zebrafish cbfβ complete cDNA coding region, 
according to its cDNA sequence available in the NCBI database (GenBank NM_199209.1). 
Amplification was performed by two steps PCR with zfCBFbFw1 and zfCBFbRev1 primers (0.3 
µM each), and either with the Taq DNA polymerase (Invitrogen) or the KOD Hot Start DNA 
Polymerase (Novagen), in a GeneAmp 2400 thermocycler (Perkin-Elmer), under conditions 
suggested by the suppliers and using as template cDNA from either ZFB1 cell line or 24 hpf 
zebrafish. The amplified product was used for the second step PCR. For this step, the 
reaction mix and PCR conditions were similar to the first step except in that the primer pairs 
zfCBFbFw2 and zfCBFbRev2 or the zfCBFbFw2 and zfCBFbRev1 (0.3 µM each) were used 
instead. Amplified fragments were cloned into pCRII-TOPO vector (Invitrogen) by standard 
TA-cloning or into pJet1.2 vector (Fermentas, Thermo Scientific) by standard blunt-cloning. 
Cloned fragments were identified by restriction digestion and by sequencing at CCMAR 
sequencing facilities (University of Algarve, Faro, Portugal). All sequence alignments were 
performed with ClustalW (Thompson et al, 1994) or using AlignX, from Vector NTI Advance® 
11.5 (Invitrogen). 
 
4.3.3 Sequence alignment and analysis 
GenBank and Ensembl databases were searched for CBFβ sequences. Amino acid sequence 
alignments were created using AlignX, from Vector NTI Advance® 11.5 (Invitrogen) or Clustal 
Omega (http://www.ebi.ac.uk/). Final adjustments to the alignments were made manually 
to obtain highly accurate consensus sequences. Percentage protein identity was calculated 
using the Sequence Manipulation Suite (Stothard, 2000) available at 
http://www.bioinformatics.org. The alternative splicing events in both human and zebrafish, 
as also for the other species, whose genomic sequence was available, were revealed by 
aligning the cDNAs against the genomic sequences, using the mRNA alignment tool Spidey 
(ncbi.nlm.nih.gov/spidey/spideyweb.cgi). 
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4.3.4 Genomic structure of zebrafish and human CBFβ gene 
Exon-intron architecture of zebrafish cbfβ gene was determined through mRNA-to-genomic 
alignment using Zv9 zebrafish genome assembly and transcript sequences determined within 
the scope of this work. Similarly, human gene structure was determined using GRCh37 
genome assembly, mRNA and expressed sequence tag (EST) sequences retrieved from NCBI 
(on 2014-04-13). 
 
4.3.5 Assessment of conserved synteny 
To examine patterns of conserved synteny, chromosomal loci of CBFβ genes in human, and 
zebrafish were compared by identifying all neighbour genes of CBFβ. The position of each of 
these genes was searched in both species using the Ensembl database search function. 
 
4.3.6 Isoform expression profile 
To determine the presence of the Cbfβ alternative transcripts (isoforms 1-4) during various 
zebrafish developmental stages and in a broad number of adult tissues, primers were 
designed in order to amplify all the four splice variants. A first RT-PCR amplification was 
performed with the primers CBFβ_F3 and CBFβ_R3 (Table 4.1). Then, 1 µl of the first 
amplification product was used to perform a second amplification with the CBFβ isoforms 1 
and 2 specific primers (CBFβ_F3 and CBFβ_R5; Table 4.1) and the CBFβ isoforms 1 and 3 
specific primers (CBFβ_F4 and CBFβ_R3; Table 4.1). The zebrafish gadph was used as control 
(Gapdh_F and Gapdh_R; Table 4.1). The RT-PCR amplification was performed with the 
DreamTaq PCR Master Mix (Thermo Scientific) in a 25 µl reaction for 40 cycles. 
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4.3.7 Plasmid construction 
The zebrafish collagen Xα1 luciferase reporter plasmid [4x(-822/-794)TATALuC] and zfrunx2 
P1-MASN (til-1ORF-pCMX-PL1) were previously described (Simões et al, 2006). The 
expression vectors of the full length and splicing variants of zebrafish cbfβ (cbfβ isoform 1-4) 
were obtained by cloning all the corresponding open reading frames into the pCMX-PL2 
expression vector (kindly provided by Dr. R. Schüle laboratory).  
The zebrafish HA-tagged cbfβ and and Flag-tagged runx2 expression constructs 
(pcDNA3.1-HA-cbfβ isoform 1-4 and pcDNA3.1-Flag-runx2 P1-MASN) were generated by 
subcloning PCR-amplified full-length cbfβ isoform 1 to 4 and runx2 P1-MASN cDNAs into the 
BamHI and XbaI sites of a pcDNA3.1 expression vector containing at the N-terminal portion 
of the proteins. 
All constructs were verified by DNA sequencing. Plasmids used for transfection studies were 
prepared using the plasmid GFX™ Micro Plasmid Prep kit (GE Healthcare).  
 
4.3.8 Cell transfection and luciferase assays 
Human embryonic kidney (HEK) 293 cell line (ATCC number CRL‐1573) was cultured in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 1% (v/v) 
penicillin/streptomycin, 2 mM L‐glutamine and 10% (v/v) fetal bovine serum at 37°C in a 5% 
CO2 humidified atmosphere. Cells were seeded at approximately 40% of confluence in 
24-well plates (5×104 cells/well) and transient transfection assays were carried out using the 
X-TREME reagent (Roche). Typically, 125 ng, 25 ng and 2.5 ng of (i) promoter‐reporter 
construct, (ii) transcriptional regulator expression vector and (iii) pRL-null internal control 
vector (Promega) were used, per well. The amount of transfected DNA was kept constant in 
both positive and negative control cells, by transfecting them with the same amount of DNA: 
125 ng of pGL3-control vector or pGL3-basic vector (both from Promega), respectively; 25 ng 
of pCMX-PL2 expression vector; and 2.5 ng of pRL‐null internal control vector. Luciferase 
activity was assayed 48 h after transfection using the standard protocol provided with the 
Dual‐luciferase reporter assay system (Promega) in a Synergy 4 microplate reader (Biotek). 
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Luciferase activity assays were performed in duplicate and are the mean of at least three 
separate experiments.  
 
4.3.9 Co-immunoprecipitation (Co-IP) Assay 
For co-immunoprecipitation assays, ≈0.1-0.2 mg of whole cell extracts from HEK293T cells 
transfected with expression vectors for the four HA-CBFβ isoforms alone or together with 
FLAG-Runx2, were prepared in buffer containing 50 mM Tris pH7.5, 150 mM NaCl, 1% 
Triton-X100, and Complete protease inhibitors (Roche), and incubated with M2 Flag-resin 
(Sigma) overnight at 4°C. The resin was washed five times with wash buffer (20mM Tris pH 
7.5, 100mM NaCl, 0.1mM EDTA, 0.05% Tween-20) and the bound material was eluted with 
200 μg/ml solution of flag peptide (Sigma), for 30 minutes at 4°C. Samples were subjected to 
western blot analysis.  
 
4.3.10 Western Blot Assay 
For western blot assays, protein extracts were subjected to 12% SDS-PAGE, and thereafter 
transferred onto a PVDF membrane (GE Healthcare) with a semi-dry blot system (BioRad). 
Mouse monoclonal 16B12 antibody against HA epitope (Covance) was used at 1:2000 
dilution and anti-flagM2 (Sigma) antibody was used at 1:5000 dilution. Blotted proteins were 
visualized using horseradish peroxidase-conjugated goat anti-mouse (Southern Biotech), the 
chemiluminescence blotting substrate detection system from Roche and X-ray films. 
 
4.3.11 Statistical analysis 
The data was presented as average and standard deviation of measurements taken at least 
in three separate experiments. Statistical significance of data was determined wherever 
indicated by analysis of variance (ANOVA) followed by a Tukey test for multiple comparisons 
within a group. Differences were considered to be significant at p<0.001. 
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4.4 Results 
4.4.1 Molecular cloning of novel spliced variants of zebrafish cbfβ 
Using a combination of bioinformatics and RT-PCR approaches, we cloned a cDNA fragment 
encoding the zebrafish cbfβ open reading frame (ORF). Sequencing predicts an ORF of 564 
bp encoding a 187 aa polypeptide. From the cDNA deduced primary structure, we identified 
the typical CBFβ domain characteristic of this family of proteins, and sequence comparison 
with the available zebraﬁsh cbfβ cDNA (accession number: NM_199209.1) showed 100% 
identity. This isoform was named in this work as isoform 4. So far, just one transcript has 
been described for the zebrafish cbfβ gene, contrasting with mammals where two major 
transcripts have been described for this gene that generate two different protein isoforms 
with a different C-terminal sequence.  
In the course of amplifying the cDNA for the entire ORF of zebrafish cbfβ using RT-PCR, we 
observed multiple amplified products. By cloning and sequencing each one of them we were 
able to identify ten novel transcript variants for zebrafish cbfβ that are described here for 
the first time. Figure 4.1 shows both the simple and compound deletion events discovered in 
this study. These transcripts result from alternative exon skipping, generating different 
protein isoforms, depending on the splicing event. The identity of the cbfβ cDNA sequences 
obtained was confirmed using blast searches against GenBank (NCBI). The nucleotide 
sequences of these new spliced variants were deposited in GenBank as cbfβ isoforms 1 
through 11 (GenBank ID: KF709194, KF709195, KF709196, KF709197, KF709198, KF709199, 
KF709200, KJ704807, KJ704808, KJ704809 and KJ704810, respectively). 
The transcript cbfβ isoform 1 corresponds to the longest transcript we cloned and has an 
additional 90 nucleotides compared to the cbfβ transcript described previously (Figure 4.1). 
This extra nucleotide sequence in cbfβ isoform 1 within the 3′ coding region generates a stop 
codon located in exon 5b, resulting in a protein isoform with a different C-terminal sequence 
from the form described previously (Figure 4.2).  
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Figure 4.1 Schematic representation of zebrafish cbfβ transcripts. The different transcripts 
originated by alternative splicing are indicated as isoforms 1-11 with the respective 
accession numbers. Black boxes indicate coding regions, white boxes represent non coding 
regions and grey boxes indicate DNA fragments removed following splicing. * Size of the 
cloned cDNA fragments obtained. 
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The transcripts of cbfβ isoform 2 and 3 are spliced variants generated by skipping exon 5a 
(i.e. a 42 bp fragment) or 5b (i.e. a 48 bp fragment), respectively. The resulting protein 
products of these alternative splicing variants are similar to cbfβ isoforms 1 and 4, 
respectively, in terms of the stop codon used (Figure 4.1). All the cbfβ isoforms 1-4 preserve 
the heterodimerization domain intact, suggesting that they produce functional proteins.  
Interestingly, we found two predicted isoforms similar to the cbfβ isoform 1 and 2 in the 
NCBI database (XM_005159048.1 and XM_005159049.1), supporting together with our 
results the existence of these alternative splicing isoforms in zebrafish cbfβ. 
The transcripts cbfβ corresponding to the isoform 5, 6 and 7, are generated by a complex 
splicing of multiple sequence fragments from different exons, resulting in truncated 
isoforms, lacking an extensive part of the characteristic CBFβ heterodimerization domain. As 
a consequence, all of these cbfβ transcripts are likely to result in loss-of-function mutants. 
The transcript cbfβ isoform 8 results from an alternative splicing event that involves a partial 
deletion of the exon 6 (5 bp). This deletion is in the 3’ UTR and does not affect the coding 
region, so the predicted protein isoform is exactly the same as the one produced by cbfβ 
isoform 1.  
The transcript cbfβ isoform 9 is also similar to the cbfβ isoform 1, differing only in a deletion 
of three nucleotides in the beginning of exon 5a and expected to result in deletion of one 
amino acid (Q166) from the encoded protein. Interestingly, an isoform similar to the cbfβ 
isoform 9 was recently submitted to the NCBI database as a predicted isoform 
(XP_005159104.1), but presenting the splicing of the exon 5b in addition to the 3 nucleotides 
deletion we characterized. 
The cbfβ isoform 10 harbours both the deletion of the 3 nucleotides present in cbfβ isoform 
9 as well as the deletion of the 5 nucleotides observed in cbfβ isoform 8. This isoform 
presents also the complete deletion of exon 2 (Figure 4.1). Since exon 2 codes for part of the 
heterodimerization domain, we hypothesize that this change leads to loss of function of this 
isoform. 
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The new transcript cbfβ isoform 11 has a splice starting at the 3’-end of exon 3 (pΔ3 51 bp) 
and utilizes a splice acceptor site within exon 6 instead of the “native” acceptor site. 
Analysing the cDNA sequence obtained for this isoform, we observe that this deletion event 
causes an out-of-frame translation and furthermore, introduces a stop codon after the 
alternative splicing (in exon 6) that is located 67 nucleotides downstream the annotated stop 
codon for the cbfβ, thereby introducing a late termination of protein translation, resulting in 
a protein isoform with a different C-terminus sequence.   
Summarizing, we found in this study simple exon-skipping events that can be categorized as 
follows: (a) simple deletions, that is skipping of complete single exons or consecutive exons 
(for example, Δ5a; Δ5b; Δ5a,5b; isoforms 2-4, respectively) and (b) partial exon deletions (for 
example, pΔ6 5 bp; pΔ5a 3 bp; isoforms 8 and 9). In addition to the five simple exon-skipping 
events shown in Figure 4.1, five more splicing events were identified that involved multiple 
exon-skipping events. In these compound exon-skipping transcripts, several splicing events 
were evident from the pre-mRNA processing (Figure 4.1). These compound splicing events 
include combinations of the whole exon-skipping and partial exon deletion (pΔ3 56 bp, pΔ4 
42 bp plus Δ5a; pΔ1 39 bp, Δ2, pΔ3 85 bp, plus Δ5a; pΔ1 39 bp, Δ2,3, pΔ4 27 bp, Δ5, plus 
pΔ5a 18 bp; Δ2, plus pΔ5a 3 bp plus pΔ6 5 bp; pΔ3 51 bp, Δ4, 5,5a,5b plus pΔ6 69 bp; 
isoforms 5-7, 10 and 11). These multiple exon skipping events all involved the entire or 
partial deletion of exon 5a, which implies that the skipping of this exon is a common event in 
the pre-mRNA processing.  
As mentioned previously, we identified in this study alternative splicing events that involve 
partial exon deletions instead of the skipping of complete exons. The splice sites used are 
shown in Table 4.2. Three of these variants (isoforms 9 and 10, pΔ5a 3bp and isoforms 8 and 
10, pΔ6 5bp) still keep their original splicing donor site (GT) in the boundary of the exon and 
intron but utilize the next possible legitimate splice acceptor site (AG) within the exon in the 
immediate vicinity area, instead of the ‘native’ acceptor site. These two partial deletion 
events do not cause out-of-frame translation and, furthermore, they use the same stop 
codon as the full transcript (isoform 1). The splicing events of the other four variants 
(isoforms 5, 6, 7 and 11) are more complex. In the partial deletions pΔ3-4 (isoform 5) and 
pΔ1-4 (isoform 7) not only are none of the original splice donor/acceptor sites used, but 
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those that are used are very atypical (Table 4.2). For the remaining variants pΔ1-3 (isoform 
6) and pΔ3-6 (isoform 11), do not use a pair of legitimate splice donor site within exon 1 
(isoform 6) or exon 3 (isoform 11) but utilize the next possible legitimate splice acceptor site 
(AG) within the exon 3 (isoform 6) or exon 6 (isoform 11), instead of the ‘native’ acceptor 
site, causing a 211 bp (isoform 6) or a 423 bp (isoform 11) deletion. 
 
Table 4.2 Splice code usages of the partial exon-skipping in cbfβ mRNA. 
 
4.4.2 Translation potential of the cbfβ spliced variants 
The predicted protein sequences translated from these alternative spliced transcripts are 
summarized in Figure 4.2. Two of these variants (isoforms 5 and 6) introduce early 
termination codons to the open reading frames after the alternative splicing event(s), which 
may produce premature proteins with only short peptides (94 aa and 26 aa, respectively) of 
Cbfβ.  
 
 
 
 
 
 
Transcripts Partial exon-
skipping 
Splice donor sites Splice acceptor sites Deletion caused 
by alternative 
splicing 
Isoform 9 and 10 pΔ5a TTGGAGgtgagagct catttagcagATGCCGATG 3 bp 
Isoform 8 and 10 pΔ6 GGACCAGGgtctgtctcc cccagcccagGCGACAGCAG 5 bp 
Isoform 5 pΔ3,4 TTCATGGGGatcagcggc agtatgtgtgATCTGGAGAG 98 bp 
Isoform 6 pΔ1,3 GTTCGAGaacgagga cgcccacccgagAATATGTGG 211 bp 
Isoform 7 pΔ1,4  GTTCGAGAACGaggagttctt atcctgaacgGAGTATGTGTG 270 bp 
Isoform 7 pΔ5a GCACAGgtacagcaaaat gatggcacagCTCAATCAT 270 bp 
Isoform 11 pΔ3,6 GATCAGCGgcaggcg gcgctagcgGCATTCAC 126 bp 
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             1                                                                   70 
 Isoform 1   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 Isoform 2   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 Isoform 3   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFMATGTNLSLQFFP 
 Isoform 4   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 Isoform 5   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 Isoform 6   MPRVVPDQRSKFENMWTSSGRRERCT-------------------------------------------- 
 Isoform 7   MPRVVPDQRSKFEN-------------------------------------------------------- 
 Isoform 8   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 Isoform 9   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
Isoform 10   MPRVVPDQRSKFENEEFFRKLSRECE-----------------------------AFVATGTNLSLQFFP 
Isoform 11   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
 
             71                                                                 140 
 Isoform 1   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
 Isoform 2   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
 Isoform 3   ANLHGDQRQAPAREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
 Isoform 4   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
 Isoform 5   ANLHGDLERLARSSPSGWHGLSGI---------------------------------------------- 
 Isoform 6   ---------------------------------------------------------------------- 
 Isoform 7   ----------------------------------GVCVIWRGWLDLHRLDGMGCLEYDDER--------- 
 Isoform 8   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
 Isoform 9   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
Isoform 10   ANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQHEDALAQ 
Isoform 11   ANLHGDQRHSPKWA-------------------------------------------------------- 
 
             141                                                                210 
 Isoform 1   AAFEEARRRTRDFEDRDRSHREDLEQMPMAQLNHLITQEDPVASKIWD---------------------- 
 Isoform 2   AAFEEARRRTRDFEDRDRSHREDLE--------------DPVASKIWD---------------------- 
 Isoform 3   AAFEEARRRTRDFEDRDRSHREDLEQMPMAQLNHLITQE---------PRRQQDPSPGSNMGNTDDHKMR 
 Isoform 4   AAFEEARRRTRDFEDRDRSHREDLE-----------------------PRRQQDPSPGSNMGNTDDHKMR 
 Isoform 5   ---------------------------------------------------------------------- 
 Isoform 6   ---------------------------------------------------------------------- 
 Isoform 7   -----------------------------AQLNHLITQEDPVASKIWD---------------------- 
 Isoform 8   AAFEEARRRTRDFEDRDRSHREDLEQMPMAQLNHLITQEDPVASKIWD---------------------- 
 Isoform 9   AAFEEARRRTRDFEDRDRSHREDLE-MPMAQLNHLITQEDPVASKIWD---------------------- 
Isoform 10   AAFEEARRRTRDFEDRDRSHREDLE-MPMAQLNHLITQEDPVASKIWD---------------------- 
Isoform 11   ---------------------------------------------------------------------- 
 
Figure 4.2 Alignment analysis of zebrafish Cbfβ protein isoform sequences. Cbfβ amino acid 
sequences were analysed using AlignX. Isoforms 5 and 6 show premature stop codons due to 
alternative splicing. Isoform 3 lacks exon 5b and isoform 4 lacks exons 5a and 5b, presenting 
a different C-terminal (white letters in black) with the occurrence of the stop codon in exon 
6. Numbering is according to the first residue of the protein. 
 
4.4.3 Chromosomal localization and structural organization of the zebrafish cbfβ gene and 
cDNA 
Chromosomal assignment of the zebrafish cbfβ gene was performed by BLAST against NCBI 
database. The zebrafish major cbfβ transcript cloned (isoform 1) was aligned with the 
zebrafish genomic sequence, and sites of exon-intron borders were deduced by comparison. 
The zebrafish cbfβ gene was found on chromosome 18 (position 22774824-22852021) with a 
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length of approximately 77.200 kb, and based on the data in this study it is organized in 8 
exons and 7 introns (Figure 4.3).  
 
Figure 4.3 Schematic representation of zebrafish cbfβ gene, isoform 1 and protein 
structures. In gene structure: exons and introns are represented by boxes and lines, 
respectively. Numbers (in bp) above the boxes indicate size of the exons and numbers below 
the lines indicate size of introns. In transcript structure:  black boxes represent the coding 
exons and white boxes the 5’ and 3’ untranslated regions; in protein structure: CBFβ 
heterodimerization domain is represented by a light grey box. 
 
All splice junctions follow the GT/AG rule (Breathnach and Chambon, 1981). The zebrafish 
cbfβ isoform 1 contains all eight exons (exons 1-6, including exons 5a and 5b) with the start 
codon in exon 1 and the termination codon in exon 5b, and exon 6 contains the 3´ UTR. The 
protein deduced from this major Cbfβ isoform is 188 amino acids long. It contains a 
heterodimerization domain of 135 amino acids starting with the first methionine, and 
spanning sequences from exon 1 through exon 4.  
 
4.4.4 Protein sequence alignment between zebrafish and orthologs  
Sequence databases at NCBI (www.ncbi.nlm.nih.gov) were searched for annotated CBFβ 
sequences. A total of 59 CBFβ sequences (containing the complete coding sequence) were 
collected. The full collection of sequences represents 29 species, including most classes of 
vertebrates (mammalia, sauropsida, amphibia, chondrochthyes and actinopterygii). 
Although this analysis was performed using sequences from a large set of organisms with 
diverse evolutionary pathways, CBFβ alignment revealed a remarkable conservation of 
protein primary structure (Figure 4.4), confirming the existence of domains in the protein 
Chapter 4 
141 
 
that are highly conserved. Interestingly, we found four different protein isoforms (labelled 
A-D) that differ only in the C-terminal region (Figure 4.4) that result from alternative splicing 
at the 3´-end. Zebrafish Cbfβ_A (isoform 4) is highly conserved between all vertebrate 
CBFβ_A (isoform 187) used in this alignment, containing exons 1-6 (excluding exons 5a and 
5b).  
 
 
 
Figure 4.4 Protein sequences comparison for CBFβ C-terminal. Sequences were aligned using 
Clustal Omega. The different C-terminal sequences are grouped and shown in different tons 
of grey to black. GenBank and Ensembl accession numbers for CBFβ: NP_074036.1 and 
NP_001746.1 (human A and B, respectively; Homo sapiens); JAA28496.1 and JAA42562.1 
(chimpanzee A and B, respectively; Pan troglodytes); AFE80636.1 and AFH29554.1 (rhesus 
macaque A and B, respectively; Macaca mulata); DAA20211.1 and DAA20210.1 (bovine A 
and B, respectively; Bos Taurus); JAA74282.1 and JAA74187.1 (pig A and B, respectively; Sus 
scrofa); NP_071704.3 and NP_001154930.1 (mouse A and B, respectively, Mus musculus); 
AAH40752.2 and AAH81946.1 (rat A and B, respectively; Rattus norvegicus); 
XP_007457364.1 and XP_007457365.1 (Yangtze River dolphin A and B, respectively; Lipotes 
vexillifer); XP_002937211.2 and XP_004913586.1 (Western clawed frog A and B, 
respectively; Xenopus tropicalis); AFH75431.1 (grass carp; Ctenopharyngodon idella); 
AAI62159.1 and KF709194 (zebrafish A and C, respectively; Danio rerio); ABA42830.1 
(Atlantic salmon; Salmo salar); NP_001087047.1 (African clawed frog; Xenopus laevis); 
NP_989901.2 (chicken; Gallus gallus); ENSAMXT00000021049 and XP_007256271.1 
(Mexican tetra A and C, respectively; Astyanax mexicanus); ENSORLT00000017254 and 
ENSORLT00000017256 (medaka A and C, respectively; Oryzias latipes); 
ENSGACT00000018489 (Stickleback; Gasterosteus aculeatus); ENSONIT00000012829, 
XP_003447081.1 and XP_005471238.1 (Nile tilapia A, C and D, respectively; Oreochromis 
niloticus); XP_007553234.1, XP_007553236.1 and XP_007553235.1 (Amazon molly A, C and 
D, respectively; Poecilia formosa), XP_005795843.1 (Southern platyfish; Xiphophorus 
maculatus), XP_004569219.1, XP_004569222.1 and XP_004569220.1 (Zebra mbuna A, C and 
D, respectively; Maylandia zebra), XP_007902879.1 (Elephant shark; Callorhinchus milii),  
XP_006019105.1 and XP_006019106.1 (Chinese alligator A and B, respectively; Alligator 
sinensis), XP_005306333.1  and XP_005306334.1 (Western painted turtle A and B, 
respectively; Chrysemys picta bellii), XP_006268225.1 and XP_006268226.1 (American 
alligator A and B, respectively; Alligator mississippiensis), XP_005490832.1 and 
XP_005490833.1 (white-throated sparrow A and B, respectively; Zonotrichia albicollis), 
XP_005526382.1 (Tibetan ground-tit; Pseudopodoces humilis), XP_006641568.1 (spotted gar; 
Lepisosteus oculatus) and XP_005152308.1 (budgerigar; Melopsittacus undulatus). 
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In contrast, the C-terminal of the zebrafish Cbfβ_C (isoform 2) shows high homology with the 
C-terminal of Cbfβ from other fish (all neoteleostei: Atlantic salmon, tilapia, Mexican tetra, 
zebra mbuna, Southern platyfish, Amazon molly, Atlantic salmon, medaka, Atlantic cod, 
turquoise killifish, Burton´s mouthbrooder, red Mwanza and lyretail cichlid (Figure 4.4 and 
results not shown). The residues from 166 to 174 in Cbfβ_C were encoded by exon 5b, that 
contains the stop codon. We also observed the presence of a C-terminal that is different 
from the named Cbfβ_A or Cbfβ_C that we called Cbfβ_B and was only found in 
Sarcopterygii, which is obtained from a long exon 5 (more 31 bp in the 3´-end) that ends in 
the exon 6 coding for the seven last amino acids and the stop codon. A fourth variant named 
Cbfβ_D has been identified in fish (all neoteleostei: Amazon molly, Nile tilapia, zebra mbuna, 
Burton´s mouthbrooder and red Mwanza) (Figure 4.4 and results not shown), that results 
from the occurrence of an alternative splicing from exon 5 to a cryptic site in exon 6. The 
transcription of exons 1, 2, 3 and 4 does not undergo any modifications and remains 
constant. We have calculated the pair-wise percentage identities among all CBFβ protein 
sequences used in this study, and we can observe a high identity between all the species 
(Table 4.S1), even if we take in account the C-terminal differences observed in the 
alignment. 
 
4.4.5 Conserved gene synteny of zebrafish cbfβ gene 
Synteny-based analysis of zebraﬁsh cbfβ gene shows strong syntenic conservation between 
human chromosome 16 and zebraﬁsh chromosome 18. In both cases, the genes DNAJA2L, 
BBS2, GOT2, CCDC79, PDP2, CES2, CES3, B3GNT9, HSF4, PARD6A, TSNAXIP1, NUTF2, EDC4, 
PSKH1, NRN1LA, CIRH1A, AARS, TAT, BCAR1, NOC4 and KIAA1049 were found in the region 
of CBFβ gene, but they appear in a different order (Figure 4.5 and Table 4.S2). Interestingly, 
from this list of genes only noc4 and kiaa1049 are present downstream side of cbfβ gene in 
zebrafish chromosome 18 (Figure 4.5). This syntenic conservation supports the identification 
of cbfβ as ortholog to human CBFβ. 
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Figure 4.5 Comparison of genomic environment and gene positional order in zebrafish and 
human chromosomes containing CBFβ. Comparison of the chromosomal locations of 22 
ortholog gene pairs between zebrafish chromosome 18 and human chromosome 16. Lines 
between the compared chromosomes connect positions of ortholog gene pairs in the two 
species. Distances between markers on a single chromosome are shown to scale, but 
compared chromosomes have been scaled to equivalent lengths. Map positions for the 
genes were obtained from http://www.ensembl.org/. 
 
4.4.6 Expression profiles of zebrafish cbfβ variants 
Expression patterns of cbfβ mRNA variants were analyzed using RT-PCR with gene-specific 
primers located on ORF exons and variant-specific primers located on respective 
leader/terminal exons (Figure 4.6). To assess the expression of the zebrafish cbfβ transcript 
variants, the coding region between exons 5 and 6, comprising the full and the alternatively 
splicing exons 5a and 5b were amplified (Figure 4.6A). The cbfβ mRNA was widely 
distributed. In a first PCR round the amplification of all four possible splicing variants 
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(isoforms 1-4) was tested using the primers CBFβ_F3 and CBFβ_R3 located in exon 5 and 
exon 6, respectively. Two amplicons corresponding to isoform 1 (199 bp) and isoforms 2 
and/or 3 (157 bp and 151 bp, respectively) were observed in all samples tested (Figure 4.6B). 
A third amplicon corresponding to isoform 4 (109 bp) was observed in all tissue samples and 
developmental stages tested, except at 1 cell stage. In order to distinguish the expression of 
isoform 2 and 3, a second amplification was performed with isoform specific primers. The 
expression of isoform 2 mRNA was analyzed using a forward primer located on the exon 5 
and a reverse primer on exon 5b (Figure 4.6A).  
 
Figure 4.6 Identification of the expression profile of zebrafish cbfβ splicing variants (isoform 
1-4). (A) Schematic representation of partial RNA structure and  PCR products resulting from 
each amplification. Dotted boxes with white background correspond to spliced exons. The 
pair of primers used for amplification and sizing of the resulting products are represented (in 
the left and right side of scheme, respectively) (B) Qualitative expression profile of the cbfβ 
isoforms (1-4) investigated by RT-PCR in zebrafish developmental stages and adult tissues. 
Zebrafish gapdh was used as control for sample integrity. Sample designations are indicated 
above and primer pairs used are indicated in the left side. M corresponds to the marker 
(Thermo Scientific GeneRuler 50 bp DNA Ladder). 
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This amplification generates two amplicons corresponding to isoform 1 (138 bp), and 
isoform 2 (96 bp). It was observed that the isoform 2 is expressed in all the developmental 
stages and tissues analysed (Figure 4.6B). The expression of isoform 3 mRNA was analysed 
using a forward primer located on the frontier of exons 5/5a and a reverse primer on exon 6, 
resulting in two amplicons corresponding to isoform 1 (151 bp) and isoform 3 (103 bp). The 
expression of isoform 3 was observed in all the developmental stages and tissues analysed 
with the exception at 1 cell stage where the corresponding amplicon was not observed 
(Figure 4.6B). 
 
4.4.7 Functional analysis of the different cbfβ splicing variants 
Given that CBFβ is a transcription co-factor, and is able to bind mammalian CBFα proteins 
and enhance their DNA binding affinity (Wang et al, 1993), we wanted to test if the zebrafish 
Cbfβ protein isoforms cloned in this work had a similar function. The newly identified 
isoforms 1-3, and also the isoform 4 that corresponds to the one previously characterized 
(AF278758) were cloned in an expression vector and used in co-transfection assays with a 
fragment of the zebrafish col10α1 promoter described previously (Simões et al, 2006). This 
promoter was previously reported to be regulated by the Runx2 transcription factor 
(zebrafish isoform MASN-Runx2) (Simões et al, 2006). To this end, HEK293 cells were 
transiently co-transfected with the pTATALuC-4×ColX(-822/-794) vector containing four 
repeated copies of the Runx2 binding site, in the presence of expression vectors containing 
MASN-Runx2 and the zebrafish cbfβ isoforms 1 to 4. Our previous studies showed that in the 
Xenopus laevis A6 cell line the transcriptional activity of the pTATALuCColX(-822/-794) 
construct is induced by MASN-Runx2 isoform, and a further increase was observed when 
four copies of this sequence element were present (Simões et al, 2006). In the present work 
we showed in HEK293 cells that the ability of MASN-Runx2 to transactivate the 4×ColX 
construct, although smaller than previously seen in A6 cells, was strongly stimulated when 
Cbfβ isoforms 1 or 2 were co-expressed (Figure 4.7). Furthermore, Cbfβ isoforms 3 and 4 
seem to have lost the ability to regulate Runx2 (Figure 4.7). All together, these results clearly 
indicate that the presence of the different amino acids in the C-terminal of the Cbfβ that are 
generated by the presence of the exon 5b, are likely to be essential for protein binding to 
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Runx2-MASN isoform and so to enhance Runx2-induced transcription. We also show that 
Cbfβ alone has no effect on 4×ColX transcription (Figure 4.7).  
 
Figure 4.7 Transcriptional co-activation of collagen type X promoter by Runx2-MASN/Cbfβ. 
HEK 293 cells were transfected with zebrafish pTATALuC-4×ColX(-822/-794) promoter 
construct, a reporter plasmid derived from the colXα1 promoter that contains four copies of 
putative Runx-binding site. Cells were cotransfected with the indicated Cbfβ (isoforms 1-4) 
expression plasmids in the presence of zebrafish Runx2-MASN isoform. The graph shows the 
fold induction expression of colX promoter construct, alone or co-transfected with Runx2 
and/or Cbfβ. The data indicated is a representative plot that shows the average and 
standard deviation (error bars) from at least three independent experiments, each done in 
duplicate. Significance was determined by One Way Anova. Asterisk (*) indicates that the 
value is statistically different (p<0.001). 
 
4.4.8 Co-immunoprecipitation of Cbfβ splicing variants and runx2 
To assess the heteromeric assembly of zebrafish Cbfβ protein isoforms 1-4 and Runx2 by an 
independent biochemical approach, co-immunoprecipitation experiments were performed. 
Protein lysates prepared from HEK293 cells expressing HA-tagged Cbfβ isoforms 1-4 alone or 
together with Flag-tagged runx2 were immunoprecipitated with an anti-Flag monoclonal 
antibody. Immunoprecipitates were subjected to SDS-gel electrophoresis and probed with 
anti-HA and anti-FLAG antibodies to visualize HA-Cbfβ isoforms 1-4 and Flag-Runx2 (Figure 
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4.S1). Flag-Runx2 was specifically co-immunoprecipitated with HA-tagged Cbfβ isoforms 1, 2 
and 4, but not HA-Cbfβ isoform 3 (Figure 4.S2). These experiments clearly indicated that 
Cbfβ isoforms 1, 2 and 4 are present in protein complexes with Runx2 in HEK293 cells, 
suggesting an interaction between these isoforms and Runx2, while the isoform 3 of Cbfβ 
failed to interact with Runx2 under these conditions.  
 
4.5 Discussion 
In this study we describe 11 different spliced variants of zebrafish cbfβ mRNA (including the 
one previously known (Blake et al, 2000) corresponding to our isoform 4, Δ5aΔ5b). These 10 
novel spliced variants greatly expand our knowledge of the isoforms of cbfβ at the level of 
mRNA in zebrafish and provide evidence for a conserved structure and splicing events 
between zebrafish and human CBFβ genes. Alternative pre-mRNA splicing plays an 
important role in regulating gene expression by generating multiple transcripts from a single 
gene with specific spatial and temporal patterns, thus contributing to generate proteome 
diversity and increasing flexibility for gene expression and regulation (Graveley, 2001; Black, 
2003). Nonetheless, much remains to be understood about the mechanisms and functional 
significance of this process. The CBFβ gene encodes a transcription factor (CBFβ) that plays 
important roles in hematopoiesis, osteogenesis and leukemia (Liu et al, 1995; Speck et al, 
1999; Miller et al, 2002). The biological relevance of CBFβ has been demonstrated in a 
knock-out mouse model that exhibits embryonic lethality due to defective fetal liver 
hematopoiesis and central nervous system bleeding, recapitulating the Runx1 null 
phenotype (Sasaki et al, 1996; Wang et al, 1996). Conversely, heterozygous Cbfβ+/- knock-in 
mice survive gestation but die soon after birth with bone developmental defects comparable 
to those observed in Runx2-/- mice although less severe (Kundu et al, 2002). In zebrafish, cbfβ 
is expressed during embryogenesis in early hematopoietic cells and in the lateral plate 
mesoderm at tail bud stage, as well as in Rohon-Beard cells, cranial nerve ganglia, hindbrain, 
retina, branchial arches, jaw, and ﬁn buds (Blake et al, 2000). Recently it was shown that 
zebrafish cbfβ knockout mutants (cbfβ-/-) retained primitive hematopoiesis and erythro-
myeloid progenitors but completely lacked all definitive blood lineages (Bresciani et al, 
2014), confirming the importance of Cbfβ in the onset of definitive hematopoiesis. Our RT-
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PCR analysis in zebrafish developmental stages and adult tissues shows that cbfβ is widely 
expressed, been detected in all samples analyzed. This is in agreement with a previous study 
(Blake et al, 2000) where they show by Northern blot hybridization that cbfβ expression is 
first detected at 3-somite stage and then continued through to at least 48 hpf and also in an 
adult sample. Our gene expression profile data demonstrate that at 1 cell stage just the cbfβ 
isoforms 1 and 2 are detected, but not isoforms 3 and 4 (Figure 4.6B). The fact that isoforms 
1 and 2 are detected at 1 cell stage indicates that they are maternally inherited, in contrast 
to isoforms 3 and 4 that are not expressed at this time, emphasizing that the biological 
function of Cbfβ splice variants should be further evaluated throughout development. Blake 
and co-workers (2000) also showed that cbfβ is expressed in the kidney as they used a 
kidney cDNA library to clone the transcript. Our data shows that cbfβ expression persists in 
adult, as we could detect all four transcript variants (isoforms 1-4) in all the tissues analyzed 
(Figure 4.6B).  
Translated variants of such an important mRNA species may have important modulatory 
functions in development or in critical cell fate decisions, although some of these isoforms 
may not be translated due to the process of nonsense-mediated mRNA decay (NMD) that 
promotes degradation of mRNAs containing premature translation termination codons. This 
process was identified and studied also in zebrafish, and shown to be essential for zebrafish 
embryonic development, preventing accumulation of potentially detrimental truncated 
proteins (Wittkopp et al, 2009). Two of the transcript variants described in this report 
present premature termination codons (isoforms 5 and 6; Figure 4.1), and thus may be 
potential targets for the NMD pathway, and not likely to be translated into protein.  
In human and mice, CBFβ resides on chromosomes 16 and 8, respectively, and both species 
show two major isoforms resulting from distinct alternative splicing events that produce, in 
each case, a frame-shift generating a termination codon so that the two proteins (of 187 and 
182 amino acids, respectively) differ in several amino acids at the carboxy terminus (Adya et 
al, 2000; Ogawa et al, 1993) (Figure 4.S3). A search of the human dbEST and non-redundant 
data bases identified three more exons in the human CBFβ gene (Figure 4.S4), giving a gene 
structure of nine exons whose alternative splicing creates ten human CBFβ isoforms. 
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Multiple alignments between major CBFβ isoforms described in different vertebrates (Figure 
4.4 and Figure 4.S5), show that zebrafish Cbfβ_A (isoform 4) is highly conserved in all species 
analysed (CBFβ_A isoform containing 187 aa). In contrast, the C-terminal of the zebrafish 
Cbfβ_C (isoform 2) shows high homology with the C-terminal of Cbfβ from other fish (e.g. 
Atlantic salmon, tilapia, and medaka isoform_C) but differs from the C-terminal of the other 
vertebrates CBFβ_B (isoform containing 182 aa) used in the alignment. This divergence in 
the C-terminal between the different species may indicate that this region has a functional 
relevance that could be species specific, possibly mediating interactions with different 
proteins from the CBF regulatory complex. Different groups (Wang et al, 1996; Kagoshima et 
al, 1996; Zhou et al, 2012; Du et al, 2013) have studied the CBFβ binding capacity to Runx co-
factors throughout the heterodimerization domain (N-terminal region), but the exact 
function of the C-terminal region of the CBFβ isoforms is still unknown at this time. 
Interestingly, an association between breast cancer and mutations in the heterodimerization 
domain of CBFβ were previously reported (Banerji et al, 2012; Taniuchi et al, 2012; Ellis et al, 
2012). Accordingly, all these CBFβ genetic changes are likely to result in loss-of-function 
mutants. Oncogenic rearrangements of CBFβ are common in acute myeloid leukemia where 
the CBFB–MYH11 translocation produces a protein product that fuses the first 165 aa of 
CBFβ to the MYH11 resulting in a hybrid molecule believed to have dominant negative 
function (Shigesada et al, 2004).  
It was previously shown that Cbfβ interacts with Runx2 in bone and cartilage and enhances 
Runx2-mediated transcription (Kundu et al, 2002; Yoshida et al, 2002; Nakashima and 
Crombrugghe, 2003; Kanatani et al, 2006; Han et al, 2010). Higashikawa et al (2009) showed 
that human COL10A1 promoter activity, which was enhanced by RUNX2, was further 
potentiated by RUNX2 in combination with the co-activator CBFβ. The same was observed 
with the osteocalcin promoter (Kanatani et al, 2006). According to previous studies, the 
C-terminal amino acids that are different between the two major CBFβ isoforms are in a 
region of the protein that is not required for the heterodimerization with the RUNX partner 
(Ogawa et al, 1993; Kagoshima et al, 1996) and so it was suggested that the amino acid 
differences in this region are not expected to affect the ability of the α/β subunits to 
heterodimerize (Blake et al, 2000). From the spliced variants cloned in this work, four of 
them seem to be potentially interesting from a functional point of view: isoforms 1-4 (the 
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complete, Δ5a, Δ5b and Δ5aΔ5b isoforms, respectively), and so their capacity for 
transcription transactivation was further analysed. Our co-transfection experiments 
demonstrate that zebrafish Cbfβ isoforms carrying the exon 5b (isoforms 1 and 2) have a 
higher capacity to enhance the induction of ColX promoter by Runx2-MASN isoform, 
compared to the isoforms lacking exon 5b (isoforms 3 and 4) (Figure 4.7). 
Immunoprecipitation data allowed us to explain the transactivation data by the direct 
interaction of Runx2 with Cbfβ isoforms 1 and 2 and not with Cbfβ isoform 3. However, an 
interaction was also observed between Runx2 and Cbfβ isoform 4, although this interaction 
does not result in a Runx2 stimulated transcription of ColX promoter in the conditions 
tested. The differences between these four Cbfβ isoforms reside in their C-terminal region 
(Figure 4.2). Isoforms 1 and 3 have distinct C-terminal sequences, while isoforms 2 and 4 
represent spliced variants of isoforms 1 and 3, respectively. These results suggest that 
isoforms 1 and 2 have a functional motif that is lacking in isoforms 3 and 4, likely located in 
exon 5b. Alternatively, the distinct C-terminal domain found in isoforms 3 and 4, (Figure 4.2) 
may be interfering with its binding to the Runx2 protein by either affecting the stabilization 
of the heterodimer, enabling the binding of some other co-factor still not identified and 
important to the function of the CBF complex, or affecting its translocation to the nucleus, 
which is required for acting as a co-factor of Runx2.  
Zebrafish Cbfβ (isoform 4; Δ5aΔ5b) has previously been shown to induce the human CBFα2 
(RUNX1-MRIPV isoform) as efficiently as the human CBFβ protein (isoform 187) (Blake et al, 
2002). In contrast with these findings, our results show no significant enhancement of 
runx2-MASN transcriptional activity in the ColXα1 promoter fragment when co-transfected 
with the Cbfβ isoform 4 (Figure 4.7). This apparent discrepancy may indicate that the 
different CBFα subunits (runx1, 2 and 3) have distinct affinities for the different Cbfβ 
isoforms. In fact, it was shown that in mammals the CBFβ (isoform 187) and CBFβ (isoform 
182) interact with RUNX1 similarly, although CBFβ (isoform 187) in conjunction with RUNX1 
transactivates SL3-3MLV enhancer more strongly (Zaiman et al, 1995). In addition, and as 
suggested previously, CBFβ proteins apart from their well-known function as co-factors of 
RUNX associated DNA-binding affinity, may have additional functions such as, (i) when 
bound to the runt domain, CBFβ proteins may induce a conformational change allowing it to 
interact with other transcriptional activators or (ii) it can act as an interacting factor between 
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RUNX proteins and other protein cofactors (Adya et al, 2000; Li and Gergen, 1999). 
Altogether it seems that CBFβ isoforms function can be modulated by the RUNX isoform 
present and thus also depends on the cell type used in each study (Adya et al, 1998). 
Higashikawa et al (2009) showed that the effect of RUNX2 in human COL10A1 promoter 
activity observed in human cells were not reproducible in the mouse chondrogenic ATDC5 
cells, in which neither RUNX2 alone nor in combination with CBFβ affected COL10A1 
promoter activity. Indeed, more recently Du et al (2013) showed that when HEK293T cells 
were co-transfected with the C-terminal-truncated CBFβ constructs and the viral infectivity 
factor (Vif) of HIV-1 (Vif-expressing vector) following repression of endogenous expression of 
CBFβ by an shRNA approach, Vif expression appeared quite variable, depending on the 
co-transfected CBFβ variant. The authors concluded that different lengths of CBFβ are 
required for its role in Vif function and for its role in RUNX-mediated gene transcription and 
hypothesized that different CBFβ domains may be required for regulation of different target 
genes (Du et al, 2013). It is also possible that still another co-activator, as yet unidentified, 
may be involved in this process of transactivation but further studies are required to clarify 
the precise mechanism of this phenomenon.  
Overall, in this work we have cloned and described for the first time a variety of zebrafish 
cbfβ alternative spliced variants. Using a bioinformatic approach we have determined the 
structures of both the zebrafish cbfβ gene and predicted protein products and shown a high 
degree of sequence identity between zebrafish Cbfβ and the mammalian CBFβ proteins, 
indicating conserved functions. Using luciferase assays, we showed that the Runx2-MASN 
mediated activation of the Col10α1 promoter is differentially co-activated by Cbfβ isoforms, 
although further work will be needed to clarify the significance of the biological function of 
these cbfβ variants. 
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4.6 Supplementary Tables 
Table 4.S1 Pairwise per cent identities among CBFβ sequences. A - From light grey to black: actinopterygii, chondrichthyes, sarcopterygii 
(amphibia, sauropsida, mammalia). Hsa, Homo sapiens (human); Ptr, Pan troglodytes (chimpanzee); Mmu, Macaca mulata (rhesus macaque); 
Ssc, Sus scrofa (pig); Bta, Bos Taurus (bovine); Mmus, Mus musculus (mouse); Rno, Rattus norvegicus (rat); Lve, Lipotes vexillifer (Yangtze River 
dolphin); Xtr, Xenopus tropicalis (Western clawed frog); Dre, Danio rerio (zebrafish); Ola, Oryzias latipes (medaka); Ame, Astyanax mexicanus 
(Mexican tetra); Phu Pseudopodoces humilis (Tibetan ground-tit); Mun, Melopsittacus undulatus (budgerigar); Gac, Gasterosteus aculeatus 
(three spined stickleback); Cid, Ctenopharyngodon idella (grass carp); Ssa, Salmo salar (Atlantic salmon); Oni, Oreochromis niloticus (Nile 
tilapia); Loc, Lepisosteus oculatus (Spotted gar); Mze Maylandia zebra (Zebra Mbuna); Pfo, Poecilia formosa (Amazon molly); Xma Xiphophorus 
maculatus (Southern platyfish); Aca, Anolis carolinensis (green anole); Cmi, Callorhinchus milii (elephant shark); Gga, Gallus gallus (chicken); 
Xla, Xenopus laevis (African clawed frog); Cpi, Chrysemys picta belli (Western painted turtle); Asi, Alligator sinensis (Chinese alligator); Zal, 
Zonotrichia albicollis (white-throated sparrow); Ami, Alligator mississippiensis (American alligator). 
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Table 4.S2 Zebrafish-human ortholog gene pairs. 
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4.7 Supplementary Figures 
 
Figure 4.S1 Preparation of fusion proteins. Whole cell extracts from untransfected HEK293 
cells or transiently expressing the indicated proteins were analysed by western blotting. 
Each lane was loaded with equivalent amounts of protein extracts (10 µg). (A) Expression of 
Runx2 detected with anti-flag antibody and (B) expression of the four isoforms of Cbfβ 
detected with anti-Ha antibody. 
 
 
Figure 4.S2 Runx2 binds to isof1, isof2 and isof4 but not to isof3 of Cbfβ. Whole cell extracts 
from HEK293 cells transiently expressing Ha-Cbfβ isoforms 1-4 (isof1, isof2, isof3 and isof4) 
alone or in combination with Flag-Runx2 were immunoprecipitated with an anti-flag 
antibody and proteins were detected by western blotting with anti-Ha and anti-flag 
antibodies. IP indicates immunoprecipitation and WB indicates western blot. The position of 
non-specific proteins (*) is indicated. 
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                         1                                                                   70 
   Hs_NM_001755.2    (1) MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
   Hs_NM_022845.2    (1) MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
Hs_XM_005256212.2    (1) MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFP 
Hs_XM_006721321.1    (1) MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEI--------------- 
 
                         71                                                                 140 
   Hs_NM_001755.2   (71) ASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQQEDALAQ 
   Hs_NM_022845.2   (71) ASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQQEDALAQ 
Hs_XM_005256212.2   (71) ASWQGEQRQTPSREYVDLEREAGK---------------------------------------QEDALAQ 
Hs_XM_006721321.1   (71) ------------------------VYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQQEDALAQ 
 
                         141                                                          187 
   Hs_NM_001755.2  (141) QAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP---------------------- 
   Hs_NM_022845.2  (141) QAFEEARRRTREFEDRDRSHREEME-----------------ARRQQDPSPGSNLGGGDDLKLR 
Hs_XM_005256212.2  (102) QAFEEARRRTREFEDRDRSHREEME-----------------ARRQQDPSPGSNLGGGDDLKLR 
Hs_XM_006721321.1  (102) QAFEEARRRTREFEDRDRSHREEME-----------------ARRQQDPSPGSNLGGGDDLKLR 
 
Figure 4.S3 Alignment analysis of human CBFβ protein isoform sequences. CBFβ amino acid 
sequences were analysed using AlignX. Numbering is according to the first residue of the 
protein. 
 
 
Figure 4.S4 Schematic representation of human CBFβ gene and corresponding transcripts. 
Curved arrow indicates site of transcription initiation, from exon 1. The gene structure of 
nine exons (boxes numbered 1-6) was obtained after assembly of all the identified 
transcripts. Numbers below the gene indicate the size of exons (in bp) and numbers in 
vertical on the top of the lines indicate the size of the introns (in kb). Ten different 
transcripts originated by alternative splicing are indicated below the gene. The 
corresponding GenBank or Ensembl accession numbers are indicated to the right of each 
transcript. Grey boxes represent coding regions; white boxes represent non coding regions.
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Western_clawed_frog_B     MPRVVPDQRAKFENEEFFRKLNRESEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANWQGEPRQAPTREYVDFEREPGKVHLKAPMILNGVCVLWKGWIDLQRLDGMGCLEFDDDRAQ 
African_clawed_frog_B     MPRVVPDQRAKFDNEEFFRKQSREGEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEPRQAPAREYVDFERESGKVYLKAPMILNGVCVLWKGWIDLQRLDGMGCLEFDDDRAQ 
Chinese_alligator_B       MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEEPQGRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Western_painted_turtle_B  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
American_alligator_B      MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
white-throated_sparrow_B  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Chicken_B                 MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRSHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Rat_B                     MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQTRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLHRLDGMGCLEFDEERAQ 
Mouse_B                   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQTRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLHRLDGMGCLEFDEERAQ 
Bovine_B                  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDFEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Yangtze_River_dolphin_B   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Chimpanzee_B              MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Rhesus_macaque_B          MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Human_B                   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Pig_B                     MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Mexican_tetra_A           MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGEQRQMPTREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGCLEYDDERAQ 
Grass_carp                MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGCLEYDDERAQ 
Zebrafish_A               MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQ 
Stickleback_A             MPRVVPEQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGDQRQLPAREYVDFERETGKVYLKAPMILNGVCVMWRGWIDLQRLDGMGYLEYDEERAQ 
Medaka_A                  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERETAQVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDQERAQ 
Amazon-molly_A            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPSREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDDERAQ 
Nile_tilapia_A            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
Zebra_mbuna_A             MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
Spotted_gar_A             MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGDQRQAPSREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGCLEFDEERAQ 
Western_clawed_frog_A     MPRVVPDQRAKFENEEFFRKLNRESEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANWQGEPRQAPTREYVDFEREPGKVHLKAPMILNGVCVLWKGWIDLQRLDGMGCLEFDDDRAQ 
Chinese_alligator_A       MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEEPQGRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Tibetan_ground-tit_A      MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Green_anole_A             MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
American_alligator_A      MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
White-throated_sparrow_A  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Budgerigar_A              MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREGGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Western_painted_turtle_A  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPTREYVDFEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Rat_A                     MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQTRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLHRLDGMGCLEFDEERAQ 
Mouse_A                   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQTRFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLHRLDGMGCLEFDEERAQ 
Bovine_A                  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDFEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Yangtze_River_dolphin_A   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Pig_A                     MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Chimpanzee_A              MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Rhesus_macaque_A          MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Human_A                   MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQ 
Elephant_shark_A          MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQMRFQNASRDGRSEIAFVATGTNLSLQFFPANWHGEQRQTPTREYVDFDRESGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGFLEFDEERAQ 
Zebrafish_C               MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGDQRQAPTREYVDFERETGKVYLKAPMILNGVCVIWRGWLDLHRLDGMGCLEYDDERAQ 
Mexican_tetra_C           MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPANLHGEQRQMPTREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGCLEYDDERAQ 
Nile_tilapia_C            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
Zebra_mbuna_C             MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
Medaka_C                  MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERETAQVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDQERAQ 
Southern_platyfish_C      MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPSREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDDERAQ 
Amazon_molly_C            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPSREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDDERAQ 
Atlantic_Salmon_C         MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNASRDGRSEIAFVATGTNLSLQFFPANLHGEQRQTPTRDYVDFDRETGKVYLKAPMILNGVCVIWKGCIDLQRLDGMGCLEFDEERAQ 
Amazon_molly_D            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPSREYVDFERETGKVYLKAPMILNGVCVIWRGWIDLQRLDGMGYLEYDDERAQ 
Nile_tilapia_D            MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
Zebra_mbuna_D             MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEVAFVATGTNLSLQFFPANLHGDQRQVPTREYVDFERESGRVYLKAPMILNGVCVIWKGWIDLQRLDGMGYLEYDDERAQ 
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Western_clawed_frog_B     HEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVLRPRCP 
African_clawed_frog_B     QEDALAQQAFEDSRRRTREFEDRDRSHREEMEVRVLRPRCP 
Chinese_alligator_B       QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLSVTGKKTARP 
Western_painted_turtle_B  QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLSVTGKKTTRP 
American_alligator_B      QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLSVTGKKTARP 
White-throated_sparrow_B  QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLSVTGKKTARP 
Chicken_B                 QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLSVTGKKTTRP 
Rat_B                     QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTARP 
Mouse_B                   QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTARP 
Bovine_B                  QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP 
Yangtze_River_dolphin_B   QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP 
Chimpanzee_B              QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP 
Rhesus_macaque_B          QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP 
Human_B                   QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP 
Pig_B                     QEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTARP 
Mexican_tetra_A           HEDALAQAAFEEARRRTRDFEDRDRSHREELEPRRQQDPSPGSNMGNTDD-HKMR 
Cave_fish_A               HEDALAQAAFEEARRRTRDFEDRDRSHREELEPRRQQDPSPGSNMGNTDD-HKMR 
Grass_carp_A              HEDALAQAAFEEARRRTRDFEDRDRSHREDLEPRRQQDPSPGSNMGNTDD-HKMR 
Zebrafish_A               HEDALAQAAFEEARRRTRDFEDRDRSHREDLEPRRQQDPSPGSNMGNTDD-HKMR 
Stickleback_A             QEDALAQAAFEEARRRTRDFEDRDRSHREDLECRRQQDPSPGSNMADADVEHKMR 
Medaka_A                  HEDALAQAAFEEARRRTRDFEDRDRSHREDLESRRQQDPSPGSNMANADMEHKMR 
Amazon-molly_A            HEDALAQAAFEEARRRTRDFEDRDRSHREDLESRRQQDPSPGSNMANADVEHKMR 
Nile_tilapia_A            HEDALAQAAFEEARRRTRDFEDRERSHREDLESRRQQDPSPGSNMANADMEHKMR 
Zebra_mbuna_A             HEDALAQAAFEEARRRTRDFEDRERSHREDLESRRQQDPSPGSNMANADMEHKMR 
Spotted_gar_A             QEDALAQQAFEEARRRTRDFEDRDRSHREDMEARRQQDPSPGSNMGGGEDR-TLR 
Western_clawed_frog_A     HEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSSG—-LGGGDDL-KLR 
Chinese_alligator_A       QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
Tibetan ground-tit_A      QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGTGDDL-KLR 
Green_anole_A             QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
American_alligator_A      QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
White-throated_sparrow_A  QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
Budgerigar_A              QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
Western_painted_turtle_A  QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGSGDDL-KLR 
Rat_A                     QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGGGDDL-KLR 
Mouse_A                   QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGGGDDL-KLR 
Bovine_A                  QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSSLGGGDDL-KLR 
Yangtze_River_dolphin_A   QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSSLGGGDDL-KLR 
Pig_A                     QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSSLGGGDDL-KLR 
Chimpanzee_A              QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGGGDDL-KLR 
Rhesus_macaque_A          QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGGGDDL-KLR 
Human_A                   QEDALAQQAFEEARRRTREFEDRDRSHREEMEARRQQDPSPGSNLGGGDDL-KLR 
Elephant_shark_A          QEDTLAQQAYEDVRRRARDFEDRDRSHRDDMEARRQQDPSPGSNLGSGDEL-KLR 
Zebrafish_C               HEDALAQAAFEEARRRTRDFEDRDRSHREDLEDPVASKIWD 
Mexican_tetra_C           HEDALAQAAFEEARRRTRDFEDRDRSHREELEDPVASKIWD 
Nile_tilapia_C            HEDALAQAAFEEARRRTRDFEDRERSHREDLEDPVVSKIWD 
Zebra_mbuna_C             HEDALAQAAFEEARRRTRDFEDRERSHREDLEDPVVSKIWD 
Medaka_C                  HEDALAQAAFEEARRRTRDFEDRDRSHREDLEDPVVSKIWD 
Southern_platyfish_C      QEDALAQAAFEEARRRTRDFEDRDRSHREDLEDPVVSKIWD 
Amazon_molly_C            HEDALAQAAFEEARRRTRDFEDRDRSHREDLEDPVVSKIWD 
Atlantic_Salmon_C         HEDALAQASFEESRRRTRDFEDRDRSHREDLEDPVASKIWD 
Amazon_molly_D            HEDALAQAAFEEARRRTRDFEDRDRSHREDLETTAGPQPWLKHGQR  
Nile_tilapia_D            HEDALAQAAFEEARRRTRDFEDRERSHREDLETTAGPQPWLKHGQR  
Zebra_mbuna_D             HEDALAQAAFEEARRRTRDFEDRERSHREDLETTAGPQPWLKHGQR                           
 
Figure 4.S5 Protein sequence comparison of CBFβ from 
different species. (For description see legend of Figure 4.4). 
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5.1 Abstract 
RUNX3 encodes a member of the runt domain-containing family of transcription factors. 
RUNX3 forms a heterodimeric complex with CBFbeta subunit and binds to the core DNA 
sequence 5'-PYGPYGGT-3' found in a number of enhancers and promoters, and can either 
activate or suppress transcription. RUNX3 expression is regulated by two promoter regions, 
designated P1 and P2. Although the importance of this transcription factor in the regulation 
of many genes is proven, not much is known about the factors that regulate RUNX3 
transcription. We showed that both Runx2 and Runx3 interact with Cbfβ to regulate 
zebrafish runx3 promoters. Using a variety of cell lines, a number of upstream regulatory 
regions in the zebrafish runx3 gene were identified. Functional analysis of these regions 
allowed the identification of four regions in runx3-P1 promoter, including two positive 
regulatory regions from -5094 to -1766 and -948 to -786 and two negative regulatory regions 
from -1766 to -948 and -662 to -559, and three regions in runx3-P2 promoter, including two 
positive regulatory regions from -1232 to -699 and -554 to -474 and one negative regulatory 
region from -3930 to -1232. These results were complemented with in silico analysis of the 
putative transcription binding sites that are present in each identified region. In addition, in 
vivo analysis of zebrafish runx3 gene expression was performed and the tissue-specific 
expression of each specific promoter fragment analysed. Taken together, the results of the 
functional differences between runx3-P1 and runx3-P2 promoters suggest differences in 
overall transcriptional activity. As these differences are probably dependent on regulation by 
different transcription factors, the first detailed map of the transcriptional regulatory 
elements of the zebrafish runx3-P1 and runx3-P2 promoter regions described in this study 
provides an important reference for further functional analysis to identify exactly how each 
factor regulates each promoter region.  
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5.2 Introduction 
Runx (runt-related) family of transcription factors comprises Runx1/AML1/Cbfa2, 
Runx2/AML2/Cbfa1 and Runx3/AML3/Cbfa3 (van Wijnen et al, 2004). RUNX proteins are 
crucial transcription factors that regulate a wide range of biological processes to orchestrate 
proper cell fate determination during the development of metazoans (Coffman, 2003). Gene 
ablation and gain of function experiments established all three proteins as important 
regulators of cell fate decisions in early embryonic development and tissue differentiation - 
blood, neurons, and bone (Westendorf and Hiebert, 1999; Ito, 2008). Runx2 and Runx3 act 
early in development and play fundamental roles in skeletal development by regulating 
chondrocyte maturation and proliferation (Komori, 2005; 2015; Soung et al, 2007). Runx3 
isoforms have also been shown to affect early neuron development (Chen et al, 2006; 
Kramer et al, 2006). Accordingly, deregulation of RUNX proteins is also involved in human 
disease (Blyth et al, 2005; Ito, 2008).  
The RUNX genes arose early in evolution and maintained extensive structural similarities in 
vertebrates. All have two promoters, located 5’ from each of the two ATG-containing exons 
and all heterodimerize with CBFβ that enhances their affinity to bind to the common DNA 
motif TGPyGGTPy (Py is a pyrimidine) (Ito, 2004; Westendorf and Hiebert, 1999). Multiple 
RUNX putative binding sites have been predicted in both promoters of all RUNX genes, and 
the cross-regulation and/or auto-regulation between the RUNX family members has been 
reported (Drissi et al, 2000; Otto et al, 2003; Spender et al, 2005; Brady et al, 2009). In 
zebrafish, a runx3 orthologue was identified and its embryonic expression described (Burns 
et al, 2002; Kataoka et al, 2000; Simões et al, unpub.). In this study, we performed an in silico 
analysis of zebrafish runx3 gene Distal (P1) and Proximal (P2) promoters with MATCH 
software that revealed the existence of several putative transcription factors binding sites 
(TFBSs) in both regions. We cloned the 5’-upstream regions of runx3 gene promoters in a 
reporter vector (runx3-P1:LuC and runx3-P2:LuC constructs) and demonstrated that the 
putative promoter regions, P1 and P2, are capable of mediating gene transcription both in 
cultured cells and in vivo, in zebrafish embryos. We performed an extensive in vitro 
functional analysis in different cell lines using several deletion mutant constructs from both 
promoter regions allowing us to identify positive and negative regulatory regions in each 
promoter and by promoter comparative analysis using DiAlignTF software we were able to 
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identify several putative TFBSs conserved in that regions, potentially involved in the 
transcriptional regulation of the runx3 gene. As our in silico analysis predicted various 
putative TFBSs for the RUNX transcription factors, the possible cross-regulation and/or auto-
regulation of the runx3 gene by Runx2 and by its own isoforms was also tested in vitro by co-
transfection of both runx3 promoter constructs into HEK293 cells, with or without the Runx 
co-factor Cbfβ, indicating that in fact, runx3 promoters are regulated by Runx2/3 isoforms. 
Additionally, using Tol2-mediated technology, runx3-P1 and runx3-P2 promoters fused 
upstream of a mutant version of the green fluorescent protein (EGFP) reporter were 
analysed in vivo for their capacity to drive EGFP expression. We observed that runx3-
P2:EGFP construct was capable to recapitulate part of the endogenous expression pattern of 
runx3 mRNA observed by in situ hybridization.  
 
5.3 Materials and Methods 
5.3.1. Ethics statement 
All zebrafish (Danio rerio) studies were conducted using the wild type (AB) strain available at 
the CCMAR zebrafish facility, University of Algarve (Faro, Portugal) and the experiments 
were conducted following the legislation for animal experimentation and welfare in 
Portugal, in accordance with the Portuguese law (Portaria 1005/02 and Portaria 1131/97) 
which transcribes the European Guideline 86/609/EC. 
 
5.3.2. Zebrafish maintenance 
Embryos were obtained from natural spawning, collected in embryo medium (Westerfield, 
2000), raised at constant temperature of 28.5°C and staged according to Kimmel and 
co-workers (1995) (occasionally, when necessary their development was slowed down or 
speeded up by incubation at 23°C or 33°C, respectively). For some experiments, embryos 
were treated with 0.003% 1-phenyl-2-thiourea (PTU; Sigma) to inhibit pigment formation for 
further imaging improvement. All specimens were deeply anesthetised in Tricane (3-amino 
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benzoic acid ethyl ester also called ethyl 3-aminobenzoate, Sigma) before manipulation as 
described in the Zebrafish Book (Westerfield, 2000).  
 
5.3.3. In silico sequence analysis 
The runx3 P1 and P2 upstream regions were identified using the BLAST tool available at NCBI 
database (National Center for Biotechnology Information, www.ncbi.nlm.nih.gov). The 
GenBank database was searched for annotated zebrafish runx3 sequences and the promoter 
sequences were extracted for analysis by selecting 5000 base pairs (bp) upstream of the 
translation start site of each isoform. Core promoter elements and binding sites for 
transcription factors were predicted by in silico analysis using the MatchTM (public version 
1.0) program that uses a library of positional weight matrices from TRANSFAC® Public 6.0, 
available at ww.gene-regulation.com/pub/programs. A Cut-off of 0.9 for core and matrix 
similarity was used.  
 
5.3.4. Genomic DNA library preparation 
The genomic DNA of an adult zebrafish specimen was prepared using the QIAGEN DNeasy 
Tissue kit and the DNA quality and quantity was evaluated by measurement of absorbance 
at 260 nm, using a NanoDrop 1000 spectrophotometer (Thermo-Fisher).  
Two genomic DNA libraries were constructed using the previous genomic DNA, digested with 
StuI and EcoRV, and prepared using standard protocols according to the manufacturer’s 
instructions for the Universal GenomeWalkerTM Kit (Clontech). 
 
5.3.5 Cloning of the 5’ upstream regions (P1 and P2) of zfrunx3 
The zebrafish runx3 sequences for P1-derived transcripts (AB043789 and AB043790) and 
P2-derived transcript (AB043788) were aligned against the zebrafish genome (Danio rerio 
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strain Tuebingen chromosome 13, GRCz10; Sequence ID: ref|NC_007124.6|) and the 5 kb 
region upstream the ATG codon for each isoform was used as template to design the runx3 
specific primers, listed in Table 5.S1. The 5’ upstream regions (P1 and P2) of zfrunx3 were 
obtained using as template either zebrafish genomic DNA or GenomeWalker EcoRV and StuI 
libraries, in a nested PCR.  
The amplifications using the GenomeWalker EcoRV and StuI libraries as templates were 
performed using Advantage Polymerase Mix (Clontech), Adaptor Primer 1 (AP1) and 
gene-specific primers. A nested PCR was then performed using a dilution of the primary PCR 
product as template, the Adaptor Primer 2 (AP2) and respective gene-specific primers 
following the conditions suggested by the supplier. Three different size fragments of the 
runx3 P2 (or PP) promoter region, named PP665, PP134 and PP104, were obtained using the 
StuI genomic library and the adaptor primers (AP1 and AP2) and the gene-specific antisense 
primers (GWZfRunx3_R4 and GWZfRunx3_R3), respectively, in primary and nested PCR 
reaction. Similarly, one fragment (PD1200) of the runx3 P1 (or PD) promoter region was 
obtained using the StuI genomic library in a primary amplification reaction with AP1 adaptor 
and the antisense gene-specific primer (GWZfRunx3_R1) and then this product was used in a 
nested PCR with a pair of gene-specific primers (GWZfRunx3_F1 and GWZfRunx3_R5). PCR 
products were size-separated by electrophoresis on an agarose gel, purified using GeneJET 
Gel Extraction Kit (Thermo Scientific), cloned into the pCRII-TOPO vector using the TOPO TA 
cloning kit (Invitrogen) and sequenced on both strands to confirm their identity. 
Zebrafish genomic DNA was used to amplify larger fragments of each P1 and P2 5’ upstream 
region, using the KOD Hot Start DNA Polymerase (Novagene) and gene-specific primers. 
Amplification conditions were those suggested by the supplier. The fragments designated 
runx3-PD(5kb) and runx3-PD(4.4kb) from the runx3-P1 promoter region were amplified 
using the same sense primer (DrRunx3PD_F2) and the antisense primers (DrRunx3II&III_R2 
and GWZfRunx3_R5, respectively) in a primary PCR and then used as template in a nested 
PCR with the sense primer (DrRunx3PD_KpnI_F5) and the antisense primers 
(DrRunx3II&III_R2 and DrRunx3PD_XhoI_R5, respectively). The fragments designated 
runx3-P2(3.4kb) and runx3-P2(3.3Kb) from the runx3-P2 promoter region were amplified 
using the same specific sense primer (DrRunx3PP_F4) and antisense (DrRunx3_R4 and 
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Runx3IntExR1_XhoI, respectively) in a primary PCR reaction and then used as template for a 
nested PCR using the sense primer (DrRunx3PPKpnI_F3) and the antisense primers 
(GWZfRunx3_R3 and Runx3IntExR1_XhoI, respectively). PCR products were size-separated by 
electrophoresis on an agarose gel, purified using GeneJET Gel Extraction Kit (Thermo 
Scientific), cloned into the pJet1.2 vector using the CloneJET PCR Cloning Kit (Thermo 
Scientific) and sequenced on both strands to confirm their identity. All the primers used are 
listed in Table 5.S1. 
 
5.3.6 Plasmid construction for promoter functional analysis assays 
The zebrafish runx3 luciferase reporter plasmid PD(-1766/-559)LuC was obtained by direct 
extraction from the respective fragment (PD1200) cloned in pCRII-TOPO vector using KpnI 
and XhoI restriction enzymes, whereas the constructs PD(-5094/-17)LuC and 
PP(-5094/-701)LuC were obtained by direct extraction from the respective fragments (PD5Kb 
and PD4.4Kb) cloned in pJet1.2 vector using KpnI and BglII restriction enzymes. The 
PD(-1766/-662)LuC, PD(-948/-662)LuC, PD(-786/-662)LuC and PD(-478/-17)LuC constructs 
were generated by PCR amplification using as template the construct PD(-1766/-559)LuC 
with sense primers (pGL3_FW2; DrRunx3PD_KpnI_F1; DrRunx3PD_KpnI_F2 and 
DrRunx3PD_KpnI_F3, respectively) and a common antisense primer (DrRunx3PD_XhoI_R2). 
The PD(-1766/-17)LuC, PD(-948/-17)LuC and PD(-786/-17)LuC constructs were generated by 
PCR amplification using as template the construct PD1200 cloned in pCRII-TOPO vector with 
sense primers (Universal M13Rev; DrRunx3PD_KpnI_F1; and DrRunx3PD_KpnI_F2, 
respectively) and a common antisense primer (DrRunx3PD_XhoI_R1). DNA fragments were 
digested with KpnI and XhoI restriction enzymes. 
The zebrafish runx3 luciferase reporter plasmids PP(-1232/-713)LuC, PP(-1232/-474)LuC and 
PP(-699/-474)LuC were obtained by direct extraction using XhoI and HindIII restriction 
enzymes, from the fragments (PP665, PP134 and PP104, respectively) cloned in pCRII-TOPO 
vector. The constructs PP(-3930/-474)LuC and PP(-3930/-554)LuC were obtained by direct 
extraction using KpnI and BglII restriction enzymes, from the respective fragments (PP3.4Kb 
and PP3.3Kb) cloned in pJet1.2 vector. The PP(-855/-554)LuC construct was generated by 
Chapter 5 
172 
 
PCR amplification using as template the construct PP(-1232/-474)LuC with the primers 
Runx3_PPF1_KpnI and Runx3IntExR1_XhoI, while the PP(-855/-18)LuC construct was 
generated by PCR amplification using zebrafish genomic DNA as template with the primers 
Runx3_PPF1_KpnI and Runx3PP_R1_XhoI. DNA fragments were digested with KpnI and XhoI 
restriction enzymes.  
All the DNA fragments described above were inserted into pGL3-Basic vector previously 
digested with the respective restriction enzymes. Constructs were verified by double 
stranded DNA sequence analysis. Plasmids used for transfection studies were prepared using 
the GFXTM Micro Plasmid Prep kit (GE Healthcare). All the primers used are listed in Table 
5.S1. 
 
5.3.7 Cell culture and growth conditions 
The cell lines used on transient transfection assays were maintained in the appropriate cell 
culture medium according to their specific requirements. Human embryonic kidney 293 
(HEK293, ATCC CRL‐1573), human bone osteosarcoma U2OS (ATCC HTB-96) and mouse 
neuroblastoma Neuro2a (ATCC CCL-131) cell lines were cultured in Dulbecco’s modified 
eagle medium (DMEM, Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS, Sigma) 
and 2mM L-Glutamine, whereas mouse chondrogenic ATDC5 (Sigma 99072806) and rat glial 
C6 (ATCC CCL-107) cell lines were maintained in DMEM:F12 (1:1) (Gibco) medium 
supplemented with 5% (v/v) FBS and F-12K (Gibco) medium supplemented with 2.5% (v/v) 
FBS plus 15% (v/v) horse serum (Gibco), respectively. 1% (v/v) penicillin/streptomycin (P/S) 
was added to cell culture media. Cells were allowed to grow in a humidified incubator at 
37°C and an atmosphere of 5% CO2 and passaged at regular intervals on reaching 
approximately 80% confluence. 
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5.3.8 Runx3 amplification from cell lines using RT-PCR 
Total RNA was extracted from A6 (Xenopus laevis; ATCC#CCL102), HEKL293, Neuro2a and C6 
cell lines with TRIzol (Sigma) as recommended by the manufacturer. RNA integrity was 
assessed through 1% (w/v) agarose/formaldehyde gel electrophoresis and RNA quantity was 
determined through spectrophotometry (NanoDrop). Total RNA (1 μg) was DNase I 
(Promega) treated before reverse‐transcribed using the Moloney‐murine leukemia virus 
(MMLV) reverse transcriptase, RNaseOUT (both from Invitrogen) and oligo(dT)‐adapter 
primer (Table 5.S1). Runx3 and control (GAPDH or Actin) genes were amplified from each 
cell line cDNA sample by PCR using the SsoFast EvaGreen Supermix (Bio-Rad) and the 
respective pair of gene-specific primers (Table 5.S2). PCR results were analysed in a 1.8% 
agarose gel. 
 
5.3.9 Transient transfection and functional promoter analysis assays  
Each cell line was seeded and transfected according to its optimal number of cells per well 
and transfection reagent. Cells were seeded at approximately 40%-70% of confluence in 
24-well plates (5×104 cells/well for HEK293 cells and 3×104 cells/well for U2OS) or in 12-
well-plates (1×104 cells/well for ATDC5 cells) and transient transfection assays were carried 
out after approximately 16 hours using the X-TREME reagent (Roche). Neuro2a and C6 cells 
were seeded in 24‐well plates (5×104 cells/well) and transfected with the Lipofectamine LTX 
with PLUS reagent (Invitrogen). The cells were transient transfected in the day after seeding 
with the promoter luciferase reporter constructs and the Tk Renilla vector (Promega), as an 
internal control. The cells were harvested 48 h post-transfection and the luciferase activity 
was obtained in a Synergy 4 microplate reader (BioTek) using the Dual-Luciferase reporter 
assay system (Promega) according to the manufacturer's instructions. Each transfection was 
normalized using the ratio between the firefly luciferase and Renilla luciferase activities.  
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5.3.10 Functional promoter analysis in vivo 
5.3.10.1 Transient luciferase assays in vivo 
Transient luciferase assays in vivo were performed by co-injection of runx3-P1 and runx3-P2 
promoter luciferase constructs (≈50 pg/embryo) and the internal control Tk Renilla vector 
(≈5 pg/embryo), into 1-cell stage zebrafish embryos, using a Nanoject II (Drummond 
Scientific Co.) apparatus and incubated at 28.5°C. Embryos were collected for analysis using 
the Dual-Luciferase reporter assay system 24 hours post-injection in groups of five embryos 
per tube, anesthetized, lysated and luciferase activities (firefly and Renilla) were assessed as 
described previously (Section 5.3.8). 
 
5.3.10.2 Generation of transgenic animals 
The construct PD(-5094/-17):EGFP was obtained by direct extraction from the construct 
PD(-5094/-17)LuC (in pGL-3-Basic vector; Section 5.3.6) using KpnI and HindIII restriction 
enzymes and the construct PP(-3930/-554):EGFP was obtained by direct extraction from the 
construct runx3-P2(3.3Kb) (in pJet1.2 vector; Section 5.3.5) using KpnI and BglII restriction 
enzymes, and independently cloned into pminiTol plasmid (Balciunas et al, 2006), a modified 
Tol2 expression vector that contains the EGFP reporter transgene. The constructs for 
injection were verified by double stranded DNA sequence analysis and purified using the 
GFXTM Micro Plasmid Prep kit. The Tol2 transposase mRNA was obtained from the template 
pCSTZ2.8 plasmid (Kawakami et al, 1998) by in vitro transcription using the SP6 mMessage 
mMachine kit (Ambion).  
To generate the zebrafish transgenic lines, each expression construct was co-injected with 
transposase mRNA into the cytoplasm of single-cell stage wild-type AB strain zebrafish 
embryos (≈125 pg/embryo each). The injected embryos were screened for GFP expression 
and the transgenic founders (F0) were raised to sexual maturity and outcrossed to wild-type, 
and their progeny (F1) analysed for GFP expression. GFP positive F1 embryos, carriers of the 
transgene, were raised to adulthood to outcross and generate the transgenic stable line. The 
embryos were mounted in 1.2% agarose and imaged in a Zeiss LSM710 confocal microscope 
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or mounted in 3% methylcellulose (Sigma) and imaged using an Olympus IX81 fluorescence 
microscope coupled with an F-view II camera (Olympus) . 
 
5.3.11 Statistical analysis 
For the promoter-reporter assays all samples were tested in duplicates in at least three 
independent experiments and the data was presented as mean and standard deviation 
(mean ± SD) of that measurements. Statistical significance of data was determined by 
analysis of variance (ANOVA) with Tukey’s post test using GraphPad Prism version 4.00 
(GraphPad Software, www.graphpad.com). A value P<0.05 was assumed to denote a 
significant difference.  
 
 
5.4. Results 
5.4.1 In silico identification of transcriptional regulators in runx3 P1 and P2 promoter 
regions  
Similar to the other two members of the Runx family of transcription factors, the 
transcription of runx3 is regulated by two distinct promoter regions (P1/distal and 
P2/proximal), located upstream of exons 1 and 2, respectively, generating two major protein 
isoforms that differ in their N-terminal sequence (Chapter II of this thesis). To predict 
putative core promoter elements and transcription factor binding sites (TFBSs) in each 
region, an in silico analysis on the regions located 1 kb upstream the translating starting 
codons of the zebrafish runx3 gene was performed using the MatchTM (public version 1.0) 
program (Figure 5.1). The results revealed a consensus TATA box and two inverted CCAAT 
boxes located at positions -43, -72 and -103, respectively, upstream the runx3-P2 TSS (Figure 
5.1B). No consensus TATA box was predicted in the runx3-P1 upstream region, but two 
CCAAT boxes were detected at positions -476 and -587 upstream the ATG codon in the 
5’UTR region in the proximity of the runx3-P1 TSSs (Figure 5.1A). The in silico analysis failed 
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to predict an Sp1 binding site, which is usually associated with TATA-less promoters,  in the 
runx3-P1 promoter region analysed, but one Sp1 binding site was predicted in runx3-P2 
region located at position -88 upstream the P2 TSS in the proximity of the TATA and CAAT 
boxes (Figure 5.1A and B). Several other TFBSs were also predicted in the 1 kb upstream 
region of each zebrafish runx3 promoters, such as Ap1, Ikaros, C-Ets, C/EBP, NF-Y, Runx, 
NFAT, Nkx, SRY, FoxD3, MyoD, among others (Figure 5.1 and data not shown). 
 
5.4.2 Characterization of the 5’ regions of the zebrafish runx3 gene 
The RUNX3 gene has been extensively studied in different organism models, but although 
several authors described the in silico analysis of RUNX3 promoters, little information is 
available about the transcriptional regulation of this gene. To date, a few studies in 
mammals have shown the functionality of both RUNX3 promoters in vitro, but no 
information is still available about the regulation of the zebrafish runx3 promoter regions. To 
address this question we have analysed each promoter for the presence of positive and 
negative regulatory regions. Various deletion constructs between -5094 and -17 of the 
runx3-P1 region and between -3930 and -18 of the runx3-P2 region were sub-cloned into the 
pGL3-Basic vector, upstream the luciferase reporter gene. Basal promoter activity was 
evaluated for each fragment by transfecting the different promoter constructs into human 
embryonic kidney HEK293 cell line (Figure 5.2A and 5.2B). The activity of each promoter 
region was also assessed in vivo, by injection of runx3-P1 and runx3-P2 constructs into 1 cell 
stage zebrafish embryos and determined 24 hours post-injection by luciferase assay (Figure 
5.S1). 
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Figure 5.1 In silico analysis of 1 kb of runx3 P1 and P2 upstream regions. Identification of core promoter elements and putative transcription 
factors binding sites by Match software. The putative TATA box is represented by red letters in a red box, the CAAT box highlighted in grey, the 
Sp1 highlighted in green, the Ap1 highlighted in blue, the Ets highlighted in pink, the C/ebp highlighted in yellow, the Ikaros in double underline 
letters and the Runx in blue circles. The translational start codon is represented highlighted in red. 
P1-upstream 
region 
P2-upstream 
region 
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Figure 5.2 Relative transcriptional activity of zebrafish (A) runx3-P1 and (B) runx3-P2 
promoter constructs. Schematic representation of the deletion constructs transfected into 
HEK293 cells and assessed by luciferase assay (left) and respective relative luciferase activity 
(right). The runx3-P1 and runx3-P2 regions are represented in the top of each figure A and B, 
respectively. Each sample was done in duplicates and at least three times. The promoter-less 
pGL3-Basic vector was used to determine the baseline. Significance (*p<0.05) compared to 
the baseline was determined by One Way ANOVA followed by Tukey’s test. The TSSs are 
represented by a black arrow; the 5’ UTR and part of the coding region are represented by 
white and black rectangles, respectively; the putative TATA and CAAT boxes are indicated by 
a filled triangle and white diamonds, respectively.  
 
5.4.2.1 Identification of regulatory regions in runx3 P1 promoter in HEK293 cell line 
The results of the longest P1 construct, comprising 5 kb of 5’ flanking region 
[PD(-5094/-17)LuC], showed a promoter activity of approximately 12 fold compared to the 
control pGL3 empty vector. However this promoter activity was significantly decreased when 
the region -5094 to -1766 was deleted in construct PD(-1766/-17)Luc. Further deletion of the 
region -1766 to -948 in PD(-948/-17)LuC slightly increased the activity of the promoter, 
although without significance, but an additional deletion in PD(-786/-17)LuC further 
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decreased significantly the activity of the promoter (Figure 5.2A). These results suggest that 
binding sites for positive regulators may be present in both regions -5094 to -1766 and -948 
to -786. The runx3-P1 promoter region has been characterized as a TATA-less promoter and 
our in silico analysis predicted two putative CAAT boxes, located in the 5’UTR region, 
positions -476 and -587 upstream from the ATG codon, as well as various putative TFBSs in 
this region (Figure 5.1). This led us to test the PD(-478/-17)LuC construct, detecting 
luciferase activity approximately 5 fold compared to the promoter-less pGL3-Basic vector 
(Figure 5.2A). This result showed that the region -478 to -17, comprising the 5’UTR, was 
capable of driving basal promoter activity. We then tested PD(-5094/-701)LuC, in which the 
two putative CAAT boxes and the 5’ UTR region were deleted. The promoter activity 
dropped to the levels of the promoter-less pGL3-Basic vector (Figure 5.2A), indicating that 
the region between -17 to -701 is essential to the basal activity of the runx3-P1 promoter. In 
order to identify a more restricted region essential to the basal activity of this promoter, two 
3’ deletion constructs were assessed for promoter activity:  PD(-1766/-559)LuC, that lacks 
one putative CAAT box, and PD(-1766/-662)Luc that lacks both putative CAAT boxes. 
PD(-1766/-559)LuC showed an activity similar to that of PD(-1766/-17)LuC, but 
PD(-1766/-662)Luc significantly increased the promoter activity compared to 
PD(-1766/-17)LuC (Figure 5.2A), indicating that the two putative CAAT boxes are not 
necessary for the basal activity of this promoter. This result also suggests that the 
region -662 to -559 may have binding sites for negative regulators, as its deletion 
significantly increased the promoter activity. PD(-948/-662)LuC showed the highest 
promoter activity (Figure 5.2A), indicating that an extra region containing binding sites for 
negative regulators may be present between -1766 to -948 as the deletion of this region 
dramatically increased the promoter activity when compared to the activity of the 
PD(-1766/-662)LuC. Result obtained with the PD(-786/-662)LuC confirmed those obtained 
with the PD(-786/-17)Luc indicative of a positive regulatory region between -948 and -786 
(Figure 5.2A).  
Together, our results show that the region essential to drive P1 basal activity in HEK293 cells 
is comprised between -701 and -17, as the deletion of this region completely abolishes the 
promoter activity; suggesting the presence of binding sites for positive elements in the -5094 
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to -1766 and -948/-786 regions, while binding sites for repressive elements are observed in 
the regions -1766 to -948 and -662 to -559 of the zebrafish runx3-P1 promoter (Figure 5.2A). 
 
5.4.2.2 Identification of regulatory regions in runx3 P2 promoter in HEK293 cell line 
A strong activity of the runx3-P2 promoter was observed in HEK293 cells (Figure 5.2B). All 
constructs were significantly highly expressed in these cells when compared to the activity of 
the promotor-less pGL3-Basic vector, with the exception of PP(-1232/-713)Luc, that lacks the 
predicted TATA and CAAT boxes and the 5’UTR region (Figure 5.2B). The constructs 
PP(-3930/-474)LuC, PP(-1232/-474)LuC and PP(-699/-474)LuC did not show significant 
differences in promoter activity among them, despite the fact that the region -3930 to -699 
is deleted. However, when the region -3930 to -855 was deleted and the PP(-855/-554)LuC 
construct used, a significant increase in promoter activity was observed compared to the 
activity of the PP(-3930/-554)LuC (Figure 5.2B), suggesting the presence of negative 
regulator in the region between -3930 to -855. Moreover, when the region -554 to -474 was 
deleted and the PP(-3930/-554)LuC construct was used we observed a significant decrease in 
the promoter activity compared to the activity of the PP(-3930/-474)LuC construct (Figure 
5.2B), indicating that the region -554 to -474 may have binding sites for positive regulators. 
Taking together, these results show that the region between -855 and -699 may also have 
binding sites for positive regulators. The capacity of the 5’UTR region to drive promoter 
activity was also assessed by the PP(-855/-18)LuC construct. The result showed that this 
construct is capable to drive higher basal promoter expression compared to the activity of 
the promoter-less pGL3-Basic vector. Nevertheless, the addition of the 5’UTR region 
significantly reduced the basal activity of the promoter compared to the activity of the 
PP(-855/-554)LuC construct (Figure 5.2B). This suggests that the region between -474 
and -18 may have binding sites for negative regulators. 
Together, our results for the activity of runx3-P2 promoter constructs, show that the region 
between -713 and -554 is essential to drive runx3-P2 basal activity in HEK293 cells, and 
suggest that (i) the regions -3930 to -855 and -474 to -18 might include binding sites for 
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repressive elements, while (ii) the regions -855 to -699 and -554 to -474 most possibly 
possesses binding sites for positive regulatory elements (Figure 5.2B). 
 
5.4.3 Functional characterization of Runx2/3 and Cbfβ interaction to regulate runx3 
promoters 
To address the possible cross-regulation between Runx2 and Runx3 and the putative auto-
regulation of runx3 promoter gene by its own isoforms, we have transfected HEK293 cells, 
that do not express Runx3 (Figure 5.S2) or any other RUNX gene (Zheng et al, 2007; Bone et 
al, 2010), with zebrafish runx3-P1 promoter construct PD(-5094/-17)LuC and runx3-P2 
promoter construct PP(-3930/-554)LuC alone or in combination with zebrafish Runx2 and 
Runx3 isoforms (MASN or M(R/H)IPV) in the presence or absence of their transcriptional 
partner Cbfβ (Figure 5.3). 
Our results for the co-transfection of runx3-P1 construct PD(-5094/-17)LuC showed a 
significant repression effect when this construct was co-transfected with the Runx3-MASN 
isoform in the presence of Cbfβ isoform 4, but no significant difference was observed when 
this construct was co-transfected with the other Runx2 and Runx3 isoforms in the present or 
absence of the Cbfβ, when the activity was compared to the activity of the control 
(promoter construct co-transfected with the empty pCMX vector) (Figure 5.3A). On the 
other hand, the results for the runx3-P2 construct PP(-3930/-554)LuC showed a significant 
decrease in the activity of the promoter when co-transfected with all Runx2 and Runx3 
isoforms and compared to the expression of the control (promoter construct co-transfected 
with the empty pCMX vector) (Figure 5.3B). The results also showed that, in general, the 
presence of Cbfβ appeared to be associated to a more consistent repression of the activity 
of the runx isoforms, but this effect was not statistically significant. 
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Figure 5.3 The transcriptional regulation of runx3 promoter regions are affected by 
co-transfection with Runx2 and Runx3 isoforms. HEK293 cells were transfected with either 
zebrafish runx3-P1 [PD(-5094/-17)LuC] or runx3-P2 [PP(-3930/-554)LUC] constructs. Cells 
were co-transfected with zebrafish Runx2 or Runx3 isoforms (MASN or M(R/H)IPV) in the 
presence or absence of Cbfβ expression plasmid. The data indicated is a representative plot 
from two experiments that were done in duplicate. Significance was determined by One 
Way ANOVA followed by Tukey test. *p<0.05. 
 
 
A 
B 
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5.4.4 in vitro analysis of runx3 promoters in different cell lines 
Because Runx3 is expressed in a variety of cell types, to analyse if runx3 promoter regions 
respond differently to different cell micro-environments we characterized their expression in 
a number of cell lines (Figure 5.4). The mouse chondrogenic ATDC5, human bone U2OS, 
mouse neural Neuro2a and rat glial C6 were selected since they are derived from different 
cell types and are well documented for in vitro transfection assays.  It was previously 
reported that ATDC5 (Wigner et al, 2013) and U2OS cells (Lai and Mager, 2012) express all 
Runx family members. As no information was available about Runx3 expression in Neuro2a 
and C6 cell lines, a PCR approach was used to address this question, confirming that both cell 
types express runx3 transcripts (Figure 5.S2). We first tested the functionality of zebrafish 
runx3 promoter regions in the different cellular contexts, by transfecting the larger P1 and 
P2 constructs, PD(-5094/-17)LuC and PP(-3930/-474)LuC respectively. The results showed 
that the larger P1 construct [PD(-5094/-17)LuC] had variable activity in osseous vs 
non-osseous cell lines and that the larger P2 construct [PP(-3930/-474)LuC] showed high 
activity in all cell lines tested (Figure 5.S3). Next, runx3-P1 and runx3-P2 deletion mutants 
were tested to further investigate their activity in the cells and analyse how they respond to 
different cell environmental stimuli (Figure 5.4).  
The results showed that in general all constructs from runx3-P2 promoter were active in all 
cells tested (Figure 5.4B). In contrast, a high variability in the expression levels of the 
runx3-P1 constructs across the different cell lines was observed (Figure 5.4A). Because the 
promoter-less pGL3-Basic vector, used to define the baseline, produced variable activity in 
the different cell lines, the absolute fold over background values cannot be compared across 
the different cell lines; rather, the relative changes in activities among different deletion 
constructs within a cell line were examined.  
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Figure 5.4 Basal activity of zebrafish (A) runx3-P1 and (B) runx3-P2 promoter regions in 
various runx3 expressing cells. Mouse chondrogenic ATDC5, human osteosarcoma U2OS, 
human neuroblastoma Neuro2a and rat glioma C6 cell lines were transiently transfected 
with runx3-P1 and runx3-P2 promoter constructs. The runx3-P1 and runx3-P2 promoter 
regions and the schematic representation of the deletion constructs are represented in the 
left. The TSSs are represented by a black arrow; the 5’ UTR and part of the coding region are 
represented by white and black rectangles, respectively; the putative TATA and CAAT boxes 
are indicated by a filled triangle and white diamonds, respectively. The promoter-less 
pGL3-Basic vector was used to determine the baseline (dotted line) and samples with 
significant higher relative expression compared to the baseline are indicated (*). n≥3 (except 
n=2 for samples indicated with #). Significance (*p<0.05) was determined by One Way 
ANOVA followed by Tukey’s test. ND - not determined. 
 
5.4.4.1. Analysis of runx3-P1 constructs activity in the different cell lines 
The results for the expression of runx3-P1 constructs showed that in ATDC5 cells only the 
PD(-948/-662)LuC and PD(-786/-662)LuC constructs had an expression significantly higher 
than the baseline (Figure 5.4A), while in U2OS cells, all constructs, except the 
PD(-5094/-17)LuC, have a relative expression activity similar to the baseline (Figure 5.4A). In 
Neuro2a cells only the constructs PD(-5097/-17)LuC and PD(-478/-17)LuC show a significant 
relative expression, however not all constructs were tested in this cell line and in C6 cells, all 
constructs, except the PD(-5094/-701)LuC have an expression higher than the baseline 
(Figure 5.4A), showing a relative expression pattern similar to that observed in HEK293 cells 
(Figure 5.2A). We compared the relative expression of the deletion constructs in each line 
and identified the regulatory regions of the runx3-P1 promoter in each cell context. These 
results are summarized in Table 5.1A. Overall, from the results obtained from all the cell 
lines tested, it was possible to identify two positive regulatory regions [A1 (-5094 to -1766) 
and A2 (-948 to -786)] and two negative regulatory regions [R1 (-1766 to -948) and R2 (-662 
to -559)] in runx3-P1 promoter (Figure 5.2A and 5.4A and Table 5.1A).  
We then analysed which putative TFBSs are conserved in the identified regulatory regions by 
our in silico comparative analysis (Section III of this thesis) (Table 5.2). We found that those 
regions are highly conserved and contain multiple putative TFBSs. Interestingly, we observed 
that the PD(-5094/-17)LuC construct, that showed high relative expression in all cell lines 
tested, with the exception of ATDC5 cells, contains the regulatory region A1, with several 
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putative TFBSs for known positive regulators (Table 5.2). The same occurs regarding the 
PD(-948/-662)LuC construct that showed the higher relative expression in three out of the 
five cell lines tested, and includes the identified positive regulatory region A2, containing 
some conserved putative TFBSs known to be important for transcription regulation (Table 
5.2). Moreover, the regions R1 and R2 identified in our results contain putative TFBSs for 
known repressors (Table 5.2). A full description of the putative TFBSs present in these 
identified regions is found in Section III of this thesis, as well as their known role in 
skeletogenesis. 
 
5.4.4.2. Analysis of runx3-P2 constructs activity in the different cell lines 
The results obtained upon the transfection of the runx3-P2 promoter constructs in different 
cell lines show that this promoter is highly active and the expression patterns of the deletion 
constructs are similar in all cells tested (Figure 5.2B and 5.4B). We compared the relative 
expression of the deletion constructs in each line and identified the regulatory regions of the 
runx3-P2 promoter region in each cell context. These results are summarized in Table 5.1B. 
Overall, we identified two positive regulatory regions [A1 (-1232 to -699) and A2 (-554 
to -474)] and one negative regulatory region [R1 (-3930 to -1232) in runx3-P2 promoter 
(Figure 5.2B and 5.4B and Table 5.2B), A1 appearing to be a positive regulatory region in all 
cells tested (Figure 5.2B and 5.4B). The second positive regulatory region, A2, was observed 
in all cell lines tested with the exception of Neuro2a cells, but the effect was only significant 
in HEK293 and C6 cells (Figure 5.2B and 5.4B and Table 5.1B). On the other hand, the 
presence of a negative regulatory region R1 was only observed in the Neuro2a and C6 cells 
lines (Figure 5.4B and Table 5.1B). The highest activity of the runx3-P2 promoter was 
observed with the construct PP(-3930/-474)LuC in ATDC5 and U2OS cells, but no significant 
difference was observed compared to the activity of the PP(-1232/-474)LuC construct, and 
for the construct PP(-1232/-474)LuC in Neuro2a and C6 cells (Figure 5.4B and Table 5.1B). 
When the runx3-P2 promoter regulatory regions identified were analysed for the presence 
of conserved putative TFBSs, determined by promoter comparative analysis in Chapter III of 
this thesis, both A1 and R1 regions contained various conserved putative TFBSs. However, no 
putative TFBSs were detected in the region A2 (Table 5.1B). 
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Table 5.1A. Activating and repressing regions identified in runx3-P1 promoter in different cell lines. 
Cell line HEK293 ATDC5 U2OS Neuro2a C6 
Activating regions      
(A1) -5094 to -1766 Yes ns Yes Yes Yes 
(A2) -948 to -786 Yes Yes ns nd Yes 
Repressing regions      
(R1) -1766 to -948 Yes Yes ns 
-1766 to -478a 
Yes 
(R2) -662 to -559 Yes Yes ns Yes 
Construct showing 
higher activity  
PD(-948/-662)LuC PD(-948/-662)LuC PD(-5094/-17)LuC PD(-478/-17)LuC PD(-948/-662)LuC 
a Deletion constructs of the region -1766 to -786 were not determined, so a smaller region could not be determined. ns – not 
significant. nd – not determined. 
 
Table 5.1B. Activating and repressing regions identified in runx3-P2 promoter in different cell lines. 
Cell line HEK293 ATDC5 U2OS Neuro2a C6 
Activating regions      
(A1) -1232 to -699 ns Yes Yes nd Yes 
(A2) -554 to -474 Yes ns ns ns Yes 
Repressing region      
(R1) -3930 to -1232 nsa ns ns Yes Yes 
Construct showing 
higher activity  
PP(-3930/-474)LuC 
PP(-1232/-474)LuC 
PP(-855/-554)LuC 
b 
PP(-3930/-474)LuC 
PP(-1232/-474)LuC 
b 
PP(-3930/-474)LuC 
PP(-1232/-474)LuC 
b 
PP(-1232/-474)LuC 
PP(-1232/-474)LuC 
PP(-855/-554)LuC 
b 
a not significant for this region, but significant for the region -3930 to -855. ns – not significant. nd – not determined. b The 
activity between the constructs is not statistically different. 
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Table 5.2. Identification of the putative TFBSs, obtained by promoter comparative analysis, in the predicted regulatory regions 
of runx3-P1 and runx3-P2 promoters.  
Activating regulatory regions Repressing regulatory regions 
runx3-P1 promoter region 
-5094 to -1766 (Region A1) -948 to -786 (Region A2) -1766 to -948 (Region R1) -662 to -559 (Region R2) 
(Blocks 1 to 8)
a
 
V$OCT1; O$PTBP; V$ZF35; V$RUSH; 
V$RU49; V$ZF03; V$HASF; V$SMAD; 
V$TCFF; V$CSEN; O$INRE; V$PAX6; 
V$AP1R; V$HAND; V$MYOD; 
V$SORY; V$NKXH; V$BRN5; 
V$HOXF; V$YY1F; V$BRNF; V$ABDB; 
V$SF1F; V$LTFM; V$RBP2 
(Block 14)
a
 
V$BRN5; V$SORY; V$BRNF; 
V$CLOX; V$GATA; V$HAND; 
V$HOMF; V$EBOX; V$HIFF; 
V$MYOD; V$HESF; V$MITF; 
V$NKXH; V$SREB; V$CAAT; 
V$NEUR; V$KLFS; O$INRE; 
V$CARE; V$SAL2; V$MIZ1 
(Blocks 9 to 13)
a
 
V$FKHD; V$NFAT; V$ABDB; 
V$BRNF; V$CDXF; V$ZF35; V$ARID; 
O$VTBP; V$SATB; V$HAML; 
V$NFKB; V$ZFHX; V$ZF08; V$SAL2; 
V$CEBP; V$OCT1; V$PAX6; 
V$BRAC; V$HASF; V$RUSH; V$CIZF; 
V$CHRF 
(Blocks 17 and 18)
a
 
V$STAT; V$XBBF; V$CEBP; V$RBPF; 
V$IKRS; V$MZF1; V$MYT1; V$ZF03; 
V$ZFHX; V$TCFF 
    
runx3-P2 promoter region 
-1232 to -699 (Region A1) -554 to -474 (Region A2) -3930 to -1232 (Region R1) 
(Block 8)a 
V$CART; V$HOMF; V$MEF2; 
V$ABDB; V$LHXF; O$PTBP; V$BRNF; 
V$CHRF; V$CLOX; V$FKHD; V$HOXC; 
O$VTBP; V$STAB 
No conserved Blocks in this 
regiona 
(Blocks 1 to 7)a 
O$VTBP; V$CDXF; V$PARF; V$FKHD; V$BRNF; V$HOMF; V$PAXH; V$RUSH;  
V$CHRF; V$ARID; V$MYBL; V$XBBF; V$OSRF; V$CSEN; V$KLFS; V$TALE; 
V$AP2F; V$HAND; V$MYOD; V$EBOX; V$HESF; V$E2FF; V$ZF5F; O$TF2B; 
V$CART; V$CREB; V$HIFF; V$LHXF; V$NKXH; V$PAX3; V$SIX3; V$HOBX; 
V$HOXF; V$PAX6; V$SATB; V$BCDF; V$DLXF; V$PIT1; V$NKX6; V$PAXH; 
V$HOXC; V$ABDB; V$OCT1; V$ZF35; O$INRE; V$TCFF; V$SATB; V$SAL1 
V$CAAT; V$TATA; V$SP1; 
V$AP1; V$CEBP 
b 
a Blocks and TFBSs conserved between zebrafish and fugu runx3 promoters (Described in chapter III of this thesis). b TFBSs 
identified in zebrafish runx3 promoter by MATCH software from TRANSFAC. 
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5.4.5 Tools for in vivo temporal and spatial analysis of zebrafish runx3 gene expression 
Although in vitro assays using cultured cell lines are powerful tools for promoter analysis and 
identification of regulatory regions, these systems have the disadvantage of poorly 
replicating the complex in vivo micro-environment. For this reason, we attempted to analyse 
the expression of runx3-P1 and -P2 promoters in vivo, by co-injecting into 1-cell stage 
zebrafish embryos the runx3-P1 [PD(-5094/-17):EGFP] and runx3-P2 [PP(-3930/-554):EGFP] 
constructs together with the transposase mRNA. The transposase enzyme is essential for 
successful delivery of the transposon transgene into the host genome after DNA-mRNA 
co-microinjection (Kawakami, 2007) and GFP expression reveals the expression pattern 
associated with each specific promoter fragment (Figure 5.5). 
Although the P0 generation will be transgenic chimaeras, we expected to observe the 
tissue-specific expression of GFP. As shown in Figure 5.5, transient runx3-P2 transgenic 
embryos show GFP expression in a variety of tissues. At 1 dpf, we could detect GFP 
expression driven by runx3-P2 promoter in retinal neuroepithelial cells in the eye, otic 
epithelium (ot), cranial ganglia (cg) as well as migrating cranial neural crest (arrow in B), in 
cells within the heart (ht) (Figure 5.5A and 5.5B) and in the trunk, with GFP expression being 
detected in migratory neural crest cells (mNCCs) (Figure 5.5C). At 2 dpf the embryos showed 
GFP expression in a small fraction of retinal neuroepithelial cells in the eye, cells within the 
heart (ht) and non-neural cells in the brain (Figure 5.5D and 5.5E), in the Rohon-Beard cell 
(arrow), Schwann cells of the spinal nerves (arrowhead) and of the dorsal branch of the 
posterior lateral line nerve (plln), and expression in the muscle cells (Figure 5.5F). At 3 dpf 
GFP expression could still be detected in cells within the heart (Figure 5.5G), in the 
trigeminal ganglion (arrowhead) and in the optic vesicle (arrow) (Figure 5.5H), in growth 
cone of the nearby Rohon-Beard neuron (arrow) (Figure 5.5I), and in interneurons (Figure 
5.5J and 5.5K). The same pattern of expression was observed when another runx3-P2 
construct [PP(-1232/-474):EGFP] was injected (data not shown). 
Even after several attempts injecting different concentrations of the runx3-P1 construct and 
mRNA transposase, the transient transgenic embryos just occasionally showed some green 
positive cells (Figure 5.5L-P). Since this is a transient analysis we would not expect to see all 
runx3-P1 derived positive cells labelled, however the few green positive cells detected were 
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not consistent comparing the multiple transient embryos, so we asked if this construct was 
working. To verify its functionality, we transfected A6 cell line with the runx3-P1 construct, 
and the runx3-P2 construct and the pEGFP-N1 vector as controls, and observed GFP 
expression 24 hours after transfection. We could detect GFP expressing cells in all three 
samples tested, confirming that the constructs are driving GFP expression (Figure 5.S4). 
The results of the transient transgenesis indicate that the tool works (at least for the 
runx3-P2 construct), but stable transgenic lines are needed to have unambiguous results and 
to be able to analyse in detail the GFP expression pattern under control of the runx3 
promoter during development. In order to make stable transgenic lines from each runx3-P1 
and runx3-P2 promoter constructs, the injected embryos (F0) were screen for GFP positive 
expressing cells and raised to sexual maturity. As few GFP positive cells were observed in the 
embryos injected with runx3-P1 construct, we raised all embryos injected that at 5 dpf were 
phenotypically normal. Then they were outcrossed with WT fish and the progeny (F1) 
screened for GFP expression. Despite the fact that the Tol2 system has been extensively 
used to create transgenic zebrafish lines and is reported to result in an integration ratio of 
50-70%, unfortunately we failed to find F1 transgenic fish expressing GFP driven by the runx3 
promoter fragments in a pattern similar to that of the endogenous runx3 gene. In total, from 
118 F0 embryos of runx3-P1 and 84 F0 embryos of runx3-P2 that were raised just 61 and 47, 
respectively, survived to adulthood. Up to the time of submission of this thesis, it was just 
possible to test 25 runx3-P1 and 18 runx3-P2 founders for the transgene integration. 
Analysing the progeny (F1) from the 25 runx3-P1, we found no embryos expressing GFP. On 
the other end, from the 18 runx3-P2 founders we found 3 that expressed GFP, but the 
expression pattern did not correspond to the expression of the endogenous runx3, as it was 
expressing GFP ubiquitously (data not shown). 
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Figure 5.5 Transient injected embryos express GFP under control of runx3 
PP(-3930/-554):EGFP promoter construct. Brightfield and fluorescent images of living 
zebrafish embryos directed by (L-P) runx3 PD(-5094/-17):EGFP and (A-K) runx3 PP(-
3930/-554):EGFP promoter constructs. (A-C, L) 1 dpf embryos; (D-F, M-N) 2 dpf embryos; (G-
K, O-P) 3 dpf embryos. (A, B) confocal projection of the head of a 1 dpf embryo showing GFP 
expression in retinal neuroepithelial cells in the eye, otic epithelium (ot), cranial ganglia (cg) 
as well as migrating cranial neural crest (arrow in B) and in cells within the heart (ht). (C) 
confocal projection of the anterior trunk of a 1 dpf embryo showing GFP expression in 
migratory neural crest cells (mNCCs). (D, E) image of the head of a 2 dpf embryo showing 
GFP expression in a small fraction of retinal neuroepithelial cells in the eye, cells within the 
heart (ht) and cells in the brain. (F) confocal projection of the trunk of a 2 dpf embryo 
showing GFP expression in the Rohon-Beard cell (arrow), Schwann cells of the spinal nerves 
(arrowhead) and of the dorsal branch of the posterior lateral line nerve (plln), and 
expression in the muscle cells. At 3 dpf GFP expression can still be detected in (G) the cells 
within the heart, (H) in the trigeminal ganglion (arrowhead) and optic vesicle (arrow), (I) in 
growth cone of the nearby Rohon-Beard neuron (arrow), and (J, K) in interneurons. (L-P) The 
runx3-P1 transgenic embryos generally showed little or no GFP fluorescence. Note that 
signals in N and P are auto-reflection of iridophores. All are ventral images, dorsal is up and 
anterior is to the left. All panels contain fluorescent images from live embryos, overlaid on 
DIC images in (A’-F’, G’, I’-K’, P’) to show embryonic context for (A-F, G, I-K, P). Images were 
obtained using a Zeiss LSM710 confocal microscope and an Olympus IX81 fluorescence 
microscope coupled with a F-view II camera (Olympus). dpf - days post-fertilization. 
 
5.4 Discussion 
RUNX3 belongs to the family of Runt domain transcription factors, that also includes RUNX1 
and RUNX2 and, as the name indicates, all three members share a conserved region of 128 
amino acid termed the Runt domain, also conserved throughout evolution (Levanon and 
Groner, 2004). This region has been shown to associate with a broad range of proteins that 
can either be co-activators or repressors to direct biological outcomes in a context-
dependent manner (reviewed in Downing, 1999). Although all three RUNX proteins bind and 
recognize the same DNA sequence, and even if in some tissues its expression overlaps, they 
have been shown to have a tissue-specific expression pattern, indicating a tight regulation as 
they are involved in different biological functions. RUNX3 is the less studied of the three 
member of the RUNX family, and although in the last years it was extensively investigated 
for its capacity to regulate transcription of a variety of target genes, data related to 
transcriptional regulation of RUNX3 itself are scarce. However, the little information 
available shows that RUNX3 promoter activity is regulated by its family RUNX members 
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(Drissi et al., 2000; Spender et al., 2005). Similar to what is described for other species, in 
zebrafish three splice variants of runx3 were identified, derived from two alternative 
promoters, and encoding two protein isoforms, Runx3-MASN and Runx3-MHIPV (Kataoka et 
al, 2000). But since there are few functional studies, it is still unclear how each isoform is 
regulated and the relative importance of the different isoforms remains unknown. We 
combined in silico, in vitro and in vivo analysis to gain insights into the regulation of the 
zebrafish runx3 gene 5’ flanking regions.  
Since the primary regulatory elements of many genes are encoded in proximal sequences 
upstream of the transcriptional start site and in the 5’ UTR region, our first analysis focused 
on the regulatory regions located 1 kb upstream the translating starting codons of the 
zebrafish runx3 gene. The in silico analysis using the MATCH software, that uses a library of 
positional weight matrices from TRANSFACR Public 6.0, predicted in each promoter several 
cis-elements described as important for transcriptional activity. Both promoters contain two 
CAAT boxes in the proximity of the TSSs located in runx3-P1 at positions -476 and -587 bp 
and in runx3-P2 at positions -634 and -665 bp upstream the translation start codon (Figure 
5.1A and 5.1B), in agreement to what has been described for other species, where no TATA 
box was detected, but a consensus CAAT box was predicted (Bangsow et al, 2001; Ng et al, 
2007; Nah et al, 2014). However, in the zebrafish runx3-P2 promoter region a TATA box was 
predicted at a consensus distance from the P2-TSS (position -43 bp), and it would be 
interesting to see if this TATA box is functional, which could indicate a divergence in the 
regulation of this gene. It has been shown that 65% of the human genes contain TATA-less 
promoters and only the remaining 35% contain a minimal canonical TATA box (3.6%), or 
have a TATA box with one or two mismatch (4.7% and 27%, respectively) (Moshonov et al, 
2008). Promoters that lack a TATA box can still direct transcription initiation from a specific 
nucleotide, but this feature has been associated with genes with multiple transcription 
initiation start sites (Moshonov et al., 2008), a characteristic of all Runx genes, including the 
zebrafish runx3. Two TSSs were reported for zebrafish runx3-P1 transcripts located at 
positions -130 and -460 bp (Kataoka et al, 2000) and we identified one more located at 
position -641 (chapter II of this thesis) from the start codon (Figure 5.1A). Furthermore, 
genes with TATA-less promoters that are regulated by CAAT boxes are usually housekeeping 
genes (Dynan and Tjian, 1985; Roy and Lee, 1995). Our in silico analysis failed to predict an 
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Sp1 binding site, which is usually associated with TATA-less promoters, in the runx3-P1 
promoter analysed, but one Sp1 binding site was predicted in runx3-P2 region located at 
position -88 upstream the P2 TSS, in the proximity of the TATA and CAAT boxes (Figure 5.1A 
and 5.1B). Several other TFBSs were predicted in the 1 kb upstream region of each zebrafish 
runx3 promoter, such as Ap1, Ikaros, C-Ets, C/ebp, Nf-y, Runx, Nfat, Nkx, Sry, FoxD3, MyoD, 
among others (Figure 5.1 and data not shown). 
One interesting feature of the Runx3 promoter regions is the identification of two very well 
conserved putative RUNX binding sites in the proximal region of the P1 promoter that are 
present in all Runx genes. This conservation has been seen not only among the different 
Runx genes, but also through evolution (Drissi et al, 2000; Bangsow et al, 2001; Nah et al, 
2014). Our in silico analysis (Figure 5.1A) indicate initially the presence of five putative Runx 
binding sites in the runx3-P1 proximal promoter region, but from those, only two were still 
detected after our comparative analysis with the fugu runx3-P1 region (Table 3.1, in the 
chapter III of this thesis). Although zebrafish and fugu runx3-P1 proximal upstream regions 
still retain two conserved putative Runx binding sites, that feature is slightly different to 
what has been seen in mammals, where these sequences are located in tandem separated 
only by three nucleotides. However, a comparative analysis between 1 kb of the zebrafish 
and human runx3-P1 upstream regions show that at least one putative RUNX binding site is 
still conserved between the two species (Figure 5.S5), suggesting  a similar regulation by 
Runx transcription factors as observed for the other species.  
To the best of our knowledge, so far there have been no studies in the transcriptional 
regulation of zebrafish runx3 isoforms. In this study, we cloned 5 kb and 4 kb from the 
translation start codon of 5’ upstream regions of the zebrafish Runx3-MASN and 
Runx3-MHIPV isoforms, respectively, and performed in vitro analysis by transfection into 
different cell lines and in vivo analysis by microinjection into zebrafish embryos, to test if 
these putative promoter regions are transcriptionally functional. We confirmed that both 
fragments are active both in vitro (Figure 5.2, 5.4 and Figure 5.S3) and in vivo (Figure 5.S1). 
So, in order to identify regulatory regions in both promoters, we performed functional in 
vitro analysis by transfection of different cell lines from different origins with various 
deletion promoter constructs (Figure 5.2 and 5.4). This analysis confirmed that both 
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promoter constructs are functional in all cells tested, with P2-promoter constructs being 
more highly expressed than the P1- constructs when compared to the promoter-less control 
vector (Figure 5.2 and 5.4). Combining the transfection results from all cell lines tested, it 
was possible to identify multiple regulatory regions in runx3-P1 and runx3-P2 promoters 
(Figure 5.2 and 5.4 and Table 5.1). In the 5 kb region of runx3-P1 promoter region tested, we 
identified four regions, two potential activating regions [(A1) from -5094 to -1766 and (A2) 
from -948 to -786] and two potential repressing regions [(R1) from -1766 to -948 and (R2) 
from -662 to -559] (Figure 5.2A and 5.4A and Table 5.1A). It was also observed that the 
PD(-948/-662)LuC construct, that comprises the potential activating region A2 of runx3-P1 
promoter, gave the highest relative expression in all cells tested, except in the U2OS cell line 
(this construct was not tested in Neuro2a cell line; Figure 5.2A and 5.4A and Table 5.1A). 
Various putative TFBSs described as important regulators of transcriptional activity of 
promoters are detected in this regions (e.g. CAAT-box (V$CAAT), E-box (V$EBOX), Inre 
(O$INRE), Sal2 (V$SAL2), Miz1 (V$MIZ1); Table 5.2). In the 4 kb region of runx3-P2 promoter 
tested, two activating regulatory regions [(A1) from -1232 to -699 and (A2) from -554 
to -474] and one repressing regulatory region [(R1) from -3693 to -1232] were observed 
(Figure 5.2B and 5.4B and Table 5.1B). We observed that, besides these regions, none of the 
constructs used showed significant differences of relative expression between each other in 
all the cell lines tested, with the exception of the construct PP(-1232/-713)LuC that showed 
low activity in all cells tested (Figure 5.2B and 5.4B and Table 5.1B). Interestingly, those 
potential activating/repressing regions identified in our study both in runx3-P1 and P2 
promoters contain putative TFBSs, such as Creb (family V$CREB), Mitf ((family V$MITF), 
Brn3a (family V$BRNF), Rbp-j (family V$RBPF), Scl/Tal1 (family V$HAND), Stat (family 
V$STAT) and Runx (family V$HAML; Table 5.2), described in the literature as regulating the 
RUNX3 gene and also identified by us in our in silico analysis (Chapter III of these thesis). 
Our in vitro analysis also allowed us to identify the essential regions for the runx3 promoter 
basal activity. For the runx3-P1 promoter, the essential region to drive basal activity is 
between -701 and -17, as the deletion of this region in PD(-5094/-701)LuC construct 
completely abolished the expression of luciferase to the level of the promoter-less control 
vector (Figure 5.2A and 5.4A). Although, our in silico analysis predicted two putative CAAT 
box in this region, our in vitro assays indicated that probably these CAAT boxes are not 
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essential to drive the runx3-P1 promoter activity, since deletion of both CAAT boxes in the 
construct PD(-786/-662)LuC did not prevent activation of luciferase expression at levels 
significantly higher than the promoter-less vector (Figure 5.2A and 5.4A). This hypothesis 
was confirmed in the cathepsin L gene by Jean and co-workers (2006) that have 
demonstrated that the CCAAT motif and GC boxes were not directly involved in the 
regulation of the high promoter activity observed in melanoma cells (Jean et al, 2006). More 
experiments will be needed to define exactly the region responsible for the basal activity of 
this promoter. Regarding the runx3-P2 promoter, we observed that the region from -713 
to -554 is essential to drive basal activity, as deletion of that region in the construct 
PP(-1232/-713)LuC abolished the promoter activity (Figure 5.2B and 5.4B). Although our 
comparative analysis did not detect any conserved blocks between zebrafish and fugu in the 
-950 bp region upstream the start codon, our in silico analysis on the zebrafish runx3-P2 
promoter region predicted various putative TFBSs known as important regulators of 
transcription in this region (e.g. TATA box, CAAT boxes, Sp1, Ap1 and C/ebp) (Figure 5.1B). It 
would be interesting to further analyse if the identified TATA box is responsible for the basal 
activity of this promoter as, so far, no TATA box has been identified in runx3 promoters in 
other species. Overall, these results indicate that the identified regions contain transcription 
factors or enhancer binding sites important for runx3 transcription, confirming the identity 
of the regions of runx3-P1 and P2 promoters important for basal transcription and providing 
a first basis to correlate expression of distinct Runx3 variants with specific transcription 
factors affecting P1 or P2 promoter activity. 
As described above, all runx genes have two conserved Runx binding sites in its P1 promoter 
region, a feature also observed in zebrafish runx3-P1 promoter region (Figure 5.1 and Table 
5.2). Furthermore, it has been confirmed in mammals that RUNX promoters are indeed 
cross-regulated by RUNX proteins (Brady el al, 2009; Levanon and Groner, 2004; Spender et 
al, 2005). In addition, both P1 and P2 promoters of RUNX genes have been shown to contain 
several dispersed putative RUNX binding sites (Ghozi et al, 1996; Ducy et al, 1999; Drissi et 
al, 2000; Bangsow et al, 2001; Otto et al, 2003). Based on those studies and on our in silico 
analysis of zebrafish runx3 promoter regions, (Figure 5.1, Table 5.1 and Chapter III of this 
thesis), we have evaluated both (i) the possible cross-regulation of zebrafish runx3 
promoters by Runx2 isoforms; (ii) the putative auto-regulation of runx3 promoter by its own 
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isoforms; and (iii) if the Cbfβ co-regulator positively enhances that regulation, as shown for a 
variety of Runx target genes (Miller et al, 2002). The co-transfection analyses were 
performed in HEK293 cells, as these cells do not express any of the RUNX family members 
(Zheng et al, 2007; Bone et al, 2010), so the interference by endogenous RUNX proteins is 
eliminated. Our co-transfection results indicate that both zebrafish runx3-P1 and -P2 
promoter fragments tested are regulated by at least one of the Runx2/3 isoforms (Figure 
5.3). For runx3-P1 promoter only the Runx3-MASN isoform, in the presence of Cbfβ, induced 
a significant repression of the promoter activity, providing evidence that at least one of the 
Runx putative TFBSs is functional (Figure 5.3A). For runx3-P2 promoter a significant effect 
was observed following co-transfection with all Runx2 and Runx3 isoforms in the presence of 
the Cbfβ co-activator partner (except with the Runx3-MHIPV isoform, where an effect was 
observed only in the absence of Cbfβ) (Figure 5.3B) also indicating the functionality of at 
least one Runx binding site. However, further experiments are needed since these results 
represent only two independent experiments. Also, these experiments needs to be 
optimized as the co-transfection of runx3-P1 with the empty pCMX vector showed a 
significant decrease in the promoter activity (Figure 5.3A).  
Finally, we have evaluated in vivo the expression pattern of each zebrafish runx3 promoter. 
We have microinjected into zebrafish embryos the runx3-P1 construct PD(-5094/-17):EGFP 
and the runx3-P2 construct PP(-3930/-554):EGFP and evaluated their expression pattern by 
analysing the EGFP expression in transient transgenics (Figure 5.5). The transient in vivo 
analysis showed that the runx3-P2 fragment used to drive the EGFP expression reproduce, in 
part, the expression pattern observed for the endogenous runx3 by RNA in situ hybridization 
(chapter II of this thesis; Kataoka et al, 2000; Kalev‐zylinska et al, 2003).  
Although the analysis of the transient embryos should be done in more detail to identify the 
exact cells expressing the EGFP, we tried to identify these cells by its location and 
morphology. The runx3-P2 promoter fragment induces EFGP expression in retinal 
neuroepithelial cells in the eye, otic epithelium, cranial ganglia, Rohon-Beard cells, Schwann 
cells of the spinal nerves and of the dorsal branch of the posterior lateral line nerve (plln), 
and migratory Neural Crest cells (Figure 5.5), a profile of expression similar to the 
endogenous runx3 expression pattern (chapter II of this thesis). The expression in cells 
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within the heart and in muscle, need further confirmation. Our in vitro analysis showed that 
runx3-P2 is highly active in all cells tested, suggesting the presence of an enhancer region 
promoting expression in a variety of tissues. Accordingly, we have previously shown by runx3 
isoform-specific qPCR that runx3-P2 transcripts are expressed in all zebrafish tissues tested 
(chapter II of this thesis).  
Regarding the transient in vivo analysis in embryos injected with the runx3-P1 construct, few 
or no cells were detected expressing GFP (Figure 5.5). This may indicate that (i) this 
construct possible lacks an important enhancer to be able to drive its expression up to 
detectable levels of EGFP in vivo, or (ii) this promoter fragment is driving EGFP expression in 
a very strict tissue-specific way, and the method used to visualise the GFP expression was 
not sensitive enough to detect positive cells.  
In conclusion, we performed an extensive analysis of the runx3-P1 and runx3-P2 upstream 
regions, identifying for each runx3 promoter the region responsible for its basal activity. 
Furthermore, we identified different putative positive and negative regulatory regions for 
this gene and a variety of putative TFBSs that can be responsible for the regulation of those 
regulatory regions. We showed that the Runx2 and Runx3 isoforms are involved in the 
regulation of both runx3 promoter regions and that this regulation can be enhanced by their 
co-operation with Cbfβ, although these results need to be confirmed. We also confirmed 
that the runx3-P2 major fragment is functionally active in vivo, and drives expression of 
EGFP, recapitulating at least partially, the endogenous runx3 expression pattern. On the 
other hand, we did not detect EGFP expression using the runx3-P1 major fragment. 
Nonetheless, we cannot exclude the possibility that this fragment drives EGFP in a 
tissue-specific way in a very small subset of cells that were not detected in our transient 
analysis, which is usually mosaic. This result is in agreement with (i) our in vitro assays, 
where this promoter region showed, in general, a low activity, (ii) our mRNA in situ 
hybridization studies where we could not detect any signal when a riboprobe specific for P1-
derived transcripts was used (chapter II of this thesis). For this reason, the generation of 
stable zebrafish transgenic lines is an essential tool to clearly identify sites of expression. This 
experiment is ongoing.  
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5.5 Supplementary Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.S1 Both runx3-P1 and runx3-P2 luciferase promoter constructs are functional in 
vivo. Relative luciferase activity obtained by microinjection of runx3 promoter constructs 
into 1-cell stage zebrafish embryos. Firefly and renilla luciferase activities were measured 24 
hours post injection. n≥4. 
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Figure 5.S2 Qualitative analysis of Runx3 amplification by RT-PCR in different cell lines shows 
that Runx3 is expressed in all cells tested, except in HEK293 cell line. Xenopus Actin and 
mouse, rat and human GAPDH were used as control (Ct) for sample integrity. Rx3 means 
Runx3. The right side of the gel corresponds to the negative controls (no cDNA). M 
corresponds to the marker (Thermo Scientific GeneRuler 100bp Plus DNA Ladder). Xl – 
Xenopus laevis; Rn – Rattus norvegicus; Mm – Mus musculus. 
 
 
 
Figure 5.S3 Basal activity of zebrafish runx3-P1 and runx3-P2 promoter regions in various 
runx3 expressing cells. Mouse chondrogenic ATDC5, human osteosarcoma U2OS, human 
neuroblastoma Neuro2a and rat glioma C6 cell lines were transiently transfected with 
runx3-P1 [PD(-5094/-17)] and runx3-P2 [PP(-3930/-474)] promoter constructs. The 
promoter-less pGL3-Basic vector was used as control and significance (*) compared to the 
baseline was determined by One Way ANOVA followed by Tukey’s test. All samples were 
tested in duplicates at least three times. *P<0.05; **P<0.01; ***P<0.001.  
 
 
 
 Chapter 5 
202 
 
 
 
 
 
 
 
Figure 5.S4 Transfection of runx3-P1 and runx3-P2 promoter constructs driving EGFP results 
is GFP expressing cells. A6 cells were transfected with runx3-P1 [PD(-5094/-17):EGFP] and 
runx3-P2 [PP(-3930/-554):EGFP] promoter constructs and analysed for GFP expression 24 
hours post-transfection under an inverted fluorescence microscope (Olympus IX81 
fluorescence microscope coupled with an F-view II camera). Arrows indicates cells 
expressing GFP. 
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zebrafish    a g a g t t t g t g   t a t g a g c t g t   a t g t t t t t g t   g g t c c c c T C T   T C A A G A A G G T 
human    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - T C T   T C T A A A A G G C 
                                           * * *  * * * * * * * * * * 
 
zebrafish    C C C A T C A T C t   t c t g g g a a a c   t c t t c a a a c a   C C A G C C A t g g   g c c a a t c a g a 
human    C G T G A C A T C a   c g g c c c a g g t   g a c c g c g g c -   C C A G C C A a t g   a g c c a a g g c c 
   * * * * * * * * *                         * * * * * * *               
 
zebrafish    t g a g t g a g a a   a g g - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - C A C T G G G A 
human    g c g a g c a g g c   t t c t c g c a t c   c t g t g a g c t g   a g g t t g g g t t   g a C A C T G G G A 
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zebrafish    A G a a a a g g a g   a a c t t g a a t g   c a t g c a a g c g   a g g g a g a g a g   a g a a c g t c a t 
human    A G g c c t g g t c   c c t c a a c c a c   a g a a c c a c a a   g g c c a g g c c c   t t g c c g c c t c 
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zebrafish    g t g a c t g g a g   t t c c a c c t a t   c a g a t c a t g g   g a t t g g c g a g   c a g c a g t g a t 
human    c a g g g c c c t g   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - g - c c c 
                                                         
 
zebrafish    a c C G C G G G A G   C T G t g a c c t c   g - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
human    t g C G C G G G A G   C T G g t t g g c t   c c t g g t g c t c   c c c a c c c c c g   g c c g c c c t c g 
     * * * * * * * *  * * *                                         
zebrafish    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
human    t a c c c a c c a g   a g c c t g g g c t   c t g t c a a g g g   t a a g c c t c a t   t c a t t c a t t c 
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zebrafish    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - G A T A C C 
human    c c c g t g g c a c   t g g a g g c g g c   c c a c t c t g c t   c t g t c a g c t t   c g g a G C T C C T 
                                                   * * * * * * 
 
zebrafish    T C A G A C A T G C   G A C T G A C A G G   C C T T T A C C A C   g g t g a t c a c c   a c t g t a a g a g 
human    C C A C C C T G G C   T G C C G A A A G C   C C C T T C C C G C   c a t c t a a t g a   t a c a c t - - - - 
   * * * * * * * * * *  * * * * * * * * * *  * * * * * * * * * *                       
 
zebrafish    c g t c a g a c a c   c t g a c a t t t c   a a c t c t c t g a   c t g a a g g c a c   g t a g a c t c t a 
human    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
                                                         
 
zebrafish    C A G C A A C C A C   T T C T G G A G A G   A g a g a g a c g c   a c a g a a g t g t   c c a t c t a c a a 
human    C T G C A T A C G C   T T C T G T T G A G   A a t - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
   * * * * * * * * * *  * * * * * * * * * *  *                                
 
zebrafish    a g g t g a g t c c   a t t t c t a t g a   g a c t t a g t g c   t g t c c t c a c t   t t g n n n n n n n 
human    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
                                                         
 
zebrafish    n n n n n n n n n n   n n n n n n n n n n   n n n n n n n g c t   c g c t c t c a c c   a c a c g g c a c a 
human    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
                                                         
 
                                                        
zebrafish    t a t g c t g t t c   t g t t a g t c g g   c T T G T G G C G A   A A G A T T C C T G   T G G C A C t c t c 
human    - - - - - - - - - -   - - - - - - - - - -   - T T G T G G C T A   G A C A T T C C T G   T G G G A C c g g g 
                          * * * * * * * * *  * * * * * * * * * *  * * * * * *     
zebrafish    a a a c c C C A A A   T T C T T G G T T G   C A g g c t g t c t   a t g t a g t t t c   t g - - - - - T A T 
human    a a t - - C C A A A   T T C T T G G G T A   C A a a c a g a a a   c t t a c t t t c c   t t g g g g a T T T 
        * * * * *  * * * * * * * * * *  * *                            * * * 
zebrafish    T T C T C T T T C T   C C G A C T G T C A   T T C T C T C A G G   C t g a a g a c g g   t a c g a c g g c g 
human    T T T T C T C T C T   C T C A C T C A C A   C A C A C T C T C G   C g t t c t t t c c   t t t t t t c t t t 
   * * * * * * * * * *  * * * * * * * * * *  * * * * * * * * * *  *                     
zebrafish    g a g a g g c c a g   c t c t t t t c c -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
human    t t c g t a g c a g   c a g g g g g g n n   n n n n n n n n n n   n n n n n n n n n n   n n n n n n n n n n 
                                                         
 
zebrafish    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
human    n n n n n g c a a c   a c c c c c c c c t   t t t a t t t t c a   a a a g t a g c t a   g a g g a a a a a a 
                                                         
 
zebrafish    - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - -   - - - - - - - - - - 
human    a a a t a a a a c a   a c a g c c a a c c   a a g t g a a t c c   c a a c c c a a c c   c c c t g a a g g g 
                                                         
 
zebrafish    - - - - - - - - - -   - - - - - - - C T T   C A G A G C G G G A   C A c a t g                
human    c t g a a a a t t c   t c g c c t t C T T   C A G A G C G G G G   C A t g - -                
                     * * *  * * * * * * * * * *  * *                    
                 
Figure 5.S5. TFBS families detected by DiAlignTF software that are conserved in the 
alignment of the runx3-P1 promoter regions between zebrafish and human. The list of the 
TFBSs obtained by DiAlignTF and the alignment showing the TFBSs conserved is represented. 
The colour code for each specific TFBS is shown above the alignment. 
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5.6 Supplementary Tables 
 
Table 5.S1 PCR primers used to amplify the zebrafish runx3 promoter regions. 
Sense primers Primer sequence (5’ to 3’)# 
GWZfRunx3_F1 ATCCATCCATTCATTCACCCATCCATCC 
DrRunx3PD_F2 TGGCTGTCCAGGGGAGAGGGCTCTGAGC 
DrRunx3PP_F4 TTTCAGGGCTTCTCATTGGCCACGT 
DrRunx3PD_KpnI_F1 CCGGAGGGTACCATAGGCCGGCCGCAACCATGTCAAAC 
DrRunx3PD_KpnI_F2 CCGGAGGGTACCCCCCAAAACCACCAAAACACACTCG 
DrRunx3PD_KpnI_F3 CCGGAGGGTACCGGATTGGCGAGCAGCAGTGATACCG 
DrRunx3PD_KpnI_F5 AGGGTACCTTTGGAAAAAGTCAGAAAAGTGGGGGTG 
Runx3_PPF1_KpnI CCGGAGGGTACCTATTTTGTCTGTGGTTTTAAAGGTT 
DrRunx3PPKpnI_F3 AGGGTACCGCGACTGTAACCGTAGAAACTGCG 
  
Antisense primers Primer sequence (5’ to 3’)# 
GWZfRunx3_R1 GCGGTATCACTGCTGCTCGCCAATCCCA 
GWZfRunx3_R3 GTCAAGCGTTCTTTCCAAATGAATGCGTAA 
GWZfRunx3_R4 GCGAGTTCCCCACTGACTTTAGCCACACAC 
GWZfRunx3_R5 CCCAGTGCCTTTCTCACTCATCTGATTG 
DrRunx3II&III_R2 CGCAGCAAACTGGGCGAGTAGCTAGAGA 
DrRunx3_R4 CGTCTGCTCGTGCTCGGGTCT 
DrRunx3PD_XhoI_R1 CACGCCTCGAGGGAAAAGAGCTGGCCTCTCCGC 
DrRunx3PD_XhoI_R2 CACGCCTCGAGGCTCATACACAAACTCTTGAGTAAA 
DrRunx3PD_XhoI_R5 GCCTCGAGATGAAGGATAGCTGAGGATTATTAGGGA 
Runx3IntExR1_XhoI CACGCCTCGAGCGCGAACGCCGCGCTCTGCACTCT 
Runx3PP_R1_XhoI CACGCCTCGAGGAGTCCTCGTGAAAAGCTCGGGCA 
  
Universal primers Primer sequence (5’ to 3’) 
Adaptor Primer 1 (AP1) GTAATACGACTCACTATAGGGC 
Adaptor Primer 2 (AP2) ACTATAGGGCACGCGTGGT 
pGL3_FW2 TAGCAAAATAGGCTGTCCCC 
oligo(dT)‐adapter primer ACGCGTCGACCTCGAGATCGATGTTTTTTTTTTTTT 
# indicates the recognition sequence for the restriction enzyme named on the primer. 
 
 
 
 
 
 
 
 
 Chapter 5 
205 
 
 
Table 5.S2 Genes and respective set of primers used for the RT-PCR performed in the cell lines. 
Cell line Specie Gene Primers Primer sequence (5’ to 3’) 
A6 
Xenopus 
laevis 
Runx3 
XlRunx3_F CTGCGGAAAGATGGGAGAGAACAACG 
XlRunx3_R TGGGACGGCAGAACTGAGCACAA 
Actin 
xAct_F ATGCTCCCCGTGCTGTTTTCCCATCTAT 
xAct_R TTCTGGTGCCACTCGCAGTTCATTGTAG 
HEK293 
Homo 
sapiens 
Runx3 
MmRunx3_F CACAATCACCGTGTTCACCAACCCTA# 
MmRunx3_R GGCCTTGGTCTGGTCTTCTATCTTCTGC# 
GAPDH 
Hs_GAPDH_F TCAACGGATTTGGTCGTATTGGGCG 
Hs_GAPDH_R CTCGCTCCTGGAAGATGGTGATGGG 
Neuro2a 
Mus 
musculus 
Runx3 
MmRunx3_F CACAATCACCGTGTTCACCAACCCTA 
MmRunx3_R GGCCTTGGTCTGGTCTTCTATCTTCTGC 
GAPDH 
MmGAPDH_F CCTTCCGTGTTCCTACCCCCAATGT 
MmGAPDH_R AGTGTAGCCCAAGATGCCCTTCAGT 
C6 
Rattus 
norvegicus 
Runx3 
MmRunx3_F CACAATCACCGTGTTCACCAACCCTA# 
MmRunx3_R GGCCTTGGTCTGGTCTTCTATCTTCTGC# 
GAPDH 
RnGAPDH_F CGGCAAGTTCAACGGCACAGTCAAG 
RnGAPDH_R GAAGACGCCAGTAGACTCCACGACAT 
# The mouse primers were used as the sequences are very similar. The different nucleotides are 
underlined. GAPDH - glyceraldehydes-3-phosphate dehydrogenase.  
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6.1 General conclusions and future perspectives 
The RUNX family of transcription factors has been extensively studied over the last years, 
due to the involvement of its members in a variety of biological processes and diseases, and 
each have been shown to be regulated by two alternative promoters (P1 and P2) that 
generate different transcript variants; these are also subject to alternative splicing events 
generating multiple RUNX protein isoforms (Coffman, 2003; Komori, 2005; Cohen, 2009; 
Wang et al, 2010; Chuang et al, 2013; among others).  
In an attempt to clone the runx3 open reading frames (ORFs), we identified and cloned 
multiple transcript variants. Besides the three different transcripts previously described for 
zebrafish runx3 (Kataoka et al, 2000), we have cloned 10 additional variants obtained by 
alternative splicing. From the new variants cloned, four are P1-derived (isoforms 2 to 5) and 
six are P2-derived (isoforms 7 to 12). Although this study focused only on the analysis of the 
two major Runx3 variants, it would be interesting to further analyse if the different protein 
isoforms generated by the splicing variants are functional, since some isoforms lack certain 
domains but contain others. This may suggest that these isoforms have additional functions 
different from those previously described, such as dominant negative or constitutively active 
proteins. This hypothesis is supported by the findings of Runx1 C-terminal deletion mutants 
in mouse and grass carp, which lack one or more domains, and have been shown to have 
different transactivation potentials and different roles in biological processes (Tanaka et al, 
1995; Kawazu et al, 2005; Yao et al, 2014). For example, in mouse, one variant that lacks the 
TAD acts as a natural negative isoform repressing the function of the non-mutated form of 
Runx1 (Tanaka et al, 1995). The existence of several alternatively spliced isoforms has been 
shown to increase cellular and functional complexity in many species, due to the different 
functions of the splicing variants (Reviewed in Kelemen et al, 2013). We also observed two 
alternatively spliced runx3-P1 5’ UTR variants (isoforms 13 and 14). Both runx3-P1 and 
runx3-P2 5’ UTR regions contain multiple upstream ATG triplets that may generate several 
putative upstream ORFs (uORFs) that vary drastically in size. These features highlight the 
complexity of both the molecular structure and the regulatory mechanism of the runx3 
gene. The functional significance of runx3 regulatory regions has not been elucidated, but 
different authors have tested the functionality of the uORFs and have shown that their 
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presence is implicated in the regulation of the translation of the main ORF (van der Velden 
and Thomas, 1999; Wang and Rothnagel, 2004) and that the size of these uORFs can affect 
differently the translation of the protein, with longer uORFs having a stronger effect in 
preventing ribosome reinitiation (Kozak, 2001).  
We then investigated the expression patterns of the runx3-P1 and runx3-P2 derived variants 
by qPCR in different stages of zebrafish development and in different adult tissues, 
concluding that both variants are differentially expressed. The runx3-P2 variant seems to be 
ubiquitously expressed and zygotically specific, in contrast to the runx3-P1 variant that is 
maternally expressed and continues to be expressed zygotically, but its expression seem to 
be tissue-specific.  
To identify the spatial-temporal expression of the runx3 transcripts we performed ISH at 
different zebrafish embryonic developmental stages, using RNA specific probes that detect i) 
the common region of all variants, and ii) specifically the 5’ UTR of each variant. Our results 
with a probe targeting the common 3’ region of the transcripts confirmed the runx3 
expression pattern in neural and cartilaginous tissues as previously reported (Kataoka et al, 
2000; Burns et al, 2002; Kalev-Zylinkska et al, 2003; Flores et al, 2006), although we could 
not detect expression in hematopoietic tissues as observed in a previous report (Kalev-
Zylinkska et al, 2003). The zebrafish runx3 expression patterns seem to be conserved 
thoughout evolution, since the expression of Runx3 in hematopoietic, neural and 
cartilagineous tissues was also observed in other lower vertebrates, such as the xenopus 
(Park and Saint-Jeannet, 2010), and in higher vertebrates, such as the mouse (Levanon et al, 
2001). However, our ISH results using isoform specific probes were not conclusive about the 
isoform specific expression patterns and their sensitivity needs to be improved, using for 
example more powerful tools that would allow us to amplify the hybridisation signal and 
decrease the background. For this, multiple transcript detection by RNAscope technology, a 
new ISH technique recently optimized for zebrafish (Wang et al, 2012), could be a great tool 
to help us determine the exact cells where each variant is expressed.  
Our preliminary results of the functional analysis targeting the Runx3 isoforms using 
translational morpholinos, together with results published by other groups, strongly suggest 
that each isoform has a different function that is cell-type specific. Morpholinos have been 
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extensively used in zebrafish to study the effects of the knockdown of a gene, but recently 
some authors have shown that sometimes morpholinos results do not completely reproduce 
the knockout results (Eisen and Smith, 2008; Kok et al, 2015). This, plus the unexpected 
nature of some of the defects we have observed, raised clear questions over the validity of 
the preliminary morpholino data we obtained. Since we performed those experiments, a 
new knockout technique was developed (the CRISPR-Cas9 system) and shown to be a simple 
and highly efficient method to mutate a gene of interest (Hwang et al, 2013a; 2013b; Xiao et 
al, 2013; Jao et al, 2013; among others). The CRISPR-Cas9 system requires the co-expression 
of a target-specific RNA (CRISPR-guide RNA) to recognize the endogenous target and a Cas9 
protein that unwinds the DNA duplex and cleaves both strands. Thus, this novel technique 
provides a method that could be readily applied to target the endogenous runx3 locus and 
test our morpholino results to determine the resulting phenotype of each isoform knockout. 
All three RUNX proteins bind and recognize the same DNA sequence, and while in some 
tissues their expression overlaps, they have all been shown to have distinct tissue-specific 
expression patterns, indicating that their regulation must be tightly controlled. RUNX3 has 
been extensively investigated in the last years for its capacity to regulate transcription of a 
variety of target genes, however, data related to transcriptional regulation of RUNX3 itself 
remains scarce. To gain insight into the regulatory mechanism of the runx3 gene, an in silico 
comparative analyses of the runx3-P1 and runx3-P2 promoter regions was performed, 
identifying numerous regions in each promoter that contain putative TFBSs that may serve 
as targets for sequence-specific enhancer/silencer transcription factors likely to contribute 
to regulation of the runx3 transcription. Our in silico analysis successfully predicted binding 
sites for TFs already known from work in mammals as transcriptional regulators of Runx3, 
but also predicted novel TFs potentially with a role in runx3 regulation. We then cloned 
these promoter regions and tested their transcriptional activity, confirming that both regions 
are functionally active in vitro and in vivo. Together, those results allowed us to define 
positive and negative regulatory regions in both runx3 promoters, and identify the putative 
TFBSs in those regions predicted by our in silico analysis, providing a powerful tool to guide 
future dissection of runx3 transcriptional regulation in vitro and/or in vivo. 
One interesting feature of the RUNX3 promoter regions is the identification of two 
evolutionarily conserved putative Runx binding sites in the proximal region of the P1 
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promoter that are present in all Runx genes (Drissi et al, 2000; Bangsow et al, 2001; Nah et 
al, 2014). CBFβ is known to heterodimerize with all Runx family members and enhance their 
transcriptional regulatory effect upon target genes. In this study, we cloned and 
characterized 10 novel zebrafish cbfβ isoforms, which are generated by alternative splicing, 
and structural conservation during evolution from fish to mammals was confirmed by a 
comparative analysis between zebrafish cbfβ gene and protein and its orthologs in different 
species. The expression of four of the cbfβ splicing variants (isoforms 1 to 4) was analysed by 
RT-PCR in different zebrafish developmental stages and in adult tissues showing that cbfβ is 
widely expressed, being detected in all samples analysed. However, our data demonstrate 
that cbfβ isoforms 1 and 2 are maternally expressed, but not isoforms 3 and 4, suggesting 
variances in the biological function of Cbfβ splice variants. The transcriptional activity of 
these four cbfβ splicing isoforms that differ in the presence or absence of the exons 5a and 
5b, was evaluated by luciferase reporter assay, using a fragment of the zebrafish collagen 
type Xα1 promoter previously shown to be regulated by Runx2-MASN isoform (Simões et al, 
2006). The results showed that zebrafish Cbfβ isoforms carrying the exon 5b (isoforms 1 and 
2) have a higher capacity to promoteinduction of ColX promoter by Runx2-MASN isoform, 
compared to the isoforms lacking exon 5b (isoforms 3 and 4). Although we confirmed by 
immunoprecipitation the direct interaction of Runx2 with Cbfβ isoforms, further 
experiments are needed to clarify the biological importance of these findings. For example, 
mass spectrometry (MS) can be used for each evaluated isoform (1-4) in order to conclude if 
these different amino acids in the C-terminal region can be interacting with different 
co-activators involved in the transcription complex. For this, specific oligos are tagged, 
anneled and incubated with cell nuclear extracts. Then, the binding mixture is coupled to 
magnetic beads to alow for efficient affinity pull-down of the putative binding proteins. After 
purification, the sample containing the DNA binding proteins from the cell nuclear extract is 
digested, usually with trypsin, and the resulting product is analysed by MS for protein 
identification. 
Our comparative in silico analysis predicted putative RUNX binding sites in both runx3-P1 
and runx3-P2 promoter regions and in vitro co-transfection analysis with Runx2 and Runx3 
isoforms showed that both runx3 promoter regions tested are regulated by at least one of 
the Runx2/3 isoforms. Furthermore, this regulation is further enhanced by the presence of 
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the co-factor Cbfβ. These results showed that zebrafish runx3 promoter regions are cross-
and auto-regulated by Runx2 and Runx3 isoforms, respectively, and indicate the 
functionality of at least one Runx TFBS predicted in both regions. Further work should be 
done, for example using deletion mutants of the promoters regions, to identify the region 
responsible for the Runx binding. Then by site-directed mutagenesis, it would be possible to 
mutate the Runx binding site and confirm the exact location responsible of the binding. 
Chromatin immunoprecipitation (ChIP) assays could also be used to investigate the 
interaction between the Runx2/3 and runx3 promoter regions in the cell. 
In conclusion, in this work we developed new molecular tools and described new findings 
that contribute to better understand the complex regulation and function of the zebrafish 
runx3 gene. Although more work needs to be performed to clarify the specific function and 
contribution of each Runx3 isoform to the embryonic development, important progress has 
been made. 
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